Phone (USA) +1 212-348-5610
Whatsapp: +1 516-336-9307
WeChat: chembuyersguide
Chemical Search
 


























Toronto Research Chemicals




Country: Canada

Toronto Research Chemicals
20 Martin Ross Avenue, North York, ON,
Canada, M3J 2K8.


Phone: (800) 727-9240
Phone 2: (416) 665-9696
FAX: (416) 665-4439
E-Mail:E-Mail this Supplier


http://www.trc-canada.com/

Toronto Research Chemicals, TRC, was founded in 1982 by Dr. David Dime to manufacture and supply researchers in the biomedical fields with specialized complex organic small molecules that were not commercially available. In 1983, the company was incorporated in Ontario as Toronto Research Chemicals Inc. It was initially located at the University of Toronto. As the business expanded, larger facilities were required to accommodate the growth.

Today, Toronto Research Chemicals Inc. employs about 250 full time staff, of which approximately 140 are PHD's, operating in a 65,000 square foot facility. TRC, currently manufactures and distributes in excess of 95,000 products to more than 95 countries. In addition, TRC has also acquired Synfine Research, in Richmond Hill, Canada with 22,000 square feet of manufacturing space as well as full analytical capabilities including an ISO 9001 registration.

Why Choose Toronto Research Chemicals?

  • specialize in providing high quality bio-chemicals in custom pack sizes to satisfy any quantity required.
  • distribute to companies worldwide, usually, providing overnight delivery in North America via Federal Express. We also offer alternative carrier options to meet worldwide delivery and special import requirements.
  • a dedicated professional customer service team positioned to ensure customer satisfaction and technical support.
  • provide special pricing for customers interested in bulk quantities.
  • provide custom synthesis- if the product you need is not in our catalogue we can manufacture in a timely manner.
  • manufacture each of our complex organic chemicals in our 65,000 square foot "state-of-the-art" laboratory .
  • in-house department dedicated to handling controlled substance logistics requirements, import and export documentation, licensing, and regulatory affairs.

Product Line:

Today, TRC's product lines include unique highly specialized chemicals for drug development, medical, biopharmaceutical and biochemical research. Many of these compounds are proprietary and developed in our laboratories through an innovative research and development process. They include the following areas.

  • APIs, impurities and Metabolites
  • Stable isotope labeled analogues
  • Building blocks
  • Carbohydrates and Oligosaccharides
  • Nucleic acid derivatives
  • Glycosidase Inhibitors
  • Enzyme Activators and Inhibitors
  • Sulfhydryl active reagents
  • Fluorescent reagents and spin labels
  • Nicotine Derivatives
  • Neurochemicals
  • Environmental compounds Mutagens, and Metabolites
  • Phthalates
  • Retinoids
  • Vitamin D derivatives
  • Drugs of Abuse/ Forensics
  • Phosphates
  • Forensics; fentanyls, steroids, opiates, benzodiazepines, barbituates, canabinols, phenethylamines, phenecyclidines, methadones/analogues, ecgonines, tryptamines, JWH compounds.

Most products are available in their stable isotope labeled analogues


Product List: 378,587

PON:Page:1 |2 |3 |4 |5 |6 |7 |8 |9 |10 |11 |12 |13 |14 |15 |16 |17 |18 |19 |20 |21 |22 |23 |24 |25 |26 |27 |28 |29 |30 |31 |32 |33 |34 |35 |36 |37 |38 |39 |40 |41 |42 |43 |44 |45 |46 |47 |48 |49 |50 |51 |52 |53 |54 |55 |56 |57 |58 |59 |60 |61 |62 |63 |64 |65 |66 |67 |68 |69 |70 |71 |72 |73 |74 |75 |76 |77 |78 |79 |80 |81 |82 |83 |84 |85 |86 |87 |88 |89 |90 |91 |92 |93 |94 |95 |96 |97 |98 |99 |100 |101 |102 |103 |104 |105 |106 |107 |108 |109 |110 |111 |112 |113 |114 |115 |116 |117 |118 |119 |120 |121 |122 |123 |124 |125 |126 |127 |128 |129 |130 |131 |132 |133 |134 |135 |136 |137 |138 |139 |140 |141 |142 |143 |144 |145 |146 |147 |148 |149 |150 |151 |152 |153 |154 |155 |156 |157 |158 |159 |160 |161 |162 |163 |164 |165 |166 |167 |168 |169 |170 |171 |172 |173 |174 |175 |176 |177 |178 |179 |180 |181 |182 |183 |184 |185 |186 |187 |188 |189 |190 |191 |192 |193 |194 |195 |196 |197 |198 |199 |200 |201 |202 |203 |204 |205 |206 |207 |208 |209 |210 |211 |212 |213 |214 |215 |216 |217 |218 |219 |220 |221 |222 |223 |224 |225 |226 |227 |228 |229 |230 |231 |232 |233 |234 |235 |236 |237 |238 |239 |240 |241 |242 |243 |244 |245 |246 |247 |248 |249 |250 |251 |252 |253 |254 |255 |256 |257 |258 |259 |260 |261 |262 |263 |264 |265 |266 |267 |268 |269 |270 |271 |272 |273 |274 |275 |276 |277 |278 |279 |280 |281 |282 |283 |284 |285 |286 |287 |288 |289 |290 |291 |292 |293 |294 |295 |296 |297 |298 |299 |300 |301 |302 |303 |304 |305 |306 |307 |308 |309 |310 |311 |312 |313 |314 |315 |316 |317 |318 |319 |320 |321 |322 |323 |324 |325 |326 |327 |328 |329 |330 |331 |332 |333 |334 |335 |336 |337 |338 |339 |340 |341 |342 |343 |344 |345 |346 |347 |348 |349 |350 |351 |352 |353 |354 |355 |356 |357 |358 |359 |360 |361 |362 |363 |364 |365 |366 |367 |368 |369 |370 |371 |372 |373 |374 |375 |376 |377 |378 |


 


Product List

(((((((2R,3R,4S,5R)-5-(2-CHLORO-6-(CYCLOPENTYLAMINO)-9H-PURIN-9-YL)-4-FLUORO-3-HYDROXYTETRAHYDROFURAN-2-YL)METHOXY)(HYDROXY)PHOSPHORYL)METHYL)PHOSPHORYL)BIS(OXY))BIS(METHYLENE) DIISOPROPYL DICARBONATE
CAS:2105904-27-4
Formula: C26H39ClFN5O14P2
C587345
ClC1=NC(N([C@H]2[C@@H](F)[C@H](O)[C@@H](COP(CP(OCO
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(((((2R,3R,4S,5R)-5-(2-CHLORO-6-(CYCLOPENTYLAMINO)-9H-PURIN-9-YL)-4-FLUORO-3-HYDROXYTETRAHYDROFURAN-2-YL)METHOXY)(HYDROXY)PHOSPHORYL)METHYL)PHOSPHONIC ACID
CAS:2105903-93-1
Formula: C16H23ClFN5O8P2
C587343
ClC1=NC(N([C@H]2[C@@H](F)[C@H](O)[C@@H](COP(CP(O)(
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
((((1R,2R)-CYCLOPROPANE-1,2-DICARBONYL)BIS(AZANEDIYL))BIS(4,1-PHENYLENE))BIS(AMINOMETHANIMINIUM)
Formula: C19H22N6O2
C210615
O=C([C@H]1[C@H](C(NC2=CC=C(C(N)=[NH2+])C=C2)=O)C1)
((((R)-1-(6-((((5-FLUORO-1-((2R,5S)-2-(HYDROXYMETHYL)-1,3-OXATHIOLAN-5-YL)-2-OXO-1,2-DIHYDROPYRIMIDIN-4-YL)AMINO)METHYL)AMINO)-9H-PURIN-9-YL)PROPAN-2-YL)OXY)METHYL)PHOSPHONIC ACID
CAS:1962115-01-0
Formula: C18H24FN8O7PS
F532125
FC(C(NCNC1=C2C(N(CC(OCP(O)(O)=O)C)C=N2)=NC=N1)=N3)
Standards; Enzyme Activators and Inhibitors;
(((1-(2-AMINOTHIAZOL-4-YL)-2-(((2S)-1-CARBOXY-2-(SULFONATOAMINO)PROPYL)AMINO)-2-OXOETHYL)AMINO)OXY)-2-METHYLPROPANOATE
Formula: C13H21N5O9S2
A435850
NC1=NC(C(C(NC(C(O)=O)[C@@H](NS(=O)(O)=O)C)=O)NOC(C
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(((1-(2-AMINOTHIAZOL-4-YL)-2-(((2S)-1-CARBOXY-2-(SULFONATOAMINO)PROPYL)AMINO)-2-OXOETHYL)AMINO)OXY)-2-METHYLPROPANOATE DISODIUM SALT
Formula: C13H19N5Na2O9S2
A435853
NC1=NC(C(C(NC(C(O)=O)[C@@H](NS(=O)(O[Na])=O)C)=O)N
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(((2R)-2-METHYL-5-(PHENYLTHIO)TETRAHYDROFURAN-3,4-DIYL)BIS(OXY))BIS(TERT-BUTYLDIMETHYLSILANE)
Formula: C23H42O3SSi2
M344115
C[C@H]1OC(SC2=CC=CC=C2)C(O[Si](C)(C(C)(C)C)C)C1O[S
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(((3AS,5AR,8AR,8BS)-2,2,7,7-TETRAMETHYLTETRAHYDRO-3AH-BIS([1,3]DIOXOLO)[4,5-B:4',5'-D]PYRAN-3A-YL)METHYL)-L-ARGININE
Formula: C18H32N4O7
T934560
CC1(C)O[C@@H]2CO[C@]3(CN[C@@H](CCCNC(N)=N)C(O)=O)[
Building Blocks; Miscellaneous;
(((4-(((4-METHYLPYRIMIDIN-2-YL)AMINO)SULFONYL)PHENYL)AMINO)METHYLENE)METHANE-1,1-DICARBONITRILE
CAS:1024209-92-4
Formula: C15H12N6O2S
M169815
CC1=NC(=NC=C1)NS(=O)(=O)C2=CC=C(C=C2)NC=C(C#N)C#N
(((4-(2,2,2-TRIFLUORO-1-HYDROXY-1-(TRIFLUOROMETHYL)ETHYL)PHENYL)AMINO)METHYLENE)METHANE-1,1-DICARBONITRILE
CAS:1022735-10-9
Formula: C13H7F6N3O
T170425
C1=CC(=CC=C1C(C(F)(F)F)(C(F)(F)F)O)NC=C(C#N)C#N
(((4-(3-CHLORO-5-(TRIFLUOROMETHYL)-2-PYRIDYLTHIO)PHENYL)AMINO)METHYLENE)METHANE-1,1-DICARBONITRILE
CAS:1024414-83-2
Formula: C16H8ClF3N4S
C169980
C1=CC(=CC=C1NC=C(C#N)C#N)SC2=C(C=C(C=N2)C(F)(F)F)C
Building Blocks; Miscellaneous;
(((4-AMINO-9,10-DIOXOANTHRYL)AMINO)METHYLENE)METHANE-1,1-DICARBONITRILE
CAS:959583-38-1
Formula: C18H10N4O2
A012644
C1=CC=C2C(=C1)C(=O)C3=C(C=CC(=C3C2=O)NC=C(C#N)C#N)
Building Blocks; Miscellaneous;
(((7-METHYLOCTA-2,6-DIEN-1-YL)OXY)METHYL)BENZENE
Formula: C16H22O
M325320
Standards; Pharmaceutical/API Drug Impurities/Metabolites; Vitamin Derivatives;
(((METHYLAZANEDIYL)BIS(METHYLENE))BIS(4,1-PHENYLENE))DIBORONIC ACID
CAS:1704074-22-5
Formula: C15H19B2NO4
M123850
B(C1=CC=C(C=C1)CN(C)CC2=CC=C(C=C2)B(O)O)(O)O
((+/-)(1'A,2'A,3'SS,4'A)-2-AMINO-1,9-DIHYDRO-9-[2-FLUORO-3-HYDROXY-4-(HYDROXYMETHYL)CYCLOPENTYL]-6H-PURIN-6-ONE
CAS:110289-24-2
Formula: C11H14FN5O3
A468230
O=C1NC(N)=NC2=C1N=CN2[C@H]3C[C@H]([C@@H]([C@H]3F)O
Standards; Nucleic Acids; Pharmaceutical/API Drug Impurities/Metabolites; Anti-virals/Anti-retrovirals;
((1,3-DICHLOROPROPAN-2-YL)OXY)METHYL ACETATE
CAS:89281-73-2
Formula: C6H10Cl2O3
D074630
CC(=O)OCOC(CCl)CCl
((1,5-DICHLOROPENTAN-3-YL)SULFONYL)BENZENE
Formula: C11H14Cl2O2S
C281118
O=S(C1=CC=CC=C1)(C(CCCl)CCCl)=O
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
((1-BENZYL-1H-1,2,3-TRIAZOL-4-YL)METHYL)GLYCINE
CAS:1058159-07-1
Formula: C12H14N4O2
B150796
OC(=O)CNCC1=CN(N=N1)CC2=CC=CC=C2
Building Blocks; Miscellaneous;
((1-CHLORO-2-METHYLPROPAN-2-YL)OXY)TRIMETHYLSILANE
CAS:31557-15-0
Formula: C7H17ClOSi
C897545
ClCC(O[Si](C)(C)C)(C)C
Building Blocks; Miscellaneous;
((1-PHENYL-1H-1,2,3-TRIAZOL-4-YL)METHYL)GLYCINE
CAS:2097995-91-8
Formula: C11H12N4O2
P158011
OC(=O)CNCC1=CN(N=N1)C2=CC=CC=C2
Building Blocks; Miscellaneous;
((10S,11S)-8-CHLORO-11-((METHYLAMINO)METHYL)-10,11-DIHYDRODIBENZO[B,F]OXEPIN-10-YL)METHANOL
Formula: C17H18ClNO2
D356565
OC[C@H]1[C@H](CNC)C2=C(C=CC=C2)OC3=C1C=C(Cl)C=C3.O
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
((1H-1,2,3-TRIAZOL-4-YL)METHYL)GLYCINE HYDROCHLORIDE
CAS:2097995-88-3
Formula: C5H9ClN4O2
H159881
Cl.OC(=O)CNCC1N=NNC=1
Building Blocks; Miscellaneous;
((1H-TETRAZOL-1-YL)METHYL CARBONIC) ACETIC ANHYDRIDE CEFTEZOLE
Formula: C16H14N12O6S3
C544315
O=C(OC(OCN1N=NN=C1)=O)C2=C(CSC3=NN=CS3)CS[C@@]([C@
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
((1R,2R)-2-(2,3-DIHYDROBENZOFURAN-4-YL)CYCLOPROPYL)METHANAMINE
CAS:1400898-49-8
Formula: C12H15NO
D446970
NC[C@@H]1C[C@H]1C2=C3C(OCC3)=CC=C2
Building Blocks; Miscellaneous;
((1R,2S)-2-(BENZYLAMINO)CYCLOHEXYL)METHANOL
CAS:71581-92-5
Formula: C14H21NO
B411235
C1=CC=C(C=C1)CN[C@H]2CCCC[C@H]2CO
Building Blocks; Chiral Molecules;
((1R,2S,5R,6S)-5-(BENZOYLOXY)-1,2,6-TRIHYDROXYCYCLOHEX-3-EN-1-YL)METHYL BENZOATE
CAS:78804-17-8
Formula: C21H20O7
B288608
C1=CC=C(C=C1)C(=O)OC[C@]2([C@H](C=C[C@H]([C@@H]2O)
Standards; Natural Products;
((1R,3R)-3-AMINO-CYCLOPENTYL)-CARBAMIC ACID TERT-BUTYL ESTER
CAS:1009075-44-8
Formula: C10H20N2O2
A629425
O=S(CC1(CCC/2C1(C)C)C(C2=C/C3=CC=C(/C=C4C(C5(CS(=O
Building Blocks; Miscellaneous;
((1R,4R)-4-(((TERT-BUTYLDIMETHYLSILYL)OXY)METHYL)CYCLOHEXYL)METHANOL
Formula: C14H30O2Si
B691695
CC(C)(C)[Si](C)(C)OCC1CCC(CC1)CO
Building Blocks; Pharmaceutical/API Drug Impurities/Metabolites;
((1R,4R)-4-(2-AMINO-6-CHLORO-9H-PURIN-9-YL)CYCLOPENT-2-EN-1-YL)METHYL FORMATE
Formula: C12H12ClN5O2
A616335
ClC1=NC(N)=NC2=C1N=CN2[C@H]3C=C[C@H](COC([H])=O)C3
Standards; Pharmaceutical/API Drug Impurities/Metabolites; Environmental Standards, Mutagens and Metabolites;
((1R,4S)-4-(2-AMINO-6-CHLORO-9H-PURIN-9-YL)CYCLOPENT-2-EN-1-YL)METHYL FORMATE
Formula: C12H12ClN5O2
A616330
ClC1=C(N=CN2[C@H]3C[C@@H](COC([H])=O)C=C3)C2=NC(N)
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
((1R,4S)-4-AMINOCYCLOPENT-2-EN-1-YL)METHANOL HYDROCHLORIDE
CAS:287717-44-6
Formula: C6H11NO • HCl
A604500
N[C@H]1C=C[C@H](CO)C1.Cl
Standards; Anti-virals/Anti-retrovirals;
((1R,5R,6S)-5-ACETOXY-6-(BENZOYLOXY)-3-(ETHOXYCARBONYL)CYCLOHEX-2-EN-1-YL)PHOSPHONIC ACID DISODIUM SALT
Formula: C18H19Na2O9P
A897605
O=C(OCC)C1=C[C@@H](P(O[Na])(O[Na])=O)[C@@H](OC(C2=
Research Tools; Molecular Biology;
((1S,2S)-2-(DIETHYLCARBAMOYL)-2-PHENYLCYCLOPROPYL)METHYL ACETATE
Formula: C17H23NO3
D443930
CC(OC[C@H]1C[C@@]1(C(N(CC)CC)=O)C2=CC=CC=C2)=O
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
((1S,2S)-2-(HYDROXYMETHYL)CYCLOHEXYL)METHYL METHANESULFONATE
Formula: C9H18O4S
H955149
OC[C@H]1CCCC[C@@H]1COS(=O)(C)=O
Building Blocks; Miscellaneous; Pharmaceutical/API Drug Impurities/Metabolites;
((1S,2S,3S,4R,5S)-2,3,4-TRIS(BENZYLOXY)-5-(4-CHLORO-3-((2,3-DIHYDROBENZO[B][1,4]DIOXIN-6-YL)METHYL)PHENYL)-6,8-DIOXABICYCLO[3.2.1]OCTAN-1-YL)METHANOL
CAS:2241491-76-7
Formula: C43H41ClO8
B010200
OC[C@]1(O2)CO[C@]2(C3=CC=C(Cl)C(CC4=CC(OCCO5)=C5C=
Standards; Enzyme Activators and Inhibitors; Pharmaceutical/API Drug Impurities/Metabolites;
((1S,2S,5R)-2-ISOPROPYL-5-METHYLCYCLOHEXYL)-DIPHENYLPHOSPHINE
CAS:43077-29-8
Formula: C22H29P
S077505
C[C@@H]1CC[C@H]([C@H](C1)P(C2=CC=CC=C2)C3=CC=CC=C3
((1S,3S,4S)-3-BROMO-7,7-DIMETHYL-2-OXOBICYCLO[2.2.1]HEPTAN-1-YL)METHANESULFONIC ACID HYDRATE
CAS:209736-59-4
Formula: C10H14BrO4S
B997510
CC1([C@@H]2CC[C@]1(C(=O)[C@H]2Br)CS(=O)(=O)O)C.O
Building Blocks; Miscellaneous;
((1S,4R)-4-(2-AMINO-6-(((1R,4S)-4-(HYDROXYMETHYL)CYCLOPENT-2-EN-1-YL)AMINO)-9H-PURIN-9-YL)CYCLOPENT-2-EN-1-YL)METHANOL
Formula: C17H22N6O2
A612540
NC1=NC2=C(N=CN2[C@H]3C=C[C@@H](CO)C3)C(N[C@@H]4C[C
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
((1S,5R,6S)-5-(BENZOYLOXY)-1,6-DIHYDROXY-2-OXOCYCLOHEX-3-EN-1-YL)METHYL BENZOATE
CAS:193410-84-3
Formula: C21H18O7
S079480
C1=CC=C(C=C1)C(=O)OC[C@@]2([C@H]([C@@H](C=CC2=O)OC
((2,2-DIETHOXYETHOXY)METHYL)BENZENE
CAS:42783-78-8
Formula: C13H20O3
D442038
CCOC(COCC1=CC=CC=C1)OCC
Building Blocks; Miscellaneous;
((2,2-DIMETHOXYETHOXY)METHYL)BENZENE
CAS:127657-97-0
Formula: C11H16O3
D472535
COC(COCC1=CC=CC=C1)OC
Building Blocks; Miscellaneous;
((2,3,5,6-TETRAMETHYLPHENYL)SULFONYL)ALANINE
CAS:1009671-00-4
Formula: C13H19NO4S
T302960
CC1=CC(=C(C)C(=C1C)S(=O)(=O)NC(C)C(=O)O)C
Building Blocks; Miscellaneous;
((2,3,5,6-TETRAMETHYLPHENYL)SULFONYL)GLYCINE
CAS:379250-94-9
Formula: C12H17NO4S
T303268
CC1=CC(C)=C(C)C(S(=O)(NCC(O)=O)=O)=C1C
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
((2,3,5,6-TETRAMETHYLPHENYL)SULFONYL)PHENYLALANINE
CAS:381687-95-2
Formula: C19H23NO4S
T207401
C1=CC=C(C=C1)CC(C(O)=O)NS(=O)(=O)C2=C(C)C(C)=CC(C)
Building Blocks; Miscellaneous;
((2,3,5,6-TETRAMETHYLPHENYL)SULFONYL)VALINE
CAS:1009595-18-9
Formula: C15H23NO4S
T303000
CC1=CC(=C(C(=C1C)S(=O)(=O)N[C@@H](C(C)C)C(=O)O)C)C
Building Blocks; Miscellaneous;
((2,5-DICHLOROPHENYL)AMINO)-N-(2-INDOL-3-YLETHYL)FORMAMIDE
CAS:1023819-24-0
Formula: C17H15Cl2N3O
D171235
C1=CC=C2C(=C1)C(=CN2)CCNC(=O)NC3=C(C=CC(=C3)Cl)Cl
Building Blocks; Miscellaneous;
((2,5-DICHLOROPHENYL)SULFONYL)(2,2-DIMETHOXYETHYL)AMINE
CAS:1024392-23-1
Formula: C10H13Cl2NO4S
D170740
COC(CNS(=O)(=O)C1=C(C=CC(=C1)Cl)Cl)OC
Building Blocks; Miscellaneous;
((2,5-DICHLOROPHENYL)SULFONYL)(2-MORPHOLIN-4-YLETHYL)AMINE
CAS:349403-14-1
Formula: C12H16Cl2N2O3S
D170725
C1COCCN1CCNS(=O)(=O)C2=C(C=CC(=C2)Cl)Cl
Building Blocks; Miscellaneous;
((2,5-DICHLOROPHENYL)SULFONYL)(4-FLUORO-3-(TRIFLUOROMETHYL)PHENYL)AMINE
CAS:497060-37-4
Formula: C13H7Cl2F4NO2S
D170705
C1=CC(=C(C=C1NS(=O)(=O)C2=C(C=CC(=C2)Cl)Cl)C(F)(F)
Building Blocks; Miscellaneous;
((2,5-DICHLOROPHENYL)SULFONYL)-2-PYRIDYLAMINE
CAS:314051-88-2
Formula: C11H8Cl2N2O2S
D170715
C1=CC=NC(=C1)NS(=O)(=O)C2=C(C=CC(=C2)Cl)Cl
Building Blocks; Miscellaneous;
((2,5-DIMETHYLPHENYL)SULFONYL)ALANINE
CAS:1103980-04-6
Formula: C11H15NO4S
D208151
OC(=O)C(C)NS(=O)(=O)C1C(C)=CC=C(C)C=1
Building Blocks; Miscellaneous;
((2,5-DIMETHYLPHENYL)SULFONYL)LEUCINE
CAS:1009793-82-1
Formula: C14H21NO4S
B416770
CC(C)CC(C(=O)O)NS(=O)(=O)C1=C(C)C=CC(=C1)C
Building Blocks; Miscellaneous;
((2,5-DIMETHYLPHENYL)SULFONYL)METHIONINE
CAS:1008965-15-8
Formula: C13H19NO4S2
B416768
CC1=CC(=C(C)C=C1)S(=O)(=O)NC(CCSC)C(=O)O
Building Blocks; Miscellaneous;
((2,5-DIMETHYLPHENYL)SULFONYL)PHENYLALANINE
CAS:1449133-74-7
Formula: C17H19NO4S
B421163
CC1=CC(=C(C)C=C1)S(=O)(=O)NC(CC2=CC=CC=C2)C(=O)O
Building Blocks; Miscellaneous;
((2,6-DICHLOROPHENYL)SULFONYL)ALANINE
CAS:1008050-81-4
Formula: C9H9NO4SCL2
B420090
CC(C(=O)O)NS(=O)(=O)C1=C(C=CC=C1Cl)Cl
Building Blocks; Miscellaneous;
((2,6-DICHLOROPHENYL)SULFONYL)GLYCINE
CAS:19818-06-5
Formula: C8H7SNO4Cl2
D484558
ClC1=CC=CC(Cl)=C1S(=O)(NCC(O)=O)=O
Research Tools; Molecular Biology; Amino Acids/Peptides;
((2,6-DICHLOROPHENYL)SULFONYL)LEUCINE
CAS:1009003-67-1
Formula: C12H15NO4SCl2
B420343
CC(C)CC(C(=O)O)NS(=O)(=O)C1=C(C=CC=C1Cl)Cl
Building Blocks; Miscellaneous;
((2,6-DICHLOROPHENYL)SULFONYL)METHIONINE
CAS:1009262-71-8
Formula: C11H13NO4S2Cl2
B420098
CSCCC(C(=O)O)NS(=O)(=O)C1=C(C=CC=C1Cl)Cl
Building Blocks; Miscellaneous;
((2,6-DICHLOROPHENYL)SULFONYL)PHENYLALANINE
CAS:1008423-33-3
Formula: C15H13NO4SCl2
B420333
C1=CC=C(C=C1)CC(C(=O)O)NS(=O)(=O)C2=C(C=CC=C2Cl)Cl
Building Blocks; Miscellaneous;
((2,6-DICHLOROPHENYL)SULFONYL)VALINE
CAS:1008267-76-2
Formula: C11H13NO4SCl2
B420553
CC(C)C(C(=O)O)NS(=O)(=O)C1=C(C=CC=C1Cl)Cl
Building Blocks; Miscellaneous;
((2,6-DIFLUOROPHENYL)SULFONYL)GLYCINE
CAS:731003-82-0
Formula: C8H7NO4F2S
D459188
FC1=CC=CC(F)=C1S(=O)(NCC(O)=O)=O
Building Blocks; Amino Acids; Miscellaneous;
((2-(DIMETHYLAMINO)ETHYL)AMINO)-N-(4-(((2-(DIMETHYLAMINO)ETHYL)AMINO)CARBONYLAMINO)PHENYL)FORMAMIDE
CAS:1024164-18-8
Formula: C16H28N6O2
D170410
CN(C)CCNC(=O)NC1=CC=C(C=C1)NC(=O)NCCN(C)C
Building Blocks; Miscellaneous;
((2-(TRIFLUOROMETHOXY)ETHOXY)METHYL)BENZENE
Formula: C10H11F3O2
T773260
FC(F)(F)OCCOCC1=CC=CC=C1
((2-AZIDOETHOXY)METHYL)BENZENE
CAS:66021-75-8
Formula: C9H11N3O
A193901
[N-]=[N+]=NCCOCC1=CC=CC=C1
Building Blocks; Miscellaneous;
((2-FLUOROPHENYL)SULFONYL)ALANINE
CAS:1008050-74-5
Formula: C9H10FNO4S
F202326
OC(=O)C(C)NS(=O)(=O)C1=C(F)C=CC=C1
Building Blocks; Miscellaneous;
((2-FLUOROPHENYL)SULFONYL)ALANINE
CAS:1212343-99-1
Formula: C9H10NO4FS
B437218
C[C@@H](C(=O)O)NS(=O)(=O)C1=CC=CC=C1F
Building Blocks; Chiral Molecules; Miscellaneous;
((2-FLUOROPHENYL)SULFONYL)LEUCINE
CAS:1041437-98-2
Formula: C12H16FNO4S
F202331
CC(C)CC(C(O)=O)NS(=O)(=O)C1=C(F)C=CC=C1
Building Blocks; Miscellaneous;
((2-FLUOROPHENYL)SULFONYL)PROLINE
CAS:1007962-28-8
Formula: C11H12FNO4S
F202336
OC(=O)C1N(CCC1)S(=O)(=O)C2=C(F)C=CC=C2
Building Blocks; Miscellaneous;
((2-FLUOROPHENYL)SULFONYL)VALINE
CAS:1009676-99-6
Formula: C11H14NO4FS
B437418
CC(C)C(C(=O)O)NS(=O)(=O)C1=CC=CC=C1F
Building Blocks; Miscellaneous;
((2-METHYLBUT-3-YN-2-YLOXY)METHYL)BENZENE
CAS:50420-73-0
Formula: C12H14O
M223470
CC(C)(C#C)OCC1=CC=CC=C1
Building Blocks; Miscellaneous;
((2R,3R,4R,5R)-3-(BENZOYLOXY)-4-FLUORO-5-(4-METHOXY-2-OXOPYRIMIDIN-1(2H)-YL)-4-METHYLTETRAHYDROFURAN-2-YL)METHYL BENZOATE
Formula: C25H23FN2O7
B208485
COC1=NC(N([C@@H]2O[C@H](COC(C3=CC=CC=C3)=O)[C@@H](
Standards; Pharmaceutical/API Drug Impurities/Metabolites; Anti-virals/Anti-retrovirals;
((2R,3R,4S)-3-ACETOXY-5-BROMO-4-FLUOROTETRAHYDROFURAN-2-YL)METHYL ACETATE
CAS:444586-87-2
Formula: C9H12BrFO5
R072890
CC(=O)OC[C@@H]1[C@H]([C@@H](C(O1)Br)F)OC(=O)C
((2R,3S)-3-((BENZYLOXY)METHYL)OXIRAN-2-YL)METHYL 4-NITROBENZOATE
CAS:78469-86-0
Formula: C18H17NO6
R077290
C1=CC=C(C=C1)COC[C@H]2[C@H](O2)COC(=O)C3=CC=C(C=C3
((2R,3S,4R)-3,4,5-TRIHYDROXYTETRAHYDROFURAN-2-YL)METHYL BARIUM PHOSPHATE
CAS:24325-23-3
Formula: C5H9BaO8P
T562145
O=[P]1(O[Ba]O1)OC[C@@H](OC(O)[C@@H]2O)[C@H]2O
Building Blocks; Miscellaneous;
((2R,3S,4R,5R)-5-(4-(BENZYLOXY)-2-OXOPYRIDIN-1(2H)-YL)-3,4-DIHYDROXYTETRAHYDROFURAN-2-YL)METHYL BIS(2-CYANOETHYL) PHOSPHATE
Formula: C23H26N3O9P
B571650
O=C1N([C@@H]2O[C@H](COP(OCCC#N)(OCCC#N)=O)[C@@H](O
Building Blocks; Nucleic Acid;
((2R,3S,4R,5R)-5-(4-(BENZYLOXY)-2-OXOPYRIDIN-1(2H)-YL)-3,4-DIHYDROXYTETRAHYDROFURAN-2-YL)METHYL DIHYDROGEN PHOSPHATE
Formula: C17H20NO9P
B571655
O=C1N([C@@H]2O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]2O)C
Building Blocks; Nucleic Acid;
((2R,3S,4R,5R)-5-(4-AMINO-2-OXO-1,3,5-TRIAZIN-1(2H)-YL)-3,4-DIHYDROXYTETRAHYDROFURAN-2-YL)METHYL FORMATE
Formula: C9H12N4O6
A619190
O[C@H]1[C@@H](O)[C@H](N2C=NC(N)=NC2=O)O[C@@H]1COC(
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
((2R,3S,4R,5R,6R)-5-ACETAMIDO-3,4-DIHYDROXY-6-((4-METHYL-2-OXO-2H-CHROMEN-7-YL)OXY)TETRAHYDRO-2H-PYRAN-2-YL)METHYL PYRIDIN-1(2H)-YL SULFATE
Formula: C23H26N2O11S
A172415
CC(C(C1=C2)=CC=C2O[C@@H]3[C@H](NC(C)=O)[C@@H](O)[C
Research Tools; Molecular Biology;
((2R,3S,4R,5R,6R)-5-ACETAMIDO-3,4-DIHYDROXY-6-(2-(TRIMETHYLSILYL)ETHOXY)TETRAHYDRO-2H-PYRAN-2-YL)METHYL 4-METHYLBENZENESULFONATE
Formula: C20H33NO8SSi
A854135
O[C@H]1[C@H](O)[C@@H](NC(C)=O)[C@H](OCC[Si](C)(C)C
Building Blocks; Carbohydrates; Miscellaneous;
((2R,3S,4R,5R,6S)-2-PROPIONATE DAPAGLIFLOZIN
Formula: C23H27ClO7
P703990
O[C@@H]1[C@@H](O)[C@H](C2=CC=C(Cl)C(CC3=CC=C(OCC)C
Standards; Enzyme Activators and Inhibitors; Pharmaceutical/API Drug Impurities/Metabolites;
((2R,3S,5R)-5-(5-(3-AMINOPROPYL)-2,4-DIOXO-3,4-DIHYDROPYRIMIDIN-1(2H)-YL)-3-HYDROXYTETRAHYDROFURAN-2-YL)METHYL TETRAHYDROGEN TRIPHOSPHATE
CAS:90015-82-0
Formula: C12H22N3O14P3
R071905
C1[C@@H]([C@H](O[C@H]1N2C=C(C(=O)NC2=O)CCCN)COP(=O
((2R,3S,5S)-5-(4-AMINO-2-OXO-1,3,5-TRIAZIN-1(2H)-YL)-3-HYDROXYTETRAHYDROFURAN-2-YL)METHYL 4-CHLOROBENZOATE
Formula: C15H15ClN4O5
A612495
ClC1=CC=C(C(OC[C@@H]2[C@@H](O)C[C@@H](N3C=NC(N)=NC
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
((2R,4R)-2-(CHLOROMETHYL)-2-(2,4-DICHLOROPHENYL)-1,3-DIOXOLAN-4-YL)METHYL 4-METHYLBENZENESULFONATE
Formula: C18H17Cl3O5S
C376660
ClC[C@@]1(C2=CC=C(Cl)C=C2Cl)O[C@@H](COS(C3=CC=C(C)
Building Blocks; Chiral Molecules;
((2R,4S)-2-(CHLOROMETHYL)-2-(2,4-DICHLOROPHENYL)-1,3-DIOXOLAN-4-YL)METHYL 4-METHYLBENZENESULFONATE
Formula: C18H17Cl3O5S
C376655
ClC[C@@]1(C2=CC=C(Cl)C=C2Cl)O[C@H](COS(C3=CC=C(C)C
Building Blocks; Chiral Molecules;
((2R,5R)-5-METHYLPIPERAZIN-2-YL)METHANOL HYDROCHLORIDE
CAS:1403898-63-4
Formula: C6H14N2O.HCl
M222108
C[C@@H]1CN[C@H](CN1)CO.Cl
Building Blocks; Miscellaneous;
((2R,5S)-5-(4-AMINO-5-FLUORO-2-OXOPYRIMIDIN-1(2H)-YL)-1,3-OXATHIOLAN-2-YL)METHYL HYDROGEN ((((R)-1-(6-AMINO-9H-PURIN-9-YL)PROPAN-2-YL)OXY)METHYL)PHOSPHONATE SODIUM SALT
Formula: C17H21FN8NaO6PS
A608480
NC1=C2C(N(C[C@@H](C)OCP(OC[C@@H]3O[C@H](N4C(N=C(N)
Standards; Enzyme Activators and Inhibitors;
((2R,5S,10AS,10BS)-10B-HYDROXY-5-ISOPROPYL-2-METHYL-3,6-DIOXOOCTAHYDRO-2H-OXAZOLO[3,2-A]PYRROLO[2,1-C]PYRAZIN-2-YL)CARBAMIC ACID BENZYL ESTER
Formula: C21H27N3O6
H946810
COc1c2c3[C@@]45C6(C[C@H]([C@](O)(C)C(C)(C)C)[C@](C
Building Blocks; Chiral Molecules;
((2R,5S,10AS,10BS)-5-BENZYL-8,10B-BIS(BENZYLOXY)-2-METHYL-3,6-DIOXOOCTAHYDRO-2H-OXAZOLO[3,2-A]PYRROLO[2,1-C]PYRAZIN-2-YL)CARBAMIC ACID BENZYL ESTER
Formula: C39H39N3O7
B287780
O=C1[C@H](CC2=CC=CC=C2)N3[C@](O[C@@](C)(NC(OCC4=CC
Building Blocks; Chiral Molecules; Pharmaceutical/API Drug Impurities/Metabolites;
((2R,6S)-4-BENZYL-6-(BENZYLOXYMETHYL)MORPHOLIN-2-YL)METHANOL
CAS:1093085-89-2
Formula: C20H25NO3
R701058
C1=CC=C(C=C1)CN2C[C@H](CO)O[C@@H](C2)COCC3=CC=CC=C
Building Blocks; Chiral Molecules;
((2S,3R)-3-(DIMETHYLAMINO)-2-HYDROXYPYRROLIDIN-1-YL)(4-(3-(DIMETHYLAMINO)PROPOXY)PHENYL)METHANONE
Formula: C18H29N3O3
D496033
CN(C)[C@@H]1CCN(C(C2=CC=C(OCCCN(C)C)C=C2)=O)[C@H]1
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
((2S,3R)-4-(4-(((((3R,3AS,6AR)-HEXAHYDROFURO[2,3-B]FURAN-3-YL)OXY)CARBONYL)AMINO)-N-ISOBUTYLPHENYLSULFONAMIDO)-3-HYDROXY-1-PHENYLBUTAN-2-YL)CARBAMIC ACID PHENYLMETHYL ESTER
Formula: C35H43N3O9S
H294840
O=S(C1=CC=C(NC(O[C@H]2CO[C@]3([H])[C@@]2([H])CCO3)
Building Blocks; Miscellaneous;
((2S,3R)-4-(METHOXYMETHOXY)-2,3-DIMETHYL-2,3-DIHYDROBENZOFURAN-3-YL)METHANOL
Formula: C13H18O4
M330658
C[C@H]1[C@@](C)(CO)C2=C(OCOC)C=CC=C2O1
Standards; Chiral Molecules; Pharmaceutical/API Drug Impurities/Metabolites;
((2S,3S)-3-((E)-6-((R)-3,3-DIMETHYLOXIRAN-2-YL)-4-METHYLHEX-3-EN-1-YL)-3-METHYLOXIRAN-2-YL)METHANOL
Formula: C15H26O3
D479508
CC(C)(O1)[C@H]1CC/C(C)=C/CC[C@](C)(O2)[C@@H]2CO
Standards; Miscellaneous;
((2S,3S)-3-((E)-6-((R)-3,3-DIMETHYLOXIRAN-2-YL)-4-METHYLHEX-3-EN-1-YL)-3-METHYLOXIRAN-2-YL)METHYL 4-NITROBENZOATE
Formula: C22H29NO6
D479523
CC(C)(O1)[C@H]1CC/C(C)=C/CC[C@](C)(O2)[C@@H]2COC(C
Standards; Miscellaneous;
((2S,3S,4R,5S)-4-FLUORO-3-HYDROXY-5-(5-METHYL-2,4-DIOXO-3,4-DIHYDROPYRIMIDIN-1(2H)-YL)TETRAHYDROFURAN-2-YL)METHYL BENZOATE
Formula: C17H17FN2O6
F597495
O[C@H]1[C@H](F)[C@H](N2C(NC(C(C)=C2)=O)=O)O[C@@H]1
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
((2S,4R)-2-(CHLOROMETHYL)-2-(2,4-DICHLOROPHENYL)-1,3-DIOXOLAN-4-YL)METHYL 4-METHYLBENZENESULFONATE
Formula: C18H17Cl3O5S
C376645
ClC[C@]1(C2=CC=C(Cl)C=C2Cl)O[C@@H](COS(C3=CC=C(C)C
Building Blocks; Chiral Molecules;
((2S,4S)-2-(CHLOROMETHYL)-2-(2,4-DICHLOROPHENYL)-1,3-DIOXOLAN-4-YL)METHYL 4-METHYLBENZENESULFONATE
Formula: C18H17Cl3O5S
C376665
ClC[C@]1(C2=CC=C(Cl)C=C2Cl)O[C@H](COS(C3=CC=C(C)C=
Building Blocks; Chiral Molecules;
((2S,4S)-4-FLUOROPYRROLIDIN-2-YL)METHANOL HYDROCHLORIDE
CAS:623583-08-4
Formula: C5H10NOF • HCl
F600298
C1[C@@H](CN[C@@H]1CO)F.Cl
Building Blocks; Chiral Molecules;
((2S,5R)-5-(4-AMINO-2-OXOPYRIMIDIN-1(2H)-YL)TETRAHYDROFURAN-2-YL)METHYL PHOSPHORODIAMIDATE
Formula: C9H16N5O4P
A619178
NC1=NC(N([C@H]2CC[C@@H](COP(N)(N)=O)O2)C=C1)=O
Standards; Miscellaneous;
((3'S)-1'-(TERT-BUTOXYCARBONYL)-2-OXO-[1,3'-BIPYRROLIDIN]-3-YL)TRIPHENYLPHOSPHONIUM BROMIDE
CAS:400045-51-4
Formula: C31H36BrN2O3P
S073230
CC(C)(C)OC(=O)N1CC[C@@H](C1)N2CCC(C2=O)[P+](C3=CC=
((3,4-DICHLOROPHENYL)AMINO)-N-(4-PYRIDYLCARBONYLAMINO)FORMAMIDE
CAS:304883-43-0
Formula: C13H10Cl2N4O2
D171230
C1=CC(=C(C=C1NC(=O)NNC(=O)C2=CC=NC=C2)Cl)Cl
Building Blocks; Miscellaneous;
((3,5-DICHLORO-4-(3-ISOPROPYL-4-METHOXYPHENOXY)-PHENYL)ETHYNYL)TRIMETHYLSILANE
CAS:525575-59-1
Formula: C21H24Cl2O2Si
D071510
CC(C)C1=C(C=CC(=C1)OC2=C(C=C(C=C2Cl)C#C[Si](C)(C)C
((3-(TERT-BUTOXY)CYCLOBUTOXY)METHYL)BENZENE
CAS:1803608-56-1
Formula: C15H22O2
B815410
CC(C)(C)OC1CC(C1)OCC2=CC=CC=C2
Building Blocks; Miscellaneous;
((3-(TRIFLUOROMETHYL)PHENYL)SULFONYL)ALANINE
CAS:250714-51-3
Formula: C10H10F3NO4S
T222091
OC(=O)C(C)NS(=O)(=O)C1=CC(=CC=C1)C(F)(F)F
Building Blocks; Miscellaneous;
((3-(TRIFLUOROMETHYL)PHENYL)SULFONYL)ALANINE
CAS:288266-54-6
Formula: C10H10NO4F3S
T901903
CC(C(=O)O)NS(=O)(=O)C1=CC=CC(=C1)C(F)(F)F
Research Tools; Molecular Biology; Amino Acids/Peptides;
((3-(TRIFLUOROMETHYL)PHENYL)SULFONYL)LEUCINE
CAS:251097-65-1
Formula: C13H16NO4F3S
T222096
CC(C)CC(C(O)=O)NS(=O)(=O)C1C=C(C=CC=1)C(F)(F)F
Building Blocks; Miscellaneous;
((3-(TRIFLUOROMETHYL)PHENYL)SULFONYL)METHIONINE
CAS:1009729-55-8
Formula: C12H14NO4F3S2
T792110
CSCCC(C(=O)O)NS(=O)(=O)C1=CC=CC(=C1)C(F)(F)F
Building Blocks; Miscellaneous;
((3-(TRIFLUOROMETHYL)PHENYL)SULFONYL)VALINE
CAS:250714-85-3
Formula: C12H14NO4F3S
T222101
CC(C)C(C(O)=O)NS(=O)(=O)C1C=C(C=CC=1)C(F)(F)F
Building Blocks; Miscellaneous;
((3-CHLORO-4-FLUOROPHENYL)SULFONYL)ALANINE
CAS:1009505-66-1
Formula: C9H9NO4FSCl
C370228
CC(C(=O)O)NS(=O)(=O)C1=CC(=C(C=C1)F)Cl
Building Blocks; Miscellaneous;
((3-CHLORO-4-FLUOROPHENYL)SULFONYL)LEUCINE
CAS:1041437-99-3
Formula: C12H15ClFNO4S
C228881
CC(C)CC(C(O)=O)NS(=O)(=O)C1C=C(Cl)C(F)=CC=1
Building Blocks; Miscellaneous;
((3-CHLORO-4-FLUOROPHENYL)SULFONYL)PHENYLALANINE
CAS:1008956-65-7
Formula: C15H13SNO4ClF
C370230
C1=CC=C(C=C1)CC(C(=O)O)NS(=O)(=O)C2=CC(=C(C=C2)F)C
Building Blocks; Miscellaneous;
((3-CHLORO-4-FLUOROPHENYL)SULFONYL)PROLINE
CAS:439093-24-0
Formula: C11H11ClFNO4S
C228886
OC(=O)C1N(CCC1)S(=O)(=O)C2C=C(Cl)C(F)=CC=2
Building Blocks; Miscellaneous;
((3-CHLOROPHENYL)SULFONYL)ALANINE
CAS:1008997-34-9
Formula: C9H10NO4SCl
C376438
CC(C(=O)O)NS(=O)(=O)C1=CC(=CC=C1)Cl
Building Blocks; Miscellaneous;
((3-CHLOROPHENYL)SULFONYL)GLYCINE
CAS:565198-64-3
Formula: C8H8NO4SCl
C613620
ClC1=CC=CC(S(=O)(NCC(O)=O)=O)=C1
Building Blocks; Miscellaneous;
((3-CHLOROPHENYL)SULFONYL)LEUCINE
CAS:1132787-68-8
Formula: C12H16ClNO4S
C229811
CC(C)CC(C(O)=O)NS(=O)(=O)C1C=C(Cl)C=CC=1
Building Blocks; Miscellaneous;
((3-CHLOROPHENYL)SULFONYL)METHIONINE
CAS:1262964-13-5
Formula: C11H14ClNO4S2
C229816
CSCCC(C(O)=O)NS(=O)(=O)C1C=C(Cl)C=CC=1
Building Blocks; Miscellaneous;
((3-CHLOROPHENYL)SULFONYL)PHENYLALANINE
CAS:1449132-27-7
Formula: C15H14ClNO4S
C229821
C1=CC=C(C=C1)CC(C(O)=O)NS(=O)(=O)C2C=C(Cl)C=CC=2
Building Blocks; Miscellaneous;
((3-CHLOROPHENYL)SULFONYL)PROLINE
CAS:1164136-21-3
Formula: C11H12ClNO4S
C229826
ClC1C=C(C=CC=1)S(=O)(=O)N2C(C(O)=O)CCC2
Building Blocks; Miscellaneous;
((3-CHLOROPHENYL)SULFONYL)VALINE
CAS:1009549-57-8
Formula: C11H14NO4SCL
C376570
CC(C)C(C(=O)O)NS(=O)(=O)C1=CC(=CC=C1)Cl
Building Blocks; Miscellaneous;
((3-FLUOROCYCLOBUTOXY)METHYL)BENZENE
CAS:1427501-98-1
Formula: C11H13OF
F402170
C1=CC=C(C=C1)COC2CC(C2)F
Building Blocks; Miscellaneous;
((3-FLUOROPHENYL)SULFONYL)ALANINE
CAS:1160933-45-8
Formula: C9H10FNO4S
F232031
OC(=O)C(C)NS(=O)(=O)C1=CC(F)=CC=C1
Building Blocks; Miscellaneous;
((3-FLUOROPHENYL)SULFONYL)GLYCINE
CAS:731815-66-0
Formula: C8H8NO4FS
F590775
O=S(C1=CC=CC(F)=C1)(NCC(O)=O)=O
Building Blocks; Miscellaneous;
((3-FLUOROPHENYL)SULFONYL)PROLINE
CAS:1101743-81-0
Formula: C11H12FNO4S
F232036
FC1C=C(C=CC=1)S(=O)(=O)N2C(C(O)=O)CCC2
Building Blocks; Miscellaneous;
((3-METHYLISOXAZOL-5-YL)METHYL)GLYCINE HYDROCHLORIDE
CAS:2098113-27-8
Formula: C7H10N2O3• HCl
M234401
Cl.OC(=O)CNCC1=CC(C)=NO1
Building Blocks; Miscellaneous;
((3-PHENOXYPHENYL)METHYLENE)METHANE-1,1-DICARBONITRILE
CAS:77103-01-6
Formula: C16H10N2O
P169355
C1=CC=C(C=C1)OC2=CC=CC(=C2)C=C(C#N)C#N
Building Blocks; Miscellaneous;
((3AR,5AS,8AS,8BR)-2,2,7,7-TETRAMETHYLTETRAHYDRO-3AH-BIS([1,3]DIOXOLO)[4,5-B:4',5'-D]PYRAN-3A-YL)METHYL DIETHYLCARBAMOYLSULFAMATE
Formula: C17H30N2O9S
T890341
CC1(C)O[C@@H]2[C@@H]3[C@@H](OC(C)(C)O3)CO[C@]2(COS
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
((3AR,6S,7S,7AR)-6,7-DIHYDROXY-2,2-DIMETHYLTETRAHYDRO-3AH-[1,3]DIOXOLO[4,5-B]PYRAN-3A-YL)METHYL SULFAMATE
CAS:152192-21-7
Formula: C9H17NO8S
D449086
CC1(C)O[C@@H]2[C@@H](O)[C@@H](O)CO[C@]2(COS(N)(=O)
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
((3S)-1-BROMO-3-HYDROXY-4-(PALMITOYLOXY)BUTYL)PHOSPHONIC ACID
CAS:944313-05-7
Formula: C20H40BrO6P
B557300
OP(O)(C(Br)C[C@H](O)COC(CCCCCCCCCCCCCCC)=O)=O
Standards; Enzyme Activators and Inhibitors; Pharmaceutical/API Drug Impurities/Metabolites;
((3S,4R)-4-(4-ETHOXYPHENYL)-1-METHYLPIPERIDIN-3-YL)METHANOL
Formula: C15H23NO2
E892735
CC(C)C(=O)C(C(=O)Nc1ccccc1)C(c2ccccc2)C(=O)c3ccccc
Building Blocks; Pharmaceutical/API Drug Impurities/Metabolites;
((3S,4R)-4-(4-ETHOXYPHENYL)-1-METHYLPIPERIDIN-3-YL)METHYL METHANESULFONATE
Formula: C16H25NO4S
E892755
COC(=O)C(C)(C)c1ccc(C#CCCN2CCC(CC2)OC(c3ccccc3)c4c
Building Blocks; Miscellaneous;
((3S,4R)-4-(4-FLUOROPHENYL)PIPERIDIN-3-YL)METHANOL
CAS:125224-43-3
Formula: C12H16NOF
F632720
C1=C(C=CC(=C1)F)[C@@H]2CCNC[C@H]2CO
Building Blocks; Chiral Molecules;
((4'-CHLORO-[1,1'-BIPHENYL]-4-YL)SULFONYL)GLYCINE
CAS:885269-36-3
Formula: C14H12NO4SCl
C258286
OC(=O)CNS(=O)(=O)C1=CC=C(C=C1)C2=CC=C(Cl)C=C2
Building Blocks; Miscellaneous;
((4'-CHLORO-[1,1'-BIPHENYL]-4-YL)SULFONYL)PHENYLALANINE
CAS:1449133-06-5
Formula: C21H18ClNO4S
C258291
ClC1=CC=C(C=C1)C2=CC=C(C=C2)S(=O)(=O)NC(C(O)=O)CC3
Building Blocks; Miscellaneous;
((4'-METHOXY-[1,1'-BIPHENYL]-4-YL)SULFONYL)GLYCINE
CAS:885269-46-5
Formula: C15H15NO5S
M258301
OC(=O)CNS(=O)(=O)C1=CC=C(C=C1)C2=CC=C(OC)C=C2
Building Blocks; Miscellaneous;
((4-((4-((4-ETHYNYLPHENYL)ETHYNYL)PHENYL)ETHYNYL)-PHENYL)ETHYNYL)TRIISOPROPYLSILANE
CAS:176977-38-1
Formula: C35H34Si
E072940
CC(C)[Si](C#CC1=CC=C(C=C1)C#CC2=CC=C(C=C2)C#CC3=CC
((4-((4-ETHYNYLPHENYL)ETHYNYL)PHENYL)-ETHYNYL)TRIISOPROPYLSILANE
CAS:176977-37-0
Formula: C27H30Si
E072935
CC(C)[Si](C#CC1=CC=C(C=C1)C#CC2=CC=C(C=C2)C#C)(C(C
((4-((4-FLUOROPHENYL)ETHYNYL)PHENYL)-ETHYNYL)TRIMETHYLSILANE
CAS:910467-79-7
Formula: C19H17FSi
F073030
C[Si](C)(C)C#CC1=CC=C(C=C1)C#CC2=CC=C(C=C2)F
((4-((4-METHOXYPHENYL)ETHYNYL)PHENYL)-ETHYNYL)TRIMETHYLSILANE
CAS:787617-56-5
Formula: C20H20OSi
M073005
COC1=CC=C(C=C1)C#CC2=CC=C(C=C2)C#C[Si](C)(C)C
((4-(2-CHLOROPHENOXY)PHENYL)SULFONYL)ALANINE
CAS:1008472-78-3
Formula: C15H14NO5SCL
C375623
CC(C(=O)O)NS(=O)(=O)C1=CC=C(C=C1)OC2=CC=CC=C2Cl
Building Blocks; Miscellaneous;
((4-(2-CHLOROPHENOXY)PHENYL)SULFONYL)GLYCINE
CAS:606945-28-2
Formula: C14H12NO5SCl
C239001
OC(=O)CNS(=O)(=O)C1=CC=C(C=C1)OC2=C(Cl)C=CC=C2
Building Blocks; Miscellaneous;
((4-(2-CHLOROPHENOXY)PHENYL)SULFONYL)LEUCINE
CAS:875901-35-2
Formula: C18H20ClNO5S
C239006
CC(C)CC(C(O)=O)NS(=O)(=O)C1=CC=C(C=C1)OC2=C(Cl)C=C
Building Blocks; Miscellaneous;
((4-(2-CHLOROPHENOXY)PHENYL)SULFONYL)PHENYLALANINE
CAS:1009715-73-4
Formula: C21H18NO5SCL
C375628
C1=CC=C(C=C1)CC(C(=O)O)NS(=O)(=O)C2=CC=C(C=C2)OC3=
Building Blocks; Miscellaneous;
((4-(2-CHLOROPHENOXY)PHENYL)SULFONYL)VALINE
CAS:1448636-37-0
Formula: C17H18ClNO5S
C239011
CC(C)C(C(O)=O)NS(=O)(=O)C1=CC=C(C=C1)OC2=C(Cl)C=CC
Building Blocks; Miscellaneous;
((4-(2-METHOXYPHENOXY)PHENYL)SULFONYL)ALANINE
CAS:1008052-20-7
Formula: C16H17NO6S
M226885
CC(C(=O)O)NS(=O)(=O)C1=CC=C(C=C1)OC2=CC=CC=C2OC
Building Blocks; Miscellaneous;
((4-(2-METHOXYPHENOXY)PHENYL)SULFONYL)GLYCINE
CAS:606944-93-8
Formula: C15H15NO6S
M239611
COC1=C(C=CC=C1)OC2=CC=C(C=C2)S(=O)(=O)NCC(O)=O
Building Blocks; Miscellaneous;
((4-(2-METHOXYPHENOXY)PHENYL)SULFONYL)LEUCINE
CAS:1008647-74-2
Formula: C19H23NO6S
M226790
CC(C)CC(C(=O)O)NS(=O)(=O)C1=CC=C(C=C1)OC2=CC=CC=C2
Building Blocks; Miscellaneous;
((4-(7-(2-(4-CHLOROPHENOXY)ETHYL)-2-(METHYLAMINO)-6-OXO-6,7-DIHYDRO-3H-PURIN-8-YL)PHENYL)DIFLUOROMETHYL)PHOSPHONIC ACID
CAS:1373822-46-8
Formula: C21H19ClF2N5O5P
C143465
O=C1N=C(NC)NC2=C1N(CCOC3=CC=C(Cl)C=C3)C(C4=CC=C(C(
Building Blocks; Miscellaneous;
((4-(BROMOMETHYL)PHENYL)SULFONYL)-(4-FLUOROPHENYL)AMINE
CAS:260969-08-2
Formula: C13H11BrFNO2S
B108785
C1=CC(=CC=C1CBr)S(=O)(=O)NC2=CC=C(C=C2)F
((4-(O-TOLYLOXY)PHENYL)SULFONYL)ALANINE
CAS:1009790-14-0
Formula: C16H17NO5S
O246176
OC(=O)C(C)NS(=O)(=O)C1=CC=C(C=C1)OC2=C(C)C=CC=C2
Building Blocks; Miscellaneous;
((4-(O-TOLYLOXY)PHENYL)SULFONYL)GLYCINE
CAS:606944-16-5
Formula: C15H15NO5S
O246181
OC(=O)CNS(=O)(=O)C1=CC=C(C=C1)OC2=C(C)C=CC=C2
Building Blocks; Miscellaneous;
((4-(O-TOLYLOXY)PHENYL)SULFONYL)LEUCINE
CAS:1008956-66-8
Formula: C19H23NO5S
O246186
CC(C)CC(C(O)=O)NS(=O)(=O)C1=CC=C(C=C1)OC2=C(C)C=CC
Building Blocks; Miscellaneous;
((4-(O-TOLYLOXY)PHENYL)SULFONYL)METHIONINE
CAS:1009755-91-2
Formula: C18H21NO5S2
O246191
CSCCC(C(O)=O)NS(=O)(=O)C1=CC=C(C=C1)OC2=C(C)C=CC=C
Building Blocks; Miscellaneous;
((4-(O-TOLYLOXY)PHENYL)SULFONYL)PHENYLALANINE
CAS:1008052-21-8
Formula: C22H21NO5S
O246196
OC(=O)C(CC1=CC=CC=C1)NS(=O)(=O)C2=CC=C(C=C2)OC3C(C
Building Blocks; Miscellaneous;
((4-(TERT-BUTYL)PHENYL)SULFONYL)ALANINE
CAS:159855-98-8
Formula: C13H19NO4S
B491125
CC(C(=O)O)NS(=O)(=O)C1=CC=C(C=C1)C(C)(C)C
Building Blocks; Amino Acids;
((4-(TERT-BUTYL)PHENYL)SULFONYL)GLYCINE
CAS:159855-97-7
Formula: C12H17NO4S
B491105
CC(C)(C1=CC=C(S(=O)(NCC(O)=O)=O)C=C1)C
Building Blocks; Miscellaneous;
((4-(TERT-BUTYL)PHENYL)SULFONYL)LEUCINE
CAS:159856-00-5
Formula: C16H25NO4S
T246996
CC(C)CC(C(O)=O)NS(=O)(=O)C1=CC=C(C=C1)C(C)(C)C
Building Blocks; Miscellaneous;
((4-(TERT-BUTYL)PHENYL)SULFONYL)METHIONINE
CAS:1393654-69-7
Formula: C15H23NO4S2
T247001
CSCCC(C(O)=O)NS(=O)(=O)C1=CC=C(C=C1)C(C)(C)C
Building Blocks; Miscellaneous;
((4-(TERT-BUTYL)PHENYL)SULFONYL)PHENYLALANINE
CAS:159856-01-6
Formula: C19H23NO4S
T247006
C1=CC=C(C=C1)CC(C(O)=O)NS(=O)(=O)C2=CC=C(C=C2)C(C)
Building Blocks; Miscellaneous;
((4-BROMO-3-METHYLBUT-2-EN-1-YL)OXY)(TERT-BUTYL)DIMETHYLSILANE
Formula: C11H23BrOSi
B808373
C/C(CBr)=C\CO[Si](C)(C)C(C)(C)C
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
((4-BROMO-3-METHYLPHENYL)CARBONYL)MORPHOLINE
CAS:149105-06-6
Formula: C12H14BrNO2
B697448
CC1=C(C=CC(=C1)C(=O)N2CCOCC2)Br
Building Blocks; Miscellaneous;
((4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL)SULFONYL)ALANINE
CAS:1008594-59-9
Formula: C10H9NO4F3SCl
B420575
CC(C(=O)O)NS(=O)(=O)C1=CC(=C(C=C1)Cl)C(F)(F)F
Building Blocks; Miscellaneous;
((4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL)SULFONYL)LEUCINE
CAS:1038619-52-1
Formula: C13H15ClF3NO4S
C251691
CC(C)CC(C(O)=O)NS(=O)(=O)C1C=C(C(Cl)=CC=1)C(F)(F)F
Building Blocks; Miscellaneous;
((4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL)SULFONYL)METHIONINE
CAS:1009232-49-8
Formula: C12H13NO4F3S2Cl
B420093
CSCCC(C(=O)O)NS(=O)(=O)C1=CC(=C(C=C1)Cl)C(F)(F)F
Building Blocks; Miscellaneous;
((4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL)SULFONYL)PHENYLALANINE
CAS:1008052-19-4
Formula: C16H13SNO4F3Cl
B420095
C1=CC=C(C=C1)CC(C(=O)O)NS(=O)(=O)C2=CC(=C(C=C2)Cl)
Building Blocks; Miscellaneous;
((4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL)SULFONYL)PROLINE
CAS:1009684-43-8
Formula: C12H11ClF3NO4S
C251696
OC(=O)C1N(CCC1)S(=O)(=O)C2C=C(C(Cl)=CC=2)C(F)(F)F
Building Blocks; Miscellaneous;
((4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL)SULFONYL)VALINE
CAS:1242095-23-3
Formula: C12H13ClF3NO4S
C251701
CC(C)C(C(O)=O)NS(=O)(=O)C1C=C(C(Cl)=CC=1)C(F)(F)F
Building Blocks; Miscellaneous;
((4-CHLORO-3-NITROPHENYL)SULFONYL)CYCLOPROPYLAMINE
CAS:1027272-32-7
Formula: C9H9ClN2O4S
C167665
C1CC1NS(=O)(=O)C2=CC(=C(C=C2)Cl)[N+](=O)[O-]
Building Blocks; Miscellaneous;
((4-ETHYNYLPHENYL)ETHYNYL)TRIISOPROPYLSILANE
CAS:175345-90-1
Formula: C19H26Si
E072915
CC(C)[Si](C#CC1=CC=C(C=C1)C#C)(C(C)C)C(C)C
((4-FLUOROPHENYL)AMINO)-N-((4-METHYLPHENYL)SULFONYL)FORMAMIDE
CAS:1513-05-9
Formula: C14H13FN2O3S
F171075
CC1=CC=C(C=C1)S(=O)(=O)NC(=O)NC2=CC=C(C=C2)F
Building Blocks; Miscellaneous;
((4-IODOPHENYL)ETHYNYL)TRIMETHYLSILANE
CAS:134856-58-9
Formula: C11H13ISi
I071670
C[Si](C)(C)C#CC1=CC=C(C=C1)I
((4-METHOXYPHENYL)ETHYNYL)TRIMETHYLSILANE
CAS:3989-14-8
Formula: C12H16OSi
M945343
COC1=CC=C(C=C1)C#C[Si](C)(C)C
Building Blocks; Miscellaneous;
((4-METHYLPHENYL)AMINO)(4-(3-PHENYLPROP-2-ENYL)PIPERAZINYL)METHANE-1-THIONE
CAS:431912-08-2
Formula: C21H25N3S
M171090
CC1=CC=C(C=C1)NC(=S)N2CCN(CC2)CC=CC3=CC=CC=C3
Building Blocks; Miscellaneous;
((4-METHYLPHENYL)SULFONYL)PROP-2-YNYLAMINE
CAS:55022-46-3
Formula: C10H11NO2S
M357938
CC1=CC=C(C=C1)S(=O)(=O)NCC#C
Building Blocks; Miscellaneous;
((4-NITROPHENYL)AMINO)(2-((PROP-2-ENYLAMINO)THIOXOMETHYL)HYDRAZINO)METHANE-1-THIONE
CAS:1027543-68-5
Formula: C11H13N5O2S2
N170460
C=CCNC(=S)NNC(=S)NC1=CC=C(C=C1)[N+](=O)[O-]
Building Blocks; Miscellaneous;
((4AS,4BS,10AR,10BS,11S,12AS)-1,11-DIHYDROXY-10A,12A-DIMETHYL-2,8-DIOXO-1,2,3,4,4A,4B,5,6,8,10A,10B,11,12,12A-TETRADECAHYDROCHRYSEN-1-YL)METHYL ACETATE
Formula: C23H30O6
D455583
C[C@@]12C(CC[C@]3([H])[C@]2([H])[C@@H](O)C[C@@](C(
Standards; Steroids; Pharmaceutical/API Drug Impurities/Metabolites;
((4AS,4BS,10AR,10BS,11S,12AS)-2,11-DIHYDROXY-10A,12A-DIMETHYL-1,8-DIOXO-1,2,3,4,4A,4B,5,6,8,10A,10B,11,12,12A-TETRADECAHYDROCHRYSEN-2-YL)METHYL ACETATE
Formula: C23H30O6
D455588
C[C@@]12C(CC[C@]3([H])[C@]2([H])[C@@H](O)C[C@@](C(
Standards; Steroids; Pharmaceutical/API Drug Impurities/Metabolites;
((4R,5R)-2,2-DIMETHYL-1,3-DIOXOLANE-4,5-DIYL)BIS(DI(NAPHTHALEN-1-YL)METHANOL)
CAS:137536-94-8
Formula: C47H38O4
R069370
CC1(O[C@H]([C@@H](O1)C(C2=CC=CC3=CC=CC=C32)(C4=CC=
((4S)-4-CYCLOHEXYL-1-[(R)-[(S)-1-HYDROXY-2-METHYLPROPOXY](4-PHENYLBUTYL)PHOSPHINYL]ACETYL-D-PROLINE PROPIONATE (ESTER) HEMIBARIUM SALT SESQUIHYDRATE)
Formula: C30H46NO7P • 0.5Ba • 1.5H2O
C989195
O=C([O-])[C@H](C[C@H](C1CCCCC1)C2)N2C(CP(CCCCC3=CC
Building Blocks;
((4S,5S)-4-ISOPROPYL-2,2,5-TRIMETHYL-1,3-DIOXOLAN-4-YL)METHANONE 1H-IMIDAZOL-1-YL
Formula: C13H20N2O3
I874405
Building Blocks; Miscellaneous;
((6-BROMO-4-METHYLHEXYL)OXY)(TERT-BUTYL)DIMETHYLSILANE
Formula: C13H29BrOSi
B687410
CCS[C@H]1C(OCc2ccccc2)C(OCc3ccccc3)[C@@H]4C(COC(c5
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
((8S,9S,10R,11S,13S,14S)-11-HYDROXY-10,13-DIMETHYL-3,17-DIOXO-6,7,8,9,10,11,12,13,14,15,16,17-DODECAHYDRO-3H-CYCLOPENTA[A]PHENANTHREN-16-YL)METHYL DIHYDROGEN PHOSPHATE
Formula: C20H27O7P
H825820
O=C1C=C[C@@]2(C)C(CC[C@]3([H])[C@]2([H])[C@@H](O)C
Standards; Steroids;
((8Z,11Z)-HEPTADECA-8,11-DIEN-1-YL)MAGNESIUM BROMIDE
Formula: C17H31BrMg
H757660
CCCCC/C=C\C/C=C\CCCCCCC[Mg]Br
Building Blocks; Miscellaneous;
((ALLYLOXY)METHYL)BENZENE
CAS:14593-43-2
Formula: C10H12O
A614468
C=CCOCC1=CC=CC=C1
Building Blocks; Monomers;
((CARBAMOYL-D-GLUTAMYL)CARBAMOYL)-L-GLUTAMIC ACID
Formula: C13H19N3O9
C250400
OC(CC[C@@H](CC(N)=O)C(NC(N[C@H](C(O)=O)CCC(O)=O)=O
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
((DIMETHYLAMINOMETHYLIDENE)AMINO)-3H-1,2,4-DITHIAZOLINE-3-THIONE
CAS:1192027-04-5
Formula: C5H7N3S3
D442010
C1(N=C(/N=C/N(C)C)SS1)=S
Building Blocks; Miscellaneous;
((DOTA-HYNIC)-D-ALANYL)-L-PROLINE-BORONIC ACID
Formula: C29H46BN9O11
D687300
O=C(N[C@H](C)C(N1[C@H](B(O)O)CCC1)=O)C2=CN=C(NNC(C
Standards; Chiral Molecules; Miscellaneous;
((E)-2-(5-AMINO)) CEFTAZIDIME 5-OXIDE
Formula: C21H21N7O8S2
C274100
O=C(N[C@H]1C2S(CC(C[N+]3=CC=CC=C3)=C(C([O-])=O)N2C
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
((E)-2-(5-AMINO))-2-CARBOXY CEFTAZIDIME
Formula: C21H23N7O8S2
C254100
O=C(N[C@@H](C(O)=O)[C@]1([H])SCC(C[N+]2=CC=CC=C2)=
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
((E)-2-(5-AMINO)-2-OXY CEFTAZIDIME
Formula: C22H23N7O7S2
C294100
O=C(N[C@@]1([H])[C@@]2([H])SCC(C[N+]3=CC=CC=C3)=C(
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
((E)-5-((M-[(2-CARBOXYETHYL)CARBAMOYL]PHENYL)AZO)-2-SALICYLIC ACID)
CAS:1798395-96-6
Formula: C17H15N3O6
C178050
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
((E)-BUT-2-ENYL)MALONIC ACID DIMETHYL ESTER
CAS:82545-71-9
Formula: C9H14O4
B938305
O=C(OC)C(C/C=C/C)C(OC)=O
Building Blocks; Miscellaneous;
((HYNIC)-D-ALANYL)-L-PROLINE-BORONIC ACID TFA SALT
Formula: C13H20BN5O4 • x(C2HF3O2)
H972225
NNC1=NC=C(C=C1)C(N[C@@H](C(N2[C@@H](CCC2)B(O)O)=O)
Standards; Chiral Molecules; Miscellaneous;
((O,O')-TERT-BUTYLDIMETHYLSILYL) EZETIMIBE
Formula: C36H49F2NO3Si2
B942748
[H][C@@]1([C@@H](N2(C)=O)C3)[C@](CCCC1)(CC2)C4=C3C
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
((O,O')-TERT-BUTYLDIMETHYLSILYL) SECO-EZETIMIBE
Formula: C36H53F2NO3Si2
B942750
O=C1C=C(O)C2=CC=C(C)NC2=N1
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
((OXYBIS(ETHANE-2,1-DIYL))BIS(OXY))BIS(ETHANE-2,1-DIYL) BIS(4-METHYLBENZENESULFONATE)
CAS:37860-51-8
Formula: C22H30O9S2
E588810
CC1=CC=C(C=C1)S(=O)(=O)OCCOCCOCCOCCOS(=O)(=O)C2=CC
Building Blocks; Miscellaneous;
((PHENYLPHOSPHINEDIYL)BIS(ETHANE-2,1-DIYL))BIS(DIPHENYLPHOSPHINE)
CAS:23582-02-7
Formula: C34H33P3
P077480
C1=CC=C(C=C1)P(CCP(C2=CC=CC=C2)C3=CC=CC=C3)CCP(C4=
((PROP-2-YN-1-YLOXY)METHYL)CYCLOPROPANE
CAS:643083-59-4
Formula: C7H10O
P308206
C#CCOCC1CC1
Building Blocks; Miscellaneous;
((R)-1-((S)-2-AMINO-3-PHENYLPROPANAMIDO)-3-METHYLBUTYL)BORONIC ACID
Formula: C14H23BN2O3
A452550
N[C@@H](CC1=CC=CC=C1)C(N[C@@H](CC(C)C)B(O)O)=O
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
((R)-1-PHENYL-3,4-DIHYDROISOQUINOLIN-2(1H)-YL)((S)-1-PHENYL-3,4-DIHYDROISOQUINOLIN-2(1H)-YL)METHANONE
CAS:2216750-52-4
Formula: C31H28N2O
P309025
O=C(N1[C@@H](C2=CC=CC=C2)C3=CC=CC=C3CC1)N4[C@H](C5
Building Blocks; Chiral Molecules; Pharmaceutical/API Drug Impurities/Metabolites;
((R)-2,2'-BIS(DIPHENYLPHOSPHINO)-1,1'-BINAPHTHYL)DICHLOROPALLADIUM
CAS:115826-95-4
Formula: C44H33Cl2P2Pd
P578020
C1=CC=C(C=C1)P(C2=CC=CC=C2)C3=C(C4=CC=CC=C4C=C3)C5
Building Blocks; Catalyst;
((R)-5-OXOPYRROLIDINE-2-CARBONYL)-L-GLUTAMIC ACID
Formula: C10H14N2O6
O860020
O=C(O)CC[C@@H](C(O)=O)NC([C@@H](CC1)NC1=O)=O
Building Blocks; Amino Acids;
((S)-2-HYDROXYPROPANOYL)-L-TYROSINE
CAS:21753-44-6
Formula: C9H19NO4
H952580
CC(C)[C@@H](C(O)=O)NC([C@@H](O)C)=O
Building Blocks; Amino Acids;
((S)-3-((((S)-3-MERCAPTO-2-METHYLPROPANOYL)-L-PROLYL)THIO)-2-METHYLPROPANOYL)-L-PROLINE
Formula: C18H28N2O5S2
M257620
[H][C@]1(C(SC[C@H](C)C(N2[C@@H](C(O)=O)CCC2)=O)=O)
Standards; Enzyme Activators and Inhibitors; Pharmaceutical/API Drug Impurities/Metabolites;
((S)-4,4-DIMETHYLPYRROLIDIN-2-YL)METHANOL
CAS:212890-85-2
Formula: C7H15NO
D461763
CC1(C)C[C@@H](CO)NC1
Building Blocks; Chiral Molecules;
((S)-OXOPYRROLIDINE-2-CARBONYL)-L-CYSTEINE
CAS:70605-67-3
Formula: C8H12N2O4S
O860015
SC[C@@H](C(O)=O)NC([C@H]1NCCC1=O)=O
Building Blocks; Amino Acids;
((TERT-BUTYL)AMINO)(4-(2-FLUOROPHENYL)PIPERAZINYL)METHANE-1-THIONE
CAS:1024126-83-7
Formula: C15H22FN3S
T170780
CC(C)(C)NC(=S)N1CCN(CC1)C2=CC=CC=C2F
Building Blocks; Miscellaneous;
((TERT-BUTYL)AMINO)(4-(DIPHENYLMETHYL)PIPERAZINYL)METHANE-1-THIONE
CAS:1005889-23-5
Formula: C22H29N3S
T170775
CC(C)(C)NC(=S)N1CCN(CC1)C(C2=CC=CC=C2)C3=CC=CC=C3
Building Blocks; Miscellaneous;
((TRANS,TRANS)-4'-PENTYL-[1,1'-BI(CYCLOHEXAN)]-4-YL)METHANOL
CAS:82598-08-1
Formula: C18H34O
T714820
CCCCCC1CCC(CC1)C2CCC(CC2)CO
Research Tools; Materials;
((TRIMETHYLACETYL)OXY)METHYL 4-NITROPHENYL CARBONATE
CAS:101623-83-0
Formula: C13H15NO7
T796255
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
()-1,1,1-TRIFLUORO-2-BUTANAMINE HYDROCHLORIDE
CAS:758-33-8
Formula: C4H8F3N • HCl
T790098
CCC(C(F)(F)F)N.Cl
Building Blocks; Miscellaneous;
(+)-(1-OXYL-2,2,5,5-TETRAMETHYLPYRROLIDIN-3-YL)METHYL METHANETHIOSULFONATE
CAS:681034-14-0
Formula: C10H20NO3S2
O873920
O=S(SC[C@H]1C(C)(C)N([O])C(C)(C)C1)(C)=O
Research Tools; Spin Labels; Sulfhydryl Active Reagents;
(+)-(14SS)-DIHYDROVINPOCETINE
CAS:57517-54-1
Formula: C22H28N2O2
D448385
O=C(OCC)[C@H]1N2C3=CC=CC=C3C4=C2[C@](N5CC4)([H])[C
Research Tools;
(+)-(14SS)-DIHYDROVINPOCETINE-D5
Formula: C22H23D5N2O2
D448387
O=C(OC([2H])([2H])C([2H])([2H])[2H])[C@H]1N2C3=CC=
Research Tools;
(+)-(18-CROWN-6)-2,3,11,12-TETRACARBOXAMIDE
CAS:57207-22-4
Formula: C24H44N4O10
C824900
O=C(N(C)C)[C@H]1[C@H](C(N(C)C)=O)OCCOCCO[C@@H](C(N
Standards; Miscellaneous;
(+)-(18-CROWN-6)-2,3,11,12-TETRACARBOXYLIC ACID
CAS:61696-54-6
Formula: C16H24O14
C825000
C1CO[C@H]([C@H](C(=O)O)OCCOCCO[C@H]([C@H](C(=O)O)O
Research Tools; Materials;
(+)-(1R,2R,5R)--ETHYL [(2-HYDROXYPINAN-3-YLENE)AMINO]ACETATE
CAS:90473-01-1
Formula: C14H23NO3
E919165
CCOC(=O)CN=C1C[C@H]2C[C@@H]([C@@]1(C)O)C2(C)C
Building Blocks; Chiral Molecules; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-(1R,2R,5R)--ETHYL [(2-HYDROXYPINAN-3-YLENE)AMINO]ACETATE-13C2
Formula: C1213C2H23NO3
E919166
O=[13C](OCC)[13CH2]/N=C1C[C@@H]2C(C)(C)[C@@H](C2)[
Building Blocks; Chiral Molecules; Isotopic Labeled Analogues;
(+)-(1R,2R,5R)-2-HYDROXY-3-PINANONE
CAS:24047-72-1
Formula: C10H16O2
H952000
O=C1C[C@@H]2C(C)(C)[C@@H](C2)[C@]1(O)C
Building Blocks; Chiral Molecules; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-(1R,2S)-1,2-DIHYDRO-1,2-NAPHTHALENEDIOL
CAS:51268-88-3
Formula: C10H10O2
D450205
O[C@H]1[C@@H](O)C=CC2=CC=CC=C21
Building Blocks; Miscellaneous;
(+)-(1R,4S)-N-BOC-4-AMINOCYCLOPENT-2-ENECARBOXYLIC ACID
CAS:151907-80-1
Formula: C11H17NO4
B603255
CC(C)(C)OC(=O)N[C@H]1C[C@H](C=C1)C(=O)O
Building Blocks; Chiral Molecules;
(+)-(1S,3R)-3-AMINO-CYCLOPENTANE CARBOXYLIC ACID
CAS:71830-07-4
Formula: C6H11NO2
S293900
C1C[C@H](C[C@H]1C(=O)O)N
(+)-(1S,3R)-N-FMOC-3-AMINOCYCLOPENTANECARBOXYLIC ACID
CAS:220497-66-5
Formula: C21H21NO4
F603675
C1C[C@H](C[C@H]1C(=O)O)NC(=O)OCC2C3=CC=CC=C3C4=CC=
Building Blocks; Chiral Molecules;
(+)-(2R,3S)-1-METHYL-2-(3-PYRIDINYL)-3-PYRROLIDINEMETHANAMINE
CAS:1391361-71-9
Formula: C11H17N3
M337925
CN1CC[C@@H](CN)[C@@H]1C2=CC=CN=C2
Standards; Pharmaceutical/API Drug Impurities/Metabolites; Nicotine Derivatives and Metabolites;
(+)-(2S,5R)-1-ALLYL-2,5-DIMETHYLPIPERAZINE, (+)-CAMPHORIC ACID SALT
CAS:186094-00-8
Formula: C19H34N2O4
A552545
C=CCN1[C@@H](C)CN[C@H](C)C1.CC2(C)[C@@]([H])(C(O)=
Building Blocks; Chiral Molecules;
(+)-(2S,5R)-BENZYL 5-AMINO-2-METHYLPIPERIDINE-1-CARBOXYLATE
CAS:1207947-49-6
Formula: C14H20N2O2
S223790
C[C@H]1CC[C@H](CN1C(=O)OCC2=CC=CC=C2)N
(+)-(2S,6Z,9S,10E)-9-{[TERT-BUTYL(DIMETHYL)SILYL]OXY}-2,6,10-TRIMETHYL-11-(2-METHYL-1,3-THIAZOL-4-YL)-UNDECA-6,10-DIEN-1-OL
CAS:210690-99-6
Formula: C24H43NO2SSi
B691605
CC1=NC(CC(C)[C@@H](O[Si](C)(C(C)(C)C)C)C/C=C(CCC[C
Building Blocks; Chiral Molecules; Miscellaneous;
(+)-(3-BROMOPROPYL)BORONIC ACID PINANEDIOL ESTER
CAS:90084-37-0
Formula: C13H22BBrO2
B686685
CC1(C)[C@H]2C[C@@H]1[C@@]3(C)[C@@H](C2)OB(CCCBr)O3
Building Blocks;
(+)-(3AS,6AS)-3A,6A-DIHYDRO-2,2-DIMETHYL-4H-CYCLOPENTA-1,3-DIOXOL-4-ONE
CAS:104010-72-2
Formula: C8H10O3
D453495
Standards; Chiral Molecules; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-(3R)-3-{[TERT-BUTYL(DIMETHYL)SILYL]OXY}DIHYDROFURAN-2(3H)-ONE
CAS:669000-31-1
Formula: C10H20O3Si
B691420
O=C1[C@H](O[Si](C)(C)C(C)(C)C)CCO1
Building Blocks; Chiral Molecules;
(+)-(3R,4R)-3,4-DIMETHYL-4-(3-HYDROXYPHENYL)PIPERIDINE
CAS:119193-19-0
Formula: C13H19NO
D479035
C[C@H]1CNCC[C@@]1(C)C2=CC(=CC=C2)O
Building Blocks; Chiral Molecules; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-(5)-TRANS CLOPROSTENOL
CAS:57968-81-7
Formula: C22H29ClO6
C588315
ClC1=CC=CC(OC[C@H](O)/C=C/[C@H]2[C@H](O)C[C@H](O)[
Standards; Chiral Molecules; Pharmaceutical/API Drug Impurities/Metabolites; Food; Lipids/Fatty Acids, Glycerol Derivatives;
(+)-(R)-PULEGONE-D3
Formula: C10H13D3O
P840142
O=C(C[C@H](C)CC/1)C1=C(C([2H])([2H])[2H])\C
Standards; Isotopic Labeled Analogues; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-(S)-(R)-BPPFA
CAS:119477-32-6
Formula: C38H37FeNP2
B676695
Building Blocks; Catalyst;
(+)-(S)-[10]-GINGEROL
CAS:23513-15-7
Formula: C21H34O4
G387225
CN1CCN(C2=CC=C3C(N=C(C4=CC=C5C(N=C(C6=CC=C(OCC)C=C
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-(S)-3-[N,N-DIMETHYLAMINO)-3-PHENYLPROPANOL
CAS:82769-75-3
Formula: C11H17NO
D155520
OCC[C@H](N(C)C)C1=CC=CC=C1
Building Blocks; Chiral Molecules;
(+)-(S)-DIHYDROKAVAIN
CAS:587-63-3
Formula: C14H16O3
D450620
COC1=CC(=O)O[C@@H](CCC2=CC=CC=C2)C1
Standards; Natural Products;
(+)-(S)-TYLOPHORINE
CAS:482-20-2
Formula: C24H27NO4
T898200
[H][C@](N1C2)(CCC1)CC3=C2C(C=C(OC)C(OC)=C4)=C4C5=C
Standards; Enzyme Activators and Inhibitors; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-(S)-TYLOPHORINE-D8
CAS:1795785-68-0
Formula: C24H19D8NO4
T898202
[H][C@](N1C2([2H])[2H])(CC([2H])([2H])C1([2H])[2H]
Standards; Isotopic Labeled Analogues; Enzyme Activators and Inhibitors; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-(S,S,S)-CIRAMADOL
CAS:63269-30-7
Formula: C15H23NO2
C490005
O[C@@H]1[C@](CCCC1)([H])[C@@H](C2=CC(O)=CC=C2)N(C)
Building Blocks; Miscellaneous;
(+)-?-ELEMENE
CAS:30824-67-0
Formula: C15H24
E501050
C=CC(CC/1)(C)[C@@H](C(C)=C)CC1=C(C)/C
Standards; Enzyme Activators and Inhibitors; Pharmaceutical/API Drug Impurities/Metabolites; Antibotics; Environmental Standards, Mutagens and Metabolites;
(+)-[(8,8-DICHLOROCAMPHORYL)SULFONYL]OXAZIRIDINE
CAS:127184-05-8
Formula: C10H13Cl2NO3S
D433990
CC1(C)[C@@H]2CC[C@@]31CS(=O)(=O)N4[C@@]3(C2(Cl)Cl)
Building Blocks; Miscellaneous;
(+)-[6]-GINGEROL
CAS:23513-14-6
Formula: C17H26O4
G387205
CCCCC[C@@H](CC(=O)CCC1=CC(=C(C=C1)O)OC)O
Standards; Enzyme Activators and Inhibitors; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-1,2-BIS((2S,5S)-2,5-DIETHYLPHOSPHOLANO)BENZENE
CAS:136779-28-7
Formula: C22H36P2
B016037
CC[C@H]1CC[C@@H](P1C2=CC=CC=C2P3[C@H](CC[C@@H]3CC)
(+)-1,2-BIS((2S,5S)-2,5-DIPHENYLPHOSPHOLANO)ETHANE
CAS:824395-67-7
Formula: C34H36P2
B430420
P1([C@H](C2=CC=CC=C2)CC[C@H]1C3=CC=CC=C3)CCP4[C@H]
Building Blocks; Chiral Molecules; Catalyst;
(+)-1,4-DI-O-BENZYL-D-THREITOL
CAS:91604-41-0
Formula: C18H22O4
D423075
C1=CC=C(C=C1)COC[C@H]([C@@H](COCC2=CC=CC=C2)O)O
Building Blocks; Miscellaneous;
(+)-1,4-DI-O-TOSYL-2,3-O-ISOPROPYLIDENE-D-THREITOL
CAS:51064-65-4
Formula: C21H26O8S2
D679265
CC1=CC=C(S(=O)(OC[C@@H]2[C@@H](COS(=O)(C3=CC=C(C)C
Standards; Chiral Molecules; Carbohydrates and Oligosaccharides;
(+)-1-(9-FLUORENYL)ETHANOL
CAS:107474-78-2
Formula: C15H14O
F647660
O[C@@H](C1C2=CC=CC=C2C3=CC=CC=C13)C
Building Blocks; Chiral Molecules; Miscellaneous;
(+)-1-(9-FLUORENYL)ETHYL CHLOROFORMATE
CAS:107474-79-3
Formula: C16H13ClO2
F647553
C[C@@H](C1C2=CC=CC=C2C3=CC=CC=C13)OC(Cl)=O
Building Blocks; Miscellaneous; Materials;
(+)-1-(9-FLUORENYL)ETHYL CHLOROFORMATE (18 MM IN ACETONE)
CAS:107474-79-3
Formula: C16H13ClO2
KIT9800
C[C@@H](C1C2=CC=CC=C2C3=CC=CC=C13)OC(Cl)=O
Building Blocks; Miscellaneous;
(+)-10-CAMPHORSULFONIMINE
CAS:107869-45-4
Formula: C10H15NO2S
C175138
CC1([C@H]2CC[C@@]13CS(=O)(=O)N=C3C2)C
Building Blocks; Chiral Molecules;
(+)-13A-HYDROXYLUPANINE
CAS:15358-48-2
Formula: C15H24N2O2
H943795
O=C1CCC[C@@]2([H])N1C[C@@]3([H])[C@@](C[C@@H](O)CC
Research Tools; Chiral Molecules;
(+)-13SS-ETHYL-17SS-HYDROXY-11-METHYLENEGON-4-EN-3-ONE
CAS:220332-82-1
Formula: C20H28O2
E917705
Standards; Chiral Molecules; Steroids;
(+)-15-DEOXYSPERGUALIN TRIHYDROCHLORIDE
CAS:220442-79-5
Formula: C17H37N7O3 · HCl
D263425
O=C(N[C@H](O)C(NCCCCNCCCN)=O)CCCCCCNC(N)=N.[3 HCl]
Standards; Chiral Molecules; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-18-METHOXYCORONARIDINE HYDROCHLORIDE
CAS:266686-75-3
Formula: C22H29ClN2O3
M262205
[H][C@@](C1[N@](CC2)C3)(CCOC)CC3C[C@@]1(C4=C2C5=CC
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-18-METHOXYCORONARIDINE-D4 HYDROCHLORIDE
Formula: C22H25D4ClN2O3
M262207
[H][C@@](C1[N@](C([2H])([2H])C2([2H])[2H])C3)(CCOC
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-19-NORANDROST-4-ENE-3,17-DIONE
CAS:734-32-7
Formula: C18H24O2
N661000
O=C1[C@@]2(C)CC[C@@]3([H])[C@@]([C@]2([H])CC1)([H]
Standards; Steroids; Pharmaceutical/API Drug Impurities/Metabolites; Controlled Substances and Drugs of Abuse for Forensic Testing;
(+)-2,9-BIS(DESMETHOXY)-2,9-DIHYDROXY-GLAUCINE HYDROCHLORIDE
CAS:16625-69-7
Formula: C19H22ClNO4
G406903
CN1CCC2=CC(=C(C3=C2[C@@H]1CC4=CC(=C(C=C43)OC)O)OC)
Standards; Chiral Molecules; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-2-AMINO-6-PROPIONAMIDO-D3-TETRAHYDROBENZOTHIAZOLE
CAS:1217680-69-7
Formula: C10H12D3N3OS
A628157
C([2H])([2H])([2H])CC(=N[C@@H]1CCC2=C(C1)SC(=N)N2)
Building Blocks; Chiral Molecules; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-2-BUTANOL
CAS:4221-99-2
Formula: C4H10O
B699858
C[C@H](O)CC
Building Blocks;
(+)-2-CARENE
CAS:4497-92-1
Formula: C10H16
C279320
CC1=C[C@H]2[C@H](C2(C)C)CC1
(+)-2-HYDROXYPINOCAMPHONE
CAS:20536-50-9
Formula: C10H16O2
H952005
Standards; Natural Products;
(+)-20-HYDROXYECDYSONE
CAS:5289-74-7
Formula: C27H44O7
H918750
O[C@@H]1[C@H](O)C[C@](C(C=C2[C@]3([H])CC[C@@]4(C)[
Research Tools; Steroids; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-20-HYDROXYECDYSONE-D3
Formula: C27H41D3O7
H918752
O[C@@H]1[C@H](O)C[C@](C(C=C2[C@]3([H])CC[C@@]4(C)[
Standards; Isotopic Labeled Analogues; Steroids;
(+)-2A,10-EPOXYPINANE
CAS:56246-58-3
Formula: C10H16O
E562465
CC1(C)[C@@H]2[C@@]3(OC3)CC[C@H]1C2
Building Blocks; Chiral Molecules;
(+)-3',4',3,5,7-PENTA-O-BENZYLCATECHIN
CAS:85443-49-8
Formula: C50H44O6
P237830
C1(OCC2=CC=CC=C2)=CC(OCC3=CC=CC=C3)=C(C[C@H](OCC4=
Building Blocks; Chiral Molecules; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-3',5'-O-(1,1,3,3-TETRAISOPROPYL-1,3-DISILOXANEDIYL)CYTIDINE
CAS:69304-42-3
Formula: C21H39N3O6Si2
D449793
NC(C=CN1[C@H]2[C@H](O)[C@H]3[C@@H](CO[Si](C(C)C)(C
Building Blocks; Chiral Molecules;
(+)-3,4,4A,5,6,10B-HEXAHYDRO-2H-NAPHTHO[1,2-B][1,4]OXAZIN-9-OL HYDROCHLORIDE
CAS:858517-21-2
Formula: C12H15NO2 • HCl
H294075
[H][C@]12NCCO[C@]1([H])C3=C(C=CC(O)=C3)CC2.Cl
Standards; Chiral Molecules; Neurochemicals; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-3,4,4A,5,6,10B-HEXAHYDRO-9-METHOXY-2H-NAPHTHO[1,2-B][1,4]OXAZIN, HYDROCHLORIDE
CAS:1422164-57-5
Formula: C13H18ClNO2
H294125
[H][C@]12NCCO[C@]1([H])C3=C(C=CC(OC)=C3)CC2.Cl
Standards; Chiral Molecules; Neurochemicals; Ephedrine; Phenethylamines/Amphetamines;
(+)-3,4,4A,5,6,10B-HEXAHYDRO-9-METHOXY-2H-NAPHTHO[1,2-B][1,4]OXAZIN-3-ONE
CAS:153153-60-7
Formula: C13H15NO3
H294150
[H][C@]12NC(CO[C@]1([H])C3=C(C=CC(OC)=C3)CC2)=O
Standards; Chiral Molecules; Neurochemicals;
(+)-3,4-METHYLENEDIOXYMETHAMPHETAMINE
CAS:66142-89-0
Formula: C11H15NO2
M336250
C[C@H](NC)CC1=CC=C2C(OCO2)=C1
Standards; Controlled Substances and Drugs of Abuse for Forensic Testing; Phenethylamines/Amphetamines;
(+)-3-(2-CARBOXYPIPERAZIN-4-YL)-PROPYL-1-PHOSPHORIC ACID
CAS:100828-16-8
Formula: C8H17N2O5P
C181505
OC(C1NCCN(CCCP(O)(O)=O)C1)=O
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-3-(TRIFLUOROACETYL)CAMPHOR
CAS:51800-98-7
Formula: C12H15F3O2
T790005
CC1(C)[C@@H]2CC[C@]1(C)C(C2C(C(F)(F)F)=O)=O
Building Blocks; Miscellaneous;
(+)-3-BROMO-8-CAMPHORSULFONIC ACID
CAS:5344-58-1
Formula: C10H15BrO4S
B682050
Br[C@@H]1C2CC[C@]([C@@]2(CS(=O)(O)=O)C)(C)C1=O
Building Blocks; Chiral Molecules;
(+)-3-BROMOCAMPHOR
CAS:10293-06-8
Formula: C10H15BrO
B678988
CC1(C)C2CCC1(C)C(=O)C2Br
Building Blocks; Chiral Molecules;
(+)-3-CARBOXY-2,2,5,5-TETRAMETHYLPYRROLIDINYL-1-OXY
CAS:50525-83-2
Formula: C9H16NO3
C182760
CC1(C)N([O])C(C)(C)C[C@H]1C(O)=O
Research Tools; Spin Labels;
(+)-4'-CHLOROTARTRANILIC ACID
CAS:748753-38-0
Formula: C10H10NO5Cl
C433068
C1=C(C=CC(=C1)NC(=O)[C@@H]([C@H](C(=O)O)O)O)Cl
Building Blocks; Miscellaneous;
(+)-4'-FLUOROTARTRANILIC ACID
CAS:206761-65-1
Formula: C10H10NO5F
F598738
C1=C(C=CC(=C1)NC(=O)[C@@H]([C@H](C(=O)O)O)O)F
Building Blocks; Miscellaneous;
(+)-4'-METHYLTARTRANILIC ACID
CAS:206761-79-7
Formula: C11H13NO5
M263715
CC1=CC=C(C=C1)NC(=O)[C@@H]([C@H](C(=O)O)O)O
Building Blocks; Miscellaneous;
(+)-4'-NITROTARTRANILIC ACID
CAS:60908-35-2
Formula: C10H10N2O7
N572345
C1=CC(=CC=C1NC(=O)[C@@H]([C@H](C(=O)O)O)O)[N+](=O)
Building Blocks; Miscellaneous;
(+)-4,5-BIS[HYDROXY(DIPHENYL)METHYL]-2-METHYL-2-PHENYL-1,3-DIOXOLANE
CAS:109306-21-0
Formula: C36H32O4
B447443
CC1(C2=CC=CC=C2)O[C@H]([C@H](C(C3=CC=CC=C3)(C4=CC=
Building Blocks; Chiral Molecules;
(+)-5-DEOXYSTRIGOL
CAS:151716-18-6
Formula: C19H22O5
D263700
O=C1/C([C@H]([C@@H]2O1)CC3=C2C(C)(C)CCC3)=C/O[C@H]
Standards; Environmental Standards, Mutagens and Metabolites;
(+)-6-AMINOPENICILLANIC ACID
CAS:551-16-6
Formula: C8H12N2O3S
A618895
CC1(C)[C@H](C(=O)O)N2C(=O)[C@H]([C@H]2S1)N
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-6-AMINOPENICILLANIC ACID-D3
Formula: C8H9D3N2O3S
A618897
[H][C@@]1([C@H](N)C2=O)N2[C@@H](C(O)=O)[C@@](C([2H
Standards; Isotopic Labeled Analogues; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-8-DEMETHYLISOAMBROX
CAS:82079-83-2
Formula: C15H26O
D230480
Building Blocks; Miscellaneous;
(+)-8-METHOXYGONIODIOL
CAS:525589-82-6
Formula: C14H16O4
M263275
O[C@H]1C[C@H](N2C=C(/C=C/C(NCCCCCCN)=O)C(NC2=O)=O)
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-9-DEME-DTBZ
CAS:1065193-59-0
Formula: C18H27NO3
D230745
OC1=C(OC)C=C2C(CCN(C[C@@H](CC(C)C)[C@H](O)C3)[C@@]
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-9-DEME-DTBZ-D3
Formula: C18H24D3NO3
D230742
[H][C@]12N(C[C@@H](CC(C)C)[C@H](O)C2)CCC3=CC(O)=C(
Standards; Isotopic Labeled Analogues; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-A-ACETYLMETHADOL HYDROCHLORIDE
CAS:53757-35-0
Formula: C23H32ClNO2
A186320
CC[C@@H](OC(C)=O)C(C1=CC=CC=C1)(C2=CC=CC=C2)C[C@H]
Standards; Pharmaceutical/API Drug Impurities/Metabolites; Controlled Substances and Drugs of Abuse for Forensic Testing;
(+)-A-BENIDIPINE HYDROCHLORIDE
CAS:129262-08-4
Formula: C28H32ClN3O6
B157495
CC(=O)NCCC(O)=O
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-A-CYPERONE
CAS:473-08-5
Formula: C15H22O
C989595
Fc1cc2c(OCCC2)cc1
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-A-DIHYDROTETRABENAZINE
CAS:85081-18-1
Formula: C19H29NO3
D453615
[H][C@]12N(C[C@@H](CC(C)C)[C@H](O)C2)CCC3=CC(OC)=C
Standards; Enzyme Activators and Inhibitors; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-A-DIHYDROTETRABENAZINE-13C2D6
Formula: C1713C2H23D6NO3
D453617
[H][C@]12N(C[C@@H](CC(C)C)[C@H](O)C2)CCC3=CC(O[13C
Standards; Isotopic Labeled Analogues; Enzyme Activators and Inhibitors; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-A-METHOXY-A-(TRIFLUOROMETHYL)PHENYLACETIC ANHYDRIDE
CAS:85541-57-7
Formula: C20H16F6O5
A576045
COC(C1=CC=CC=C1)(C(=O)OC(=O)C(C2=CC=CC=C2)(C(F)(F)
Building Blocks; Chiral Molecules;
(+)-A-METHYL-SS-ALANINE
CAS:4249-19-8
Formula: C4H9NO2
M276560
C[C@@H](CN)C(=O)O
Building Blocks; Chiral Molecules; Miscellaneous;
(+)-A-METHYL-SS-ALANINE HYDROCHLORIDE
CAS:925704-45-6
Formula: C4H9NO2• HCi
M276555
C[C@@H](CN)C(=O)O.Cl
Building Blocks; Miscellaneous;
(+)-A-METHYLBENZYLAMINE (-)-2,2-DIMETHYLCYCLOPROPANECARBOXYLATE
CAS:28624-56-8
Formula: C6H10O2 • C8H11N
D286245
N[C@H](C)C1=CC=CC=C1.CC2(C)C[C@H]2C(O)=O
Building Blocks; Chiral Molecules; Miscellaneous;
(+)-A-NORACETYLMETHADOL HYDROCHLORIDE
Formula: C22H30ClNO2
N660590
CC[C@@H](OC(C)=O)C(C1=CC=CC=C1)(C2=CC=CC=C2)C[C@@H
Standards; Pharmaceutical/API Drug Impurities/Metabolites; Controlled Substances and Drugs of Abuse for Forensic Testing;
(+)-A-PRODINE HYDROCHLORIDE
CAS:17046-73-0
Formula: C16H23NO2 • HCl
P170460
CN1CC[C@](C2=CC=CC=C2)(OC(CC)=O)[C@H](C)C1.Cl
Standards;
(+)-ABSCISIC ALDEHYDE
CAS:41944-86-9
Formula: C15H20O3
A110005
O=C1CC(C)(C)[C@@](O)(/C=C/C(C)=C\C([H])=O)C(C)=C1
Standards; Chiral Molecules;
(+)-AJ 76 HYDROCHLORIDE
CAS:85378-82-1
Formula: C15H23NO • HCl
A965388
CCCN[C@@H]1CCC2=C(C=CC=C2[C@@H]1C)OC.Cl
Building Blocks; Miscellaneous;
(+)-ALLOCOCAINE HYDROCHLORIDE
Formula: C17H22ClNO4
A545025
[H][C@@]1(C(OC)=O)[C@@]([H])(OC(C2=CC=CC=C2)=O)C[C
Standards; Enzyme Activators and Inhibitors; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-ALLOHYDROXYCITRIC ACID
CAS:27750-11-4
Formula: C6H8O8
A546295
OC(C[C@@](C(O)=O)(O)[C@H](O)C(O)=O)=O
Standards; Enzyme Activators and Inhibitors; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-ALLOPSEUDOCOCAINE HYDROCHLORIDE
CAS:131829-34-0
Formula: C17H22ClNO4
A545035
[H][C@]1(C(OC)=O)[C@@]([H])(OC(C2=CC=CC=C2)=O)C[C@
Standards; Enzyme Activators and Inhibitors; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-ALPHA-TOCOPHEROL SULFO-NHS SUCCINATE
CAS:1644658-47-8
Formula: C37H56NO10SNa
A221575
CC1=C(C(=C(C2=C1O[C@](CC2)(C)CCC[C@H](C)CCC[C@H](C
(+)-AMABILINE
CAS:17958-43-9
Formula: C15H25NO4
A575970
O[C@@H](C)C(C(OCC1=CCN2[C@@]1([H])CCC2)=O)(O)C(C)C
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-ANABASINE HYDROCHLORIDE
CAS:53912-89-3
Formula: C10H14N2 • HCl
A637185
C1([C@H]2NCCCC2)=CC=CN=C1.Cl
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-ANATOXIN A HYDROCHLORIDE
CAS:64314-16-5
Formula: C10H15NO • HCl
A653360
O=C(C)C1=CCCC2CCC1N2.Cl
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-ANATOXIN A-D6
Formula: C10H12D3NO
A637252
n1ccc(cc1)CNc2c(cccn2)C(=O)Nc3cc4c(cc3)C(C)(C)CN4
Standards; Natural Products;
(+)-ANGELMARIN
CAS:876384-53-1
Formula: C23H20O6
A637600
CC(C)([C@@H]1CC2=C(O1)C=CC3=C2OC(=O)C=C3)OC(=O)/C=
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-ANYMOL
CAS:76738-75-5
Formula: C15H26O
A697863
C[C@@](O)([C@]1([H])CCC(C)=CC1)CC/C=C(C)/C
Building Blocks; Miscellaneous;
(+)-ANYMOL-D3
Formula: C15H23D3O
A697864
O=C(OC(C)(C)C)N1C[C@H](C(F)(F)F)NCC1
Standards; Isotopic Labeled Analogues;
(+)-APHIDICOLIN
CAS:38966-21-1
Formula: C20H34O4
A726260
Standards; Pharmaceutical/API Drug Impurities/Metabolites; Anti-virals/Anti-retrovirals;
(+)-AR-TURMERONE
CAS:532-65-0
Formula: C15H20O
T897275
C[C@@H](CC(/C=C(C)/C)=O)C1=CC=C(C)C=C1
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-AR-TURMERONE-D3
Formula: C15H17D3O
T897277
O=C(CC(C1=CC=C(C)C=C1)C([2H])([2H])[2H])/C=C(C)/C
Standards; Isotopic Labeled Analogues; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-ARABINOGALACTAN (TECHNICAL GRADE)
CAS:9036-66-2
Formula: N/A
A764213
FC1=CC=C(OC(CO)=C2)C2=C1
Building Blocks;
(+)-AROMADENDRENE
CAS:489-39-4
Formula: C15H24
A794200
C[C@H](CC1)[C@]2([H])[C@]1([H])C(CC[C@@H]3[C@H]2C3
Standards; Pharmaceutical/API Drug Impurities/Metabolites; Anti-virals/Anti-retrovirals;
(+)-AUSTRODORAL
CAS:511546-04-6
Formula: C14H24O
A484525
[H][C@]12C(C)(C)CCC[C@]1(C)[C@@](C([H])=O)(C)CC2
Standards; Pharmaceutical/API Drug Impurities/Metabolites; Anti-virals/Anti-retrovirals;
(+)-AUSTRODORIC ACID
CAS:511546-05-7
Formula: C14H24O2
A484520
[H][C@]12C(C)(C)CCC[C@]1(C)[C@@](C(O)=O)(C)CC2
Standards; Pharmaceutical/API Drug Impurities/Metabolites; Anti-virals/Anti-retrovirals;
(+)-AVARONE
CAS:55303-99-6
Formula: C21H28O2
A794683
O=C1C(C[C@]2(C)[C@@H](C)CC[C@]3(C)C(C)=CCC[C@@]23[
Standards; Pharmaceutical/API Drug Impurities/Metabolites; Antibotics;
(+)-BAY-1251152
CAS:1610358-56-9
Formula: C19H18F2N4O2S
B119025
N=S(CC1=CC(NC2=NC=C(F)C(C3=CC=C(F)C=C3OC)=C2)=NC=C
Standards; Enzyme Activators and Inhibitors; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-BENZOTETRAMISOLE
CAS:885051-07-0
Formula: C15H12N2S
B677463
C1=CC=C(C=C1)[C@@H]2CN3C4=CC=CC=C4SC3=N2
Building Blocks; Chiral Molecules;
(+)-BENZYLMETHYLPHENYLSILYLACETIC ACID
CAS:95373-54-9
Formula: C16H18O2Si
B535613
C[Si](CC1=CC=CC=C1)(CC(=O)O)C2=CC=CC=C2
Building Blocks; Chiral Molecules;
(+)-BERBAMINE DIHYDROCHLORIDE
CAS:6078-17-7
Formula: C37H40N2O6 • 2(HCl)
B119590
BrC1=C(C(C=CC=C2)=C2Br)C=C(Br)C=C1
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-BERBAMUNINE
CAS:485-18-7
Formula: C36H40N2O6
B125400
OC1=C(OC)C=C(CCN(C)[C@H]2CC3=CC=C(OC4=C(O)C=CC(C[C
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-BETULONIC ACID
CAS:4481-62-3
Formula: C30H46O3
B330270
CCOC(=O)Cc1c(O)cccc1
Building Blocks; Chiral Molecules; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-BICIFADINE HYDROCHLORIDE
CAS:66504-82-3
Formula: C12H16ClN
B382240
CC1=CC=C(C=C1)[C@@]23C[C@@H]2CNC3.Cl
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-BIOTIN (+)-SULFOXIDE
CAS:10406-89-0
Formula: C10H16N2O4S
B389050
O=[S]1[C@H]([C@](NC2=O)([H])[C@](N2)([H])C1)CCCCC(
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-BIOTIN 4-AMIDOBENZOIC ACID, SODIUM SALT
CAS:102418-74-6
Formula: C17H20N3NaO4S
B389060
O=C1N[C@@H]2[C@@H]([C@H](CCCCC(NC3=CC=C(C(O[Na])=O
Research Tools; Molecular Biology; Fluorescent Reagents;
(+)-BIOTIN METHYL ESTER
CAS:608-16-2
Formula: C11H18N2O3S
B390480
O=C1N[C@@H]2[C@@H]([C@H](CCCCC(OC)=O)SC2)N1
Building Blocks; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-BIOTIN-(PEO)3-MALEIMIDE(I)
CAS:305372-39-8
Formula: C23H35N5O7S
B016526
C1[C@H]2[C@@H]([C@@H](S1)CCCCC(=O)NCCOCCOCCNC(=O)C
(+)-BIOTIN-PEG3 ACID
CAS:252881-76-8
Formula: C19H33N3O7S
B390628
O=C(O)CCOCCOCCOCCNC(CCCC[C@H]1[C@@H]2[C@@H](NC(N2)
Building Blocks; Chiral Molecules;
(+)-BIOTIN-PFP-ESTER
CAS:120550-35-8
Formula: C16H15F5N2O3S
B389030
O=C(OC(C(F)=C(F)C(F)=C1F)=C1F)CCCC[C@H]2[C@](NC3=O
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-BIOTIN-SARCOSINE
CAS:154024-76-7
Formula: C13H21N3SO4
B016478
CN(CC(=O)O)C(=O)CCCC[C@H]1[C@@H]2[C@H](CS1)NC(=O)N
(+)-BIOTINOL
CAS:53906-36-8
Formula: C10H18N2O2S
B539060
O=C1NC2C(CS[C@H]2CCCCCO)N1
Building Blocks; Miscellaneous;
(+)-BIOTINYL 3,6,9-TRIOXAUNDECANEDIAMINE
CAS:359860-27-8
Formula: C18H34N4O5S
B395045
NCCOCCOCCOCCNC(CCCC[C@H]1[C@@H]2[C@@H](NC(N2)=O)CS
Building Blocks; Cross-linkers;
(+)-BIS[(R)-1-PHENYLETHYL]AMINE
CAS:23294-41-9
Formula: C16H19N
B413730
C[C@H](C1=CC=CC=C1)N[C@H](C)C2=CC=CC=C2
Building Blocks; Chiral Molecules;
(+)-BORNEOL GLUCURONATE
Formula: C16H26O7
B675570
CC1(C)[C@]2(C)CC[C@@H]1CC2OC([C@H]3[C@@H](O)[C@H](
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-BORNEOL HYDROGEN SULFATE
Formula: C10H18O4S
B675565
CC1(C)[C@]2(C)CC[C@@H]1CC2OS(=O)(O)=O
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-BORNYL ACETATE
CAS:20347-65-3
Formula: C12H20O2
B675535
O=C(C)O[C@H]1[C@@]2(C)CC[C@H](C2(C)C)C1
Building Blocks; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-BRUSATOL
CAS:14907-98-3
Formula: C26H32O11
B701056
CC(=CC(=O)O[C@@H]1[C@@H]2[C@]34CO[C@@]2([C@H]([C@@
Standards; Enzyme Activators and Inhibitors; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-BULBOCAPNINE
CAS:298-45-3
Formula: C19H19NO4
B215015
CN1CCC2=CC3=C(C4=C2[C@@H]1CC5=C4C(=C(C=C5)OC)O)OCO
(+)-BULBOCAPNINE HYDROCHLORIDE
CAS:632-47-3
Formula: C19H19NO4 •HCl
B694325
OC1=C2C(C[C@@]3([H])C(C2=C(OCO4)C4=C5)=C5CCN3C)=CC
Standards; Enzyme Activators and Inhibitors; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-BUTACLAMOL HYDROCHLORIDE
CAS:55528-07-9
Formula: C25H31NO •HCl
B694310
CC(C)(C)[C@@](CC1)(O)C[C@@](N1C2)([H])C3=CC=CC4=C3
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-BYAKANGELICIN
CAS:482-25-7
Formula: C17H18O7
B810928
O=C1C=CC2=C(OC)C3=C(OC=C3)C(OC[C@@H](O)C(C)(O)C)=C
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-CALANOLIDE A
CAS:142632-32-4
Formula: C22H26O5
C125000
O=C1C=C(C2=C(O1)C([C@H]3O)=C(O[C@H](C)[C@H]3C)C4=C
Research Tools;
(+)-CALYSTEGINE A3
CAS:131580-36-4
Formula: C7H13NO3
C148950
O[C@@]1(N2)[C@@H](O)[C@H](O)C[C@H]2CC1
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-CAMPHENE
CAS:5794-03-6
Formula: C10H16
C173133
CC1([C@H](CC2)C[C@H]2C1=C)C
Building Blocks; Miscellaneous;
(+)-CAMPHENE-13C,D2
Formula: C913CH14D2
C173134
[2H]/[13C]([2H])=C1C(C)(C)[C@@H]2CC[C@H]\1C2
Building Blocks; Isotopic Labeled Analogues;
(+)-CARDIOBUTANOLIDE
CAS:532439-71-7
Formula: C13H16O6
C183405
O[C@@H]([C@@H]([C@@H](C1=CC=CC=C1)O)O)C2OC(C[C@H]2
Standards; Natural Products;
(+)-CARNITINE BENZYL ESTER CHLORIDE
CAS:14548-21-1
Formula: C14H22ClNO3
C184140
OC(CC(OCC1=C[C]=CC=C1)=O)C[N+](C)(C)C.[Cl-]
Building Blocks; Amino Acids; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-CARNITINE HYDROCHLORIDE
CAS:10017-44-4
Formula: C7H16ClNO3
C279410
C[N+](C)(C)C[C@H](CC(=O)O)O.[Cl-]
(+)-CAROTOL
CAS:465-28-1
Formula: C15H26O
C058510
O[C@@]1([C@@H](C(C)C)CC2)[C@]2(CC=C(C)CC1)C
Standards; Natural Products; Extracted;
(+)-CATECHIN
CAS:154-23-4
Formula: C15H14O6
C217500
OC1=CC([C@@H](O2)[C@@H](O)CC3=C2C=C(O)C=C3O)=CC=C1
Standards; Chiral Molecules; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-CATECHIN GALLATE-13C3
Formula: C1913C3H18O10
C217517
OC1=CC(O)=C([13CH2][13C@H](OC(C2=CC(O)=C(O)C(O)=C2
Standards; Isotopic Labeled Analogues; Enzyme Activators and Inhibitors; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-CATECHIN MONOHYDRATE
CAS:225937-10-0
Formula: C15H14O6•H2O
C217518
O[C@H]1CC2=C(O)C=C(O)C=C2O[C@@H]1C3=CC=C(O)C(O)=C3
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-CATECHIN-13C3
CAS:1261254-33-4
Formula: C1213C3H14O6
C217503
OC1=CC(O)=C([13CH2][13C@H](O)[13C@@H](C2=CC=C(O)C(
Standards; Isotopic Labeled Analogues; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-CATECHIN-D4
Formula: C15H10D4O6
C217501
[2H]C1([2H])C2=C(O)C([2H])=C(O)C([2H])=C2O[C@H](C3
Standards; Isotopic Labeled Analogues; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-CEDROL
CAS:77-53-2
Formula: C15H26O
C228820
CC1=NC(C(F)(F)F)=NC=C1C(O)=O
Standards; Chiral Molecules;
(+)-CEMBRENE
CAS:1898-13-1
Formula: C20H32
C256558
C/C/1=C/CC/C(=C\C/C=C(\C=C/C(CC1)C(C)C)/C)/C
Standards; Environmental Standards, Mutagens and Metabolites;
(+)-CHLORO(P-MENTH-3-YLOXY)DIMETHYLSILANE
CAS:19470-77-0
Formula: C12H25ClOSi
C194705
CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O[Si](C)(Cl)C
Research Tools; Molecular Biology; Enzyme Activators and Inhibitors;
(+)-CHLOROPSEUDOEPHEDRINE HYDROCHLORIDE (~90%)
CAS:94133-42-3
Formula: C10H14ClN • HCl
C585378
CN[C@@H](C)[C@@H](Cl)C1=CC=CC=C1.Cl
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-CI 1044
CAS:197894-84-1
Formula: C23H19N5O2
C441005
O=C(C1=CC=CN=C1)N[C@H]2C(N3C4=C(CC3)C=C(N)C=C4C(C5
Research Tools; Molecular Biology; Enzyme Activators and Inhibitors;
(+)-CIS,TRANS-ABSCISIC ACID
CAS:14398-53-9
Formula: C15H20O4
A110004
CC(/C=C/[C@@](C(C)=C1)(O)C(CC1=O)(C)C)=C/C(O)=O
Standards; Environmental Standards, Mutagens and Metabolites;
(+)-CIS,TRANS-ABSCISIC ACID
CAS:21293-29-8
Formula: C15H20O4
A110000
CC1(C)CC(C=C(C)[C@@]1(/C=C/C(C)=C\C(O)=O)O)=O
Standards; Chiral Molecules;
(+)-CIS,TRANS-ABSCISIC ACID-D6
CAS:35671-08-0
Formula: C15H14D6O4
A110003
CC(/C=C/[C@@](C(C([2H])([2H])[2H])=C1[2H])(O)C(C([
Standards; Isotopic Labeled Analogues; Environmental Standards, Mutagens and Metabolites;
(+)-CIS,TRANS-ABSCISIC ACID-D6
CAS:721948-65-8
Formula: C15H14D6O4
A110002
CC(/C=C/[C@@]1(O)C(C([2H])([2H])[2H])=C([2H])C(C([
Standards; Chiral Molecules; Isotopic Labeled Analogues;
(+)-CIS,TRANS-ABSCISIC ACID-GLYCINE
CAS:1285591-89-0
Formula: C20H29NO5S
A110060
CC1=CC(CC(C)(C)[C@]1(O)/C=C/C(C)=C\C(N[C@@H](CCSC)
Standards; Environmental Standards, Mutagens and Metabolites;
(+)-CIS,TRANS-ABSCISIC ACID-L-ALANINE
CAS:1285591-80-1
Formula: C18H25NO5
A110065
CC1=CC(CC(C)(C)[C@]1(O)/C=C/C(C)=C\C(N[C@H](C(O)=O
Standards; Environmental Standards, Mutagens and Metabolites;
(+)-CIS,TRANS-ABSCISIC ACID-L-ASPARTIC ACID
CAS:1285592-10-0
Formula: C19H25NO7
A110085
CC1=CC(CC(C)(C)[C@]1(O)/C=C/C(C)=C\C(N[C@@H](CC(O)
Standards; Environmental Standards, Mutagens and Metabolites;
(+)-CIS,TRANS-ABSCISIC ACID-L-GLUTAMIC ACID
CAS:1285592-12-2
Formula: C20H27NO7
A110045
O=C1C=C(C)[C@](/C=C/C(C)=C\C(N[C@@H](CCC(O)=O)C(O)
Standards; Environmental Standards, Mutagens and Metabolites;
(+)-CIS,TRANS-ABSCISIC ACID-L-ISOLEUCINE
CAS:1285591-88-9
Formula: C21H31NO5
A110080
CC1=CC(CC(C)(C)[C@]1(O)/C=C/C(C)=C\C(N[C@@H]([C@@H
Standards; Environmental Standards, Mutagens and Metabolites;
(+)-CIS,TRANS-ABSCISIC ACID-L-LEUCINE
CAS:1285591-85-6
Formula: C21H31NO5
A110075
CC1=CC(CC(C)(C)[C@]1(O)/C=C/C(C)=C\C(N[C@@H](CC(C)
Standards; Environmental Standards, Mutagens and Metabolites;
(+)-CIS,TRANS-ABSCISIC ACID-L-PHENYLALANINE
CAS:1285591-91-4
Formula: C24H29NO5
A110050
O=C(/C=C(C)\C=C\C(C(C)(C)C1)(O)C(C)=CC1=O)N[C@H](C
Standards; Environmental Standards, Mutagens and Metabolites;
(+)-CIS,TRANS-ABSCISIC ACID-L-PROLINE
CAS:1285591-90-3
Formula: C20H27NO5
A110090
O=C(/C=C(C)\C=C\[C@]1(O)C(C)=CC(CC1(C)C)=O)N2CCC[C
Standards; Environmental Standards, Mutagens and Metabolites;
(+)-CIS,TRANS-ABSCISIC ACID-L-TRYPTOPHAN
CAS:1285591-94-7
Formula: C26H30N2O5
A110055
O=C(O)[C@@H](NC(/C=C(C)\C=C\[C@@](C(C)=C1)(O)C(C)(
Standards; Environmental Standards, Mutagens and Metabolites;
(+)-CIS,TRANS-ABSCISIC ACID-L-TYROSINE
CAS:1285592-04-2
Formula: C24H29NO6
A110095
OC1=CC=C(C[C@@H](C(O)=O)NC(/C=C(\C=C\[C@]2(O)C(C)=
Standards; Environmental Standards, Mutagens and Metabolites;
(+)-CIS,TRANS-ABSCISIC ACID-L-VALINE
CAS:1285591-82-3
Formula: C20H29NO5
A110070
CC1=CC(CC(C)(C)[C@]1(O)/C=C/C(C)=C\C(N[C@@H](C(C)C
Standards; Environmental Standards, Mutagens and Metabolites;
(+)-CIS-10-METHOXYVINCAMINE
CAS:57430-34-9
Formula: C22H28N2O4
M271765
O[C@@](C[C@]1(CC)CCC2)(C(OC)=O)N3C4=CC=C(OC)C=C4C5
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-CIS-2-BENZAMIDOCYCLOHEXANECARBOXYLIC ACID
CAS:26685-82-5
Formula: C14H17NO3
C290350
C1CC[C@H]([C@H](C1)C(=O)O)NC(=O)C2=CC=CC=C2
(+)-CIS-ABIENOL
CAS:17990-16-8
Formula: C20H34O
A107600
C=C/C(C)=C\C[C@@H]1[C@]2(C)[C@@](C(C)(C)CCC2)([H])
Building Blocks; Miscellaneous; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-CIS-ANTI-N2-BPDE-DG
CAS:66141-82-0
Formula: C30H27N5O7
B676645
COc1cc2c(cc1)[C@H]3[C@@H](CC2)[C@@H]4[C@@](CC3)(C)
Standards; Pharmaceutical/API Drug Impurities/Metabolites; Environmental Standards, Mutagens and Metabolites;
(+)-CIS-ANTI-N2-BPDE-DG-D8
Formula: C30H19D8N5O7
B676647
[Na+].[Na+].[Na+].O=S([O-])(=O)Oc1cc2c(cc1)[C@@H]3
Standards; Isotopic Labeled Analogues; Pharmaceutical/API Drug Impurities/Metabolites; Environmental Standards, Mutagens and Metabolites;
(+)-CIS-CHRYSANTHEMIC ACID
CAS:26771-11-9
Formula: C10H16O2
C596180
O=C1N(CCC2=CC=C(Br)C=C2)C(C3=C1C=CC=C3)=O
Standards; Miscellaneous;
(+)-CIS-DILTIAZEM-D3 HCL (ACETOXY-D3)
CAS:1217860-13-3
Formula: C22H24D3ClN2O4S
D460621
O=C1N(CCN(C)C)C2=CC=CC=C2S[C@@H](C3=CC=C(OC)C=C3)[
Standards; Chiral Molecules; Isotopic Labeled Analogues; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-CIS-KHELLACTONE
CAS:24144-61-4
Formula: C14H14O5
K432105
O[C@@H]1C(C(OC2=O)=C(C=C2)C=C3)=C3OC(C)(C)[C@@H]1O
Standards; Chiral Molecules;
(+)-CIS-PENTAZOCINE
CAS:7361-76-4
Formula: C19H27NO
P274290
Clc1nc(nc(Cl)n1)Nc2c(Cl)cccc2
Standards; Pharmaceutical/API Drug Impurities/Metabolites; Controlled Substances and Drugs of Abuse for Forensic Testing;
(+)-CIS-PENTAZOCINE N-OXIDE
Formula: C19H27NO2
P274330
OC1=CC2=C(C=C1)C[C@H]([C@@H](C)[C@]2(C)CC3)N3(C/C=
Standards; Pharmaceutical/API Drug Impurities/Metabolites; Controlled Substances and Drugs of Abuse for Forensic Testing;
(+)-CIS-PERMETHRINIC ACID
CAS:55667-40-8
Formula: C8H10Cl2O2
P287710
CCOC(=O)C[N+](=O)[O-]
Standards; Environmental Standards, Mutagens and Metabolites;
(+)-CIS-PHENOTHRIN
CAS:51186-88-0
Formula: C23H26O3
P318100
O=C([C@@H]1[C@@H](C1(C)C)/C=C(C)\C)OCC2=CC(OC3=CC=
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-CIS-TRAMADOL (S)-(+)-MANDELATE
CAS:280565-80-2
Formula: C24H33NO5
C068685
CN(C)CC1CCCC[C@@]1(C2=CC(=CC=C2)OC)O.C1=CC=C(C=C1)
(+)-CIS-VINCAMINIC ACID ETHYL ESTER
CAS:40163-56-2
Formula: C22H28N2O3
V314210
[H][C@]12[C@]3(CC)C[C@@](C(OCC)=O)(O)N(C1=C4CCN2CC
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-CIS-VINCAMINIC ACID ETHYL-D5 ESTER
Formula: C22H23D5N2O3
V314212
[H][C@]12[C@]3(CC)C[C@@](C(OC([2H])([2H])C([2H])([
Building Blocks; Isotopic Labeled Analogues;
(+)-CITRAMALIC ACID
CAS:6236-09-5
Formula: C5H8O5
C520525
O[C@@](C)(CC(O)=O)C(O)=O
Building Blocks; Chiral Molecules;
(+)-CITRONELLAL
CAS:2385-77-5
Formula: C10H18O
C525025
C/C(C)=C\CC[C@@H](C)CC=O
Standards; Natural Products;
(+)-COCAINE HYDROCHLORIDE
CAS:113775-05-6
Formula: C17H22ClNO4
C633475
[H][C@@]1(C(OC)=O)[C@]([H])(OC(C2=CC=CC=C2)=O)C[C@
Standards; Enzyme Activators and Inhibitors; Pharmaceutical/API Drug Impurities/Metabolites; Controlled Substances and Drugs of Abuse for Forensic Testing;
(+)-COCLAURINE HYDROCHLORIDE
CAS:19894-19-0
Formula: C17H19NO3•HCl
C633555
OC1=CC2=C(C=C1OC)CCN[C@@H]2CC3=CC=C(O)C=C3.Cl
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-COLUMBIANETIN
CAS:3804-70-4
Formula: C14H14O4
C642500
CC(C)([C@@H]1CC2=C(C=CC3=C2OC(=O)C=C3)O1)O
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-COREY LACTONE
CAS:39265-57-1
Formula: C21H20O5
H294010
Building Blocks; Chiral Molecules; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-COREY LACTONE BENZOATE
CAS:53275-53-9
Formula: C15H16O5
C694985
[H][C@@]1(CC(O2)=O)[C@@]2([H])C[C@H](OC(C3=CC=CC=C
Building Blocks; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-CORYDINE
CAS:476-69-7
Formula: C20H23NO4
C685725
COC1=C(OC)C=CC2=C1C3=C(O)C(OC)=CC4=C3[C@](N(C)CC4)
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-CORYNANTHEINE
CAS:18904-54-6
Formula: C22H28N2O3
C685610
[H][C@@]12N(C[C@H](CC)[C@@H](/C(C(OC)=O)=C\OC)C2)C
Standards; Natural Products;
(+)-CORYPALMINE
CAS:6018-40-2
Formula: C20H23NO4
C214530
COC1=C(C2=C(C[C@H]3C4=CC(=C(C=C4CCN3C2)O)OC)C=C1)O
(+)-COSTUNOLIDE
CAS:553-21-9
Formula: C15H20O2
C697550
CCOC(=O)NS(=O)(=O)c1ccc(CCNC(=O)c2ncc(C)nc2)cc1
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-COUMACHLOR
CAS:95271-89-9
Formula: C19H15ClO4
C725055
OC(C1=CC=CC=C1O2)=C([C@H](CC(C)=O)C3=CC=C(Cl)C=C3)
Standards; Chiral Molecules; Environmental Standards, Mutagens and Metabolites; Pesticides;
(+)-CP 47,497
CAS:134308-14-8
Formula: C21H34O2
C781603
OC1=C([C@H](CCC2)C[C@H]2O)C=CC(C(C)(C)CCCCCC)=C1
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-CP 55940
CAS:83002-05-5
Formula: C24H40O3
C781415
OC1=C(C=CC(C(C)(CCCCCC)C)=C1)[C@H]2[C@@H](CC[C@H](
Standards; Pharmaceutical/API Drug Impurities/Metabolites; Controlled Substances and Drugs of Abuse for Forensic Testing;
(+)-CUCURBIC ACID
CAS:58240-50-9
Formula: C12H20O3
C838600
O[C@H]1CC[C@H](CC(O)=O)[C@@H]1C/C=C\CC
Standards; Environmental Standards, Mutagens and Metabolites;
(+)-CYCLAZOCINE
CAS:7313-87-3
Formula: C18H25NO
C987735
C[C@@H]1[C@@H]2CC3=C([C@]1(CCN2CC4CC4)C)C=C(C=C3)O
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-CYCLAZOCINE-D3
Formula: C18H22D3NO
C987737
OC1=CC2=C(C=C1)C[C@@H]3N(C([2H])([2H])C4([2H])CC4)
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-CYTISINE
CAS:55821-72-2
Formula: C11H14N2O
C998505
C1=CC(=O)N2C[C@@H]3C[C@@H](CNC3)C2=C1
Building Blocks; Miscellaneous;
(+)-D-SELINENE
CAS:28624-28-4
Formula: C15H24
S253175
CC1=C(C=C(C(C)C)CC2)[C@]2(C)CCC1
Standards; Natural Products; Extracted;
(+)-DARUNAVIR
CAS:1399859-60-9
Formula: C27H37N3O7S
D193535
[H][C@]12CCO[C@@]1([H])OC[C@H]2OC(N[C@H](CC3=CC=CC
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-DARUNAVIR-D9
Formula: C27H28D9N3O7S
D193537
O=C(N[C@H](CC1=CC=CC=C1)[C@@H](O)CN(C([2H])([2H])C
Standards; Isotopic Labeled Analogues; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-DEOXOCASSINE
CAS:38726-62-4
Formula: C18H37NO
D231490
O[C@H]1[C@H](C)N[C@H](CCCCCCCCCCCC)CC1
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-DEOXYFEBRIFUGINE DIHYDROBROMIDE
CAS:1820023-27-5
Formula: C16H21Br2N3O2
D232210
O=C1C2=CC=CC=C2N=CN1CC(C[C@H]3NCCCC3)=O.[2HBr]
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-DEOXYHALOFEBRIFUGINE DIHYDROBROMIDE
CAS:1819989-16-6
Formula: C16H19Br3ClN3O2
D232220
BrC1=C(Cl)C=C(C(N(CC(C[C@@H]2CCCCN2)=O)C=N3)=O)C3=
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-DI-TERT-BUTYL L-TARTRATE
CAS:117384-45-9
Formula: C12H22O6
D679105
CC(C)(C)OC(=O)[C@@H]([C@H](C(=O)OC(C)(C)C)O)O
Building Blocks; Chiral Molecules;
(+)-DIACETYL-D-TARTARIC ACID
CAS:66749-60-8
Formula: C8H10O8
D493208
CC(=O)O[C@@H]([C@@H](C(=O)O)OC(=O)C)C(=O)O
Building Blocks; Chiral Molecules;
(+)-DIBENZOYL-D-TARTARIC ACID MONOHYDRATE
CAS:80822-15-7
Formula: C18H14O8 • H2O
D422798
C1=CC=C(C=C1)C(=O)O[C@@H]([C@@H](C(=O)O)OC(=O)C2=C
Building Blocks; Miscellaneous; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-DIHYDRO-A-CYPEROL
CAS:200343-74-4
Formula: C15H26O
D744345
C[C@@]1(CC[C@@H](O)[C@@H]2C)[C@]2([H])C[C@@H](C(C)
Building Blocks; Miscellaneous;
(+)-DIHYDROCARVONE (MIXTURE OF (2S)/(2R) ISOMERS)
CAS:5524-05-0
Formula: C10H16O
D459740
C=C([C@@H](CC[C@@H]1C)CC1=O)C
Building Blocks; Miscellaneous;
(+)-DIHYDROCARVONE -
CAS:7764-50-3
Formula: C10H16O
D268140
CC1CCC(CC1=O)C(=C)C
(+)-DIHYDROQUINIDINE
CAS:1435-55-8
Formula: C20H26N2O2
D452095
CC[C@H]1CN2CC[C@H]1C[C@@H]2[C@H](C3=C4C=C(C=CC4=NC
Building Blocks; Chiral Molecules;
(+)-DIISOPROPYL L-TARTRATE
CAS:2217-15-4
Formula: C10H18O6
D455325
CCOC(=O)Nc1c(cccc1)Oc2ccc(Cl)cc2
Building Blocks; Chiral Molecules;
(+)-DIMETHYL L-TARTRATE
CAS:608-68-4
Formula: C6H10O6
D479105
O=C([C@H](O)[C@@H](O)C(OC)=O)OC
Building Blocks; Chiral Molecules;
(+)-DIPIVALOYL-D-TARTARIC ACID
CAS:76769-55-6
Formula: C14H22O8
D493213
CC(C)(C)C(=O)O[C@@H]([C@@H](C(=O)O)OC(=O)C(C)(C)C)
Building Blocks; Chiral Molecules;
(+)-DONEPEZIL
CAS:142698-19-9
Formula: C24H29NO3
D531770
O=C1[C@H](CC2CCN(CC3=CC=CC=C3)CC2)CC4=C1C=C(OC)C(O
Research Tools; Enzyme Activators and Inhibitors; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-ECHIMIDINE
CAS:520-68-3
Formula: C20H31NO7
E325580
O[C@@H](C)[C@@](C(OCC1=CCN2[C@@]1([H])[C@H](OC(/C(
Standards; Natural Products;
(+)-ECHIMIDINE N-OXIDE
CAS:41093-89-4
Formula: C20H31NO8
E325585
O[C@@H](C)[C@@](C(OCC1=CCN2([C@@]1([H])[C@H](OC(/C
Standards; Natural Products;
(+)-ECHIMIDINE N-OXIDE-D3
Formula: C20H28D3NO8
E325587
O[C@@H](C)[C@@](C(OCC1=CCN2([C@@]1([H])[C@H](OC(/C
Building Blocks; Isotopic Labeled Analogues;
(+)-ECHIMIDINE-D3
Formula: C20H28D3NO7
E325582
O[C@@H](C)[C@@](C(OCC1=CCN2[C@@]1([H])[C@H](OC(/C(
Standards; Isotopic Labeled Analogues;
(+)-ECHINATINE
CAS:480-83-1
Formula: C15H25NO5
E325623
CC(C(C1=CC=C(O)C(OC)=C1)=O)=O
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-ENT-PERAMIVIR
CAS:229615-12-7
Formula: C15H28N4O4
P285505
O[C@@H]1[C@@]([C@H](NC(C)=O)C(CC)CC)([H])[C@@H](NC
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-EPI-QUERCITOL
CAS:131435-06-8
Formula: C6H12O5
E592260
C1[C@H]([C@@H](C([C@H]([C@H]1O)O)O)O)O
Building Blocks; Chiral Molecules;
(+)-EPIBATIDINE
CAS:140111-52-0
Formula: C11H13ClN2
E582205
Standards; Enzyme Activators and Inhibitors; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-EPINEPHRINE (-)-BITARTRATE
CAS:21282-30-4
Formula: C13H19NO9
E588675
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-ERINACIN A
CAS:156101-08-5
Formula: C25H36O6
E600090
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-ERINACIN A-D3
Formula: C25H33D3O6
E600092
O[C@@H]1[C@@H](O)[C@H](O)CO[C@H]1O[C@@H]2[C@](C3=C
Standards; Isotopic Labeled Analogues; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-ERYTHRALINE
CAS:466-77-3
Formula: C18H19NO3
E658508
CO[C@@H]1C[C@@]23N(CC=C3C=C1)CCC4=CC5=C(OCO5)C=C42
Standards; Natural Products; Extracted;
(+)-ERYTHRO-ETHYLNAPHTHIDATE HYDROCHLORIDE
Formula: C19H23NO2 . (HCl)
T433445
O=C([C@@H]([C@@]1([H])NCCCC1)C2=CC3=CC=CC=C3C=C2)O
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-FANGCHINOLINE
CAS:436-77-1
Formula: C37H40N2O6
F102360
O[C@H]1[C@H](O)[C@@H](O)[C@H](OC(C(C(C)C)=C2)=CC=C
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-FEMOXETINE
CAS:59859-58-4
Formula: C20H25NO2
F322535
CN1C[C@H](COC2=CC=C(OC)C=C2)[C@@H](C3=CC=CC=C3)CC1
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-FENCHONE
CAS:4695-62-9
Formula: C10H16O
F247420
NNC1=CC=NC=C1.Cl
Standards; Chiral Molecules; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-GALANTHAMINYL (-)-CAMPHANATE
Formula: C27H33NO6
G188560
CN1CC2=C3[C@]4(C=C[C@H](OC([C@]5(CC6)OC([C@@]6(C)C
Standards; Miscellaneous;
(+)-GALLOCATECHIN
CAS:970-73-0
Formula: C15H14O7
G188995
OC1=CC(O)=C(C[C@H](O)[C@@H](C2=CC(O)=C(O)C(O)=C2)O
Standards; Chiral Molecules; Enzyme Activators and Inhibitors;
(+)-GALLOCATECHIN GALLATE
CAS:5127-64-0
Formula: C22H18O11
G214800
C1[C@@H]([C@H](OC2=CC(=CC(=C21)O)O)C3=CC(=C(C(=C3)
(+)-GALLOCATECHIN GALLATE-13C3
Formula: C1913C3H18O11
G188982
OC1=CC(O)=C([13CH2][13C@H](OC(C2=CC(O)=C(O)C(O)=C2
Standards; Isotopic Labeled Analogues; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-GALLOCATECHIN-13C3
Formula: C1213C3H14O7
G188997
OC1=CC(O)=C([13CH2][13C@H](O)[13C@@H](C2=CC(O)=C(O
Standards; Isotopic Labeled Analogues; Enzyme Activators and Inhibitors; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-GEOSMIN
CAS:104873-46-3
Formula: C12H22O
G364605
C[C@]12[C@@]([C@H](C)CCC2)(O)CCCC1
Standards; Chiral Molecules; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-GONIOPYPYRONE
CAS:129578-07-0
Formula: C13H14O5
G003900
O[C@H]([C@]1([H])O2)[C@H](C3=CC=CC=C3)O[C@]([H])([
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-GYMNEMIC ACID I
CAS:122168-40-5
Formula: C43H66O14
G931818
O=C(C)OC[C@]1([C@H]2O)[C@](CC(C)(C)[C@H]2OC(/C(C)=
Standards; Environmental Standards, Mutagens and Metabolites;
(+)-HORSFILINE
CAS:160024-53-3
Formula: C13H16N2O2
H669625
CC1(O)C(C)CC2=CC(O)=C(OC)C(OC)=C2C3=C(OC)C(OC)=C(O
Standards; Natural Products;
(+)-HUPERZINE A-D6
Formula: C15H12D6N2O
H826004
N[C@]1(CC(C([2H])([2H])[2H])=C2)C(C=CC3=O)=C(N3)C[
Building Blocks; Isotopic Labeled Analogues; Molecular Biology;
(+)-HYALODENDRIN
CAS:51920-94-6
Formula: C14H16N2O3S2
H674270
Standards; Chiral Molecules; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-HYALODENDRIN-D5
Formula: C14H11D5N2O3S2
H674272
OC[C@]1(C(N(C)[C@@]2(CC3=C([2H])C([2H])=C([2H])C([
Standards; Isotopic Labeled Analogues;
(+)-INDOLACTAM V
CAS:90365-56-3
Formula: C17H23N3O2
I577423
O=C([C@@H](C(C)C)N1C)N[C@H](CO)CC2=CNC3=CC=CC1=C32
Standards; Chiral Molecules; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-IRINOTECAN
CAS:97682-44-5
Formula: C33H38N4O6
I767523
O=C(N1CCC(N2CCCCC2)CC1)OC3=CC=C4N=C(C(C5)=C(CC)C4=
Research Tools; Molecular Biology; Enzyme Activators and Inhibitors;
(+)-ISOALTENUENE
CAS:887751-92-0
Formula: C15H16O6
I779968
COC1=CC(O)=C(C(O[C@]2(C)C3=C[C@@H](O)[C@H](O)C2)=O
Standards; Pharmaceutical/API Drug Impurities/Metabolites; Anti-virals/Anti-retrovirals;
(+)-ISOLIENSININE
CAS:6817-41-0
Formula: C37H42N2O6
I820155
ClC1=CC=C2NC3=CC=CC=C3C2=C1
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-ISOLYSERGIC ACID DIETHYLAMIDE
CAS:2126-78-5
Formula: C20H25N3O
I821060
[H][C@]1(C2=C[C@@H](C(N(CC)CC)=O)CN1C)CC3=CNC4=C3C
Standards; Neurochemicals; Pharmaceutical/API Drug Impurities/Metabolites; Lysergic Acid Derivatives; Tryptamines;
(+)-ISOLYSERGIC ACID DIETHYLAMIDE (100 ?G/ML IN ACETONITRILE)
CAS:2126-78-5
Formula: C20H25N3O
KIT1380
[H][C@]1(C2=C[C@@H](C(N(CC)CC)=O)CN1C)CC3=CNC4=C3C
Standards; Neurochemicals; Pharmaceutical/API Drug Impurities/Metabolites; Lysergic Acid Derivatives; Tryptamines; Solutions; Kits;
(+)-ISOLYSERGIC ACID DIETHYLAMIDE-D10
Formula: C20H15D10N3O
I821062
O=C(N(C([2H])(C([2H])([2H])[2H])[2H])C([2H])(C([2H
Standards; Isotopic Labeled Analogues; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-ISOMENTHOL
CAS:23283-97-8
Formula: C10H20O
I821310
Building Blocks; Chiral Molecules;
(+)-ISOMENTHONE
CAS:1196-31-2
Formula: C10H18O
M199545
O=C1[C@@H](C(C)C)CC[C@@H](C)C1
Standards; Environmental Standards, Mutagens and Metabolites;
(+)-ISOMENTHONE-D3
Formula: C10H15D3O
M199547
O=C1[C@](C(C)C)([2H])CC[C@@H](C)C1([2H])[2H]
Standards; Isotopic Labeled Analogues; Natural Products;
(+)-ISOPHENMETRAZINE HYDROCHLORIDE
Formula: C11H16ClNO
I821910
C[C@@H]1NC[C@H](C2=CC=CC=C2)OC1.Cl
Standards; Chiral Molecules; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-ISOPULEGOL
CAS:104870-56-6
Formula: C10H18O
I824615
CC([C@H]1CC[C@H](C)C[C@@H]1O)=C
Building Blocks; Chiral Molecules;
(+)-JQ1 CARBOXYLIC ACID
CAS:202592-23-2
Formula: C19H17ClN4O2S
J216090
CC1=C(SC2=C1C(=N[C@H](C3=NN=C(N32)C)CC(=O)O)C4=CC=
Research Tools; Molecular Biology; Enzyme Activators and Inhibitors;
(+)-JUNIPER CAMPHOR
CAS:473-04-1
Formula: C15H26O
J212003
OC1=C(C(Cl)=O)C=CC=C1
Standards; Chiral Molecules; Pharmaceutical/API Drug Impurities/Metabolites; Natural Products;
(+)-KETOCONAZOLE
CAS:142128-59-4
Formula: C26H28Cl2N4O4
K186020
CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OCC3COC(O3)(CN4C=CN=C
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-KOBUSIN
CAS:36150-23-9
Formula: C21H22O6
K655050
[H][C@@]1([C@@H](C2=CC(OC)=C(OC)C=C2)OC3)[C@@]3([H
Standards; Enzyme Activators and Inhibitors; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-L-ALLIIN
CAS:556-27-4
Formula: C6H11NO3S
A543530
C=CCs(C[C@H](N)C(O)=O)o
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-LACTACYSTIN
CAS:133343-34-7
Formula: C15H24N2O7S
L101000
O[C@H](C(C(SC[C@H](NC(C)=O)C(O)=O)=O)([C@H](O)C(C)
Standards; Enzyme Activators and Inhibitors;
(+)-LACTACYSTIN ALLYL ESTER
Formula: C18H28N2O7S
L101030
O[C@H](C(C(SC[C@H](NC(C)=O)C(OCC=C)=O)=O)([C@H](O)
Standards; Enzyme Activators and Inhibitors;
(+)-LAPPACONITINE >90%
CAS:32854-75-4
Formula: C32H44N2O8
L175850
CCN1C2C3([C@H](C4)[C@@]5(O)[C@]6(O)C[C@H](OC)[C@@H
Standards; Chiral Molecules; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-LARICIRESINOL
CAS:27003-73-2
Formula: C20H24O6
L175925
OC[C@@H]1[C@@H](C2=CC=C(O)C(OC)=C2)OC[C@@H]1CC3=CC
Research Tools;
(+)-LEDENE
CAS:21747-46-6
Formula: C15H24
L320070
CC1(C)[C@@H]2[C@H]1CCC(C)=C3[C@@]2([H])[C@H](C)CC3
Standards; Chiral Molecules; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-LIMONENE
CAS:5989-27-5
Formula: C10H16
L461740
Standards; Food;
(+)-LIMONENE 2,3,3,5,5,-D5 (MAJOR)
Formula: C10H11D5
L461743
CC([C@@H]1C([2H])([2H])CC(C)=C([2H])C1([2H])[2H])=
Building Blocks; Chiral Molecules; Isotopic Labeled Analogues;
(+)-LOLINE DIHYDROCHLORIDE
CAS:25161-92-6
Formula: C8H14N2O • 2HCl
I707255
NCC(=O)N1C[C@H](C)N(CCC1)S(=O)(=O)c2c3c(cncc3C)ccc
Standards; Chiral Molecules; Natural Products;
(+)-LOLINE-D3 DIHYDROCHLORIDE
Formula: C8H13D3Cl2N2O
I707257
NCC[C@@H](O)C(=O)NC1C(O)[C@@H](OC(CO)[C@@H]1O)O[C@
Building Blocks; Isotopic Labeled Analogues;
(+)-LUPANINE PERCHLORATE
CAS:550-90-3
Formula: C15H25ClN2O5
L474830
O=C1CCC[C@@]2([H])N1C[C@@]3([H])[C@@](CCCC4)([H])N
Research Tools; Chiral Molecules;
(+)-LY-338979
Formula: C20H21N5O7
L486645
O=C(N[C@H](C(O)=O)CCC(O)=O)C1=CC=C(CC[C@H](C(N2)=O
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-LYCOPSAMINE HYDROCHLORIDE (~90%)
Formula: C15H25NO5 • HCl
L487545
O[C@@H](C)C(C(OCC1=CCN2[C@@]1([H])[C@H](O)CC2)=O)(
Building Blocks; Chiral Molecules;
(+)-LYCOPSAMINE N-OXIDE
CAS:95462-15-0
Formula: C15H25NO6
L487530
O[C@@H](C)C(C(OCC1=CCN2([C@@]1([H])[C@H](O)CC2)=O)
Standards; Natural Products;
(+)-LYCOPSAMINE N-OXIDE-D7
Formula: C15H18D7NO6
L487532
O[C@@H](C)[C@@](C(OCC1=CCN2([C@@]1([H])[C@H](O)CC2
Standards; Chiral Molecules; Isotopic Labeled Analogues; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-LYCOPSAMINE-D7
Formula: C15H18D7NO5
L487527
O[C@@H](C)[C@@](C(OCC1=CCN2[C@@]1([H])[C@H](O)CC2)
Standards; Chiral Molecules; Isotopic Labeled Analogues; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-LYSERGIDE
CAS:50-37-3
Formula: C20H25N3O
L488010
CCN(C([C@@H]1C=C([C@]2([H])N(C)C1)C3=CC=CC4=C3C(C2
Standards; Chiral Molecules; Stimulant; Pharmaceutical/API Drug Impurities/Metabolites; Controlled Substances and Drugs of Abuse for Forensic Testing; Lysergic Acid Derivatives; Tryptamines;
(+)-LYSERGIDE-D10
CAS:1794752-84-3
Formula: C20H15D10N3O
L488013
Cl.NC(=N)NCCC[C@H](NC(C)=O)C(N)=O
Standards; Isotopic Labeled Analogues; Pharmaceutical/API Drug Impurities/Metabolites; Controlled Substances and Drugs of Abuse for Forensic Testing;
(+)-LYSERGIDE-D3
CAS:136765-38-3
Formula: C20H22D3N3O
L488012
Nc1nc(C)c(C)cc1
Standards; Isotopic Labeled Analogues; Pharmaceutical/API Drug Impurities/Metabolites; Controlled Substances and Drugs of Abuse for Forensic Testing;
(+)-MAJUSCULOIC ACID
CAS:2186693-85-4
Formula: C15H23BrO2
M712600
OC(CC[C@@H]1[C@@H](CC/C=C/C=C(Br)/CCC)C1)=O
(+)-MARMESIN
CAS:13849-08-6
Formula: C14H14O4
M000230
CC(C)(O)[C@@H](O1)CC2=C1C=C(OC(C=C3)=O)C3=C2
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-MATRINE
CAS:519-02-8
Formula: C15H24N2O
M197870
O=C(CCC1)N2[C@@]1([H])[C@](CCCN3CCC4)([H])[C@]3([H
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-MATRINE-D3
Formula: C15H21D3N2O
M197872
O=C1N(C[C@@]2([H])[C@@]3([H])[C@]4([H])CCCN3CCC2)[
Standards; Natural Products;
(+)-MENISPERINE IODIDE
CAS:17669-18-0
Formula: C21H26NO4·I
M245880
C[N+]1(CCC2=CC(=C(C3=C2[C@@H]1CC4=C3C(=C(C=C4)OC)O
(+)-MENTHONE
CAS:3391-87-5
Formula: C10H18O
M199555
O=C1[C@@H](C(C)C)CC[C@H](C)C1
Standards; Chiral Molecules; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-MENTHOXYACETIC ACID
CAS:94133-41-2
Formula: C12H22O3
M224510
C[C@H]1CC[C@@H]([C@H](C1)OCC(=O)O)C(C)C
Building Blocks; Miscellaneous;
(+)-MENTHYL CHLOROFORMATE
CAS:7635-54-3
Formula: C11H19ClO2
M224598
C[C@H]1CC[C@@H]([C@H](C1)OC(=O)Cl)C(C)CCC1CCC(C(C
Building Blocks; Miscellaneous;
(+)-METARAMINOL
CAS:61-59-6
Formula: C9H13NO2
M321975
C[C@@H](N)[C@H](C1=CC=CC(O)=C1)O
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-METHYL (3S)-5-{[TERT-BUTYLDIMETHYLSILYL)OXY]}-3-HYDROXY-2,2-DIMETHYLPENTANOATE
CAS:263900-32-9
Formula: C14H30O4Si
M294410
O=C(C(C)(C)[C@@H](O)CCO[Si](C)(C)C(C)(C)C)OC
Building Blocks; Chiral Molecules;
(+)-MK 801 HYDROGEN MALEATE
CAS:77086-22-7
Formula: C20H19NO4
M424950
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-MUSCARINE CHLORIDE
CAS:2303-35-7
Formula: C9H20ClNO2
M814003
O[C@H]1[C@H](C)O[C@H](C[N+](C)(C)C)C1.[Cl-]
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-MUSCARINE IODIDE
CAS:24570-49-8
Formula: C9H20INO2
M814000
O[C@@H]1C[C@H](C[N+](C)(C)C)O[C@H]1C.[I-]
Standards; Chiral Molecules; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-MUSCARINE-D9 IODIDE
Formula: C9H11D9INO2
M814002
O[C@@H]1C[C@@H](C[N+](C([2H])([2H])[2H])(C([2H])([
Standards; Chiral Molecules; Isotopic Labeled Analogues; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-N,N'-(1S,2S)-1,2-DIAMINOCYCLOHEXANEDIYLBIS(2-PYRIDINECARBOXAMIDE)
CAS:172138-95-3
Formula: C18H20N4O2
N271115
C1CC[C@@H]([C@H](C1)NC(=O)C2=CC=CC=N2)NC(=O)C3=CC=
(+)-N,N-BISDESMETHYL TRAMADOL
CAS:931115-27-4
Formula: C14H21NO2
B426110
O[C@]1(C2=CC(OC)=CC=C2)CCCC[C@]1([H])CN
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-N,O-DIDESMETHYL TRAMADOL
CAS:144830-18-2
Formula: C14H21NO2
D441230
OC1=CC=CC([C@@]2(O)CCCC[C@]2([H])CNC)=C1
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-N-[1-(S)-ETHOXYCARBONXYL-3-PHENYLPROPYL]-L-ALANINE
CAS:82717-96-2
Formula: C15H21NO4
E891586
CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)O
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-N-ACETYL 3,4,4A,5,6,10B-HEXAHYDRO-2H-NAPHTHO[1,2-B][1,4]OXAZINE-9-OL TRIISOPROPYLSILYL ETHER
CAS:1034706-81-4
Formula: C23H37NO3Si
A178275
O=C(C)N1CCO[C@H]2C3=CC(O[Si](C(C)C)(C(C)C)C(C)C)=C
Research Tools; Chiral Molecules; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-N-ALLYL NORMETAZOCINE HYDROCHLORIDE
CAS:133005-41-1
Formula: C17H24ClNO
A559000
OC1=CC2=C(C=C1)CC3N(CC=C)CCC2(C)C3C.Cl
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-N-DEACETYLLAPPACONITINE
CAS:11033-64-0
Formula: C30H42N2O7
D198640
C#C[C@](OC(C)=O)(CC1)[C@]2([C@]1([H])[C@@](CC=C3[C
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-N-DESMETHYL TRAMADOL
CAS:147762-57-0
Formula: C15H23NO2
D294725
O[C@]1(C2=CC(OC)=CC=C2)CCCC[C@]1([H])CNC
Standards; Pharmaceutical/API Drug Impurities/Metabolites; Controlled Substances and Drugs of Abuse for Forensic Testing;
(+)-N-DESMETHYL TRAMADOL-D3
CAS:1261395-92-9
Formula: C15H20D3NO2
D294727
O[C@]1(C2=CC(OC)=CC=C2)CCCC[C@@H]1CNC([2H])([2H])[
Building Blocks; Isotopic Labeled Analogues; Controlled Substances and Drugs of Abuse for Forensic Testing;
(+)-N-METHYLACTINODAPHNINE
CAS:5890-28-8
Formula: C19H19NO4
C589000
COC1=C(O)C=C(C[C@@]2([H])C(C3=C4C(OCO4)=C5)=C5CCN2
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-NALTREXONE HYDROCHLORIDE
CAS:114274-32-7
Formula: C20H23NO4 • HCl
N285740
O[C@@]1([C@@H]2C3)[C@]4(CCN2CC5CC5)C6=C3C=CC(O)=C6
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-NEBIVOLOL
CAS:118457-15-1
Formula: C22H25F2NO4
N387896
FC1=CC(CC[C@]([C@H](O)CNC[C@@H](O)[C@@]2([H])CCC(C
Standards; Chiral Molecules; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-NEBIVOLOL O-SS-D-GLUCURONIDE(MIXTURE OF 2 DIASTEREOMERS)
Formula: C28H33F2NO10
N387885
FC1=CC(CC[C@]([C@H](O)CNC[C@@H](O[C@@H]2O[C@H](C(O
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-NEBIVOLOL-D4 HYDROCHLORIDE
Formula: C22H22D4ClF2NO4
N387898
FC1=CC(CC[C@]([C@H](O)C([2H])([2H])NC([2H])([2H])[
Standards; Chiral Molecules; Isotopic Labeled Analogues; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-NEFOPAM HYDROCHLORIDE
CAS:53648-31-0
Formula: C17H19NO • HCl
N385745
CN1CC2=C(C=CC=C2)[C@H](C3=CC=CC=C3)OCC1.Cl
Standards; Chiral Molecules; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-NEOMENTHOL
CAS:2216-52-6
Formula: C10H20O
N672510
O[C@@H]1[C@H](C(C)C)CC[C@@H](C)C1
(+)-NEOMENTHOL-D4
Formula: C10H16D4O
N390032
C/C=C(\C)/C=C/CP(OCC)(=O)OCC
Standards; Chiral Molecules;
(+)-NEOMENTHYL ACETATE
CAS:2552-91-2
Formula: C12H22O2
N390037
O=C(C)O[C@@H]1[C@H](C(C)C)CC[C@@H](C)C1
Standards; Chiral Molecules; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-NEOMENTHYL TOSYLATE
CAS:2230-77-5
Formula: C17H26O3S
N393700
CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1OS(C2=CC=C(C)C=C2)(
Standards; Chiral Molecules; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-NILIC ACID METHYL ESTER
CAS:65830-31-1
Formula: C6H12O3
N465350
Building Blocks; Miscellaneous;
(+)-NIMBIDIOL
CAS:113332-25-5
Formula: C17H22O3
N476270
O=[13C](O)[13C]1=[13C]([H])[13C]([H])=[13C]([13C](
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-NITRENDIPINE
CAS:80890-07-9
Formula: C18H20N2O6
N490145
O=C(OC)C1=C(C)NC(C)=C(C(OCC)=O)[C@@H]1C2=CC([N+]([
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-NOE’S REAGENT
CAS:87248-50-8
Formula: C24H38O3
N887465
CC1(C)C2CCC1(C)C3C2CC(OC4CC5C6CCC(C)(C5O4)C6(C)C)O
Building Blocks; Chiral Molecules;
(+)-NORADRENALINE BITARTRATE
CAS:636-88-4
Formula: C8H11NO3 • C4H6O6
N661025
OC1=CC=C([C@H](O)CN)C=C1O.OC([C@H](O)[C@@H](O)C(O)
Research Tools; Chiral Molecules; Ephedrine; Pharmaceutical/API Drug Impurities/Metabolites; Phenethylamines/Amphetamines;
(+)-NORADRENALINE-D5 BITARTRATE
Formula: C12H12D5NO9
N661028
OC1=C([2H])C([2H])=C([C@@H](C([2H])([2H])N)O)C([2H
Research Tools; Chiral Molecules; Isotopic Labeled Analogues; Ephedrine; Pharmaceutical/API Drug Impurities/Metabolites; Phenethylamines/Amphetamines;
(+)-NORISOBOLDINE
CAS:23599-69-1
Formula: C18H19NO4
N692025
[H][C@]1(NCC2)CC3=CC(O)=C(OC)C=C3C4=C1C2=CC(OC)=C4
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-NORISOBOLDINE HYDROCHLORIDE
Formula: C18H19NO4
N692030
[H][C@@]1(CC2=CC(O)=C(C=C23)OC)NCCC4=CC(OC)=C(O)C3
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-NORMETAZOCINE
CAS:16670-83-0
Formula: C14H19NO
N721905
Standards; Pharmaceutical/API Drug Impurities/Metabolites; Controlled Substances and Drugs of Abuse for Forensic Testing;
(+)-O,O’-DI-P-TOLUOYL-D-TARTARIC ACID
CAS:32634-68-7
Formula: C20H18O8
D494380
O=C(O[C@H](C(O)=O)[C@@H](C(O)=O)OC(C1=CC=C(C)C=C1)
Building Blocks; Chiral Molecules;
(+)-O-DESMETHYL TRAMADOL HYDROCHLORIDE
CAS:148262-77-5
Formula: C15H24ClNO2
D294755
OC1=CC=CC([C@@]2(O)CCCC[C@]2([H])CN(C)C)=C1.Cl
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-O-DESMETHYL TRAMADOL HYDROCHLORIDE (1.0 MG/ML IN METHANOL)
CAS:148262-77-5
Formula: C15H24ClNO2
KIT2580
OC1=CC=CC([C@@]2(O)CCCC[C@@]2(CN(C)C)[H])=C1.Cl
Standards; Pharmaceutical/API Drug Impurities/Metabolites; Solutions; Kits;
(+)-O-DESMETHYL TRAMADOL-D6 HYDROCHLORIDE
CAS:1261393-87-6
Formula: C15H18D6ClNO2
D294757
OC1=CC=CC([C@@]2(O)CCCC[C@@]2(CN(C([2H])([2H])[2H]
Building Blocks; Chiral Molecules; Isotopic Labeled Analogues; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-O-DESMETHYL TRAMADOL-D6 HYDROCHLORIDE (0.1MG/ML IN METHANOL)
CAS:1261393-87-6
Formula: C15H18D6ClNO2
KIT2582
OC1=CC=CC([C@@]2(O)CCCC[C@@]2(CN(C([2H])([2H])[2H]
Standards; Isotopic Labeled Analogues; Pharmaceutical/API Drug Impurities/Metabolites; Solutions; Kits;
(+)-O-DESMETHYL-N,N-BISDESMETHYL TRAMADOL
CAS:1235568-21-4
Formula: C13H19NO2
D291155
OC1=CC=CC([C@@]2(O)CCCC[C@]2([H])CN)=C1
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-OBTUSIFOLIOL
CAS:16910-32-0
Formula: C30H50O
E599210
C[C@H](CCC(C(C)C)=C)[C@]1([H])[C@@]2(C)CCC([C@]3(C
Standards; Steroids;
(+)-P-METHOXYAMPHETAMINE HYDROCHLORIDE
CAS:50505-81-2
Formula: C10H15NO • HCl
M589940
COC1=CC=C(C[C@@H](N)C)C=C1.Cl
Standards; Pharmaceutical/API Drug Impurities/Metabolites; Controlled Substances and Drugs of Abuse for Forensic Testing; Phenethylamines/Amphetamines;
(+)-PAPAVEROXINOLINE
CAS:106982-93-8
Formula: C24H29NO8
P190530
[H][C@@]1([C@@H](OC(C)=O)C2=C(CO)C(OC)=C(OC)C=C2)N
Standards; Pharmaceutical/API Drug Impurities/Metabolites; Natural Products;
(+)-PAPAVEROXINOLINE ACETATE
CAS:106982-95-0
Formula: C26H31NO9
P190535
[H][C@@]1([C@@H](OC(C)=O)C2=C(COC(C)=O)C(OC)=C(OC)
Standards; Pharmaceutical/API Drug Impurities/Metabolites; Natural Products;
(+)-PAREDRINE
CAS:1693-66-9
Formula: C9H13NO
P193240
OC1=CC=C(C[C@@H](N)C)C=C1
Standards; Chiral Molecules; Molecular Biology; Neurochemicals; Stimulant; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-PD 128907 HYDROCHLORIDE
CAS:300576-59-4
Formula: C14H19NO3 • (HCl)
P218288
OC1=CC=C2C([C@@]3([H])OCCN(CCC)[C@]3([H])CO2)=C1.C
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-PENTAZOCINE HYDRATE
Formula: C19H29NO2
P274315
OC1=CC2=C(C=C1)C[C@H]3N(CCC(O)(C)C)CC[C@@]2(C)[C@@
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-PERILLYL ALCOHOL
CAS:57717-97-2
Formula: C10H16O
P287438
CC([C@@H]1CCC(CO)=CC1)=C
Research Tools; Standards; Molecular Biology; Enzyme Activators and Inhibitors;
(+)-PHYTONE
CAS:16825-16-4
Formula: C18H36O
P398050
O=C(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C
Building Blocks; Chiral Molecules; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-PICFELTARRAENIN IA
CAS:97230-47-2
Formula: C41H62O13
P436350
CCCCCCCCCCCCCCC(C)=O
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-PINANEDIO (1S)-1-CHLORO-2-METHYLPROPYLBORONATE
CAS:89618-77-9
Formula: C14H24BClO2
P931495
CC1(C)[C@@H]2C[C@@H]3[C@@](C)(OB([C@@H](C(C)C)Cl)O
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-PINANEDIOL BORANE
CAS:90084-43-8
Formula: C10H17BO2
P458420
O=C(C([C@@H](NC(C1CCCCCC1)=O)C2CCOCC2)=O)N/N=C3SC[
Building Blocks; Catalyst;
(+)-PINANEDIOL-2-O-(HYDROGEN SULFATE)
CAS:1193176-37-2
Formula: C10H18O5S
P458410
CC1(C)[C@H]2C[C@H](O)[C@](C)(OS(O)(=O)=O)[C@@H]1C2
Building Blocks;
(+)-PINORESINOL (>80% EE)
CAS:487-36-5
Formula: C20H22O6
P468890
OC1=CC=C([C@H]2OC[C@@]3([H])[C@]2([H])CO[C@@H]3C4=
Standards; Natural Products;
(+)-PROTO-QUERCITOL
CAS:488-73-3
Formula: C6H12O5
Q509523
C1[C@H]([C@@H](C([C@H]([C@@H]1O)O)O)O)O
Building Blocks; Chiral Molecules;
(+)-PROTOLICHESTERIC ACID
CAS:1448-96-0
Formula: C19H32O4
P838940
O=C1C([C@H](C(O)=O)[C@@H](CCCCCCCCCCCCC)O1)=C
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-PSEUDOCOCAINE HYDROCHLORIDE
CAS:112547-19-0
Formula: C17H22ClNO4
P839510
[H][C@]1(C(OC)=O)[C@]([H])(OC(C2=CC=CC=C2)=O)C[C@H
Standards; Enzyme Activators and Inhibitors; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-PSEUDOECGONINE METHYL ESTER
CAS:65913-90-8
Formula: C10H17NO3
P840165
CCOC(=O)C(=O)c1ccccc1
Standards; Neurochemicals; Pharmaceutical/API Drug Impurities/Metabolites; Ecgonines/Cocaine Derivatives;
(+)-PSI REAGENT
Formula: C16H16F5OPS3
P839698
C=C(C)[C@H]1CC[C@](S[P@](O2)(SC3=C(F)C(F)=C(F)C(F)
Building Blocks;
(+)-PSYCHOTRIASINE
CAS:1253641-92-7
Formula: C22H26N4
P840190
C[C@]1(O2)CC[C@@]3([H])[C@H](C)CC[C@@]4([H])[C@@](
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-QUISQUALIC ACID
CAS:52809-07-1
Formula: C5H7N3O5
Q825000
NC(C(O)=O)CN(C(N1)=O)OC1=O
Standards; Amino Acids; Neurochemicals;
(+)-REGIOMONTANIN
CAS:52151-92-5
Formula: C20H20O6
R225225
COC1=C(C=CC(=C1)[C@@H]2[C@H]3CO[C@@H]([C@H]3CO2)C4
(+)-RETRONECINE
CAS:480-85-3
Formula: C8H13NO2
R278000
[H][C@@]1([C@H](O)CC2)N2CC=C1CO
Standards; Miscellaneous;
(+)-RHEADINE
CAS:2718-25-4
Formula: C21H21NO6
R317500
CN1CCC2=CC3=C(C=C2[C@@H]4[C@H]1C5=C([C@H](O4)OC)C6
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-RUTAMARIN
CAS:13164-05-1
Formula: C21H24O5
R701825
O=C1C(C(C)(C)C=C)=CC2=CC3=C(O[C@H](C(C)(OC(C)=O)C)
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-S-N-METHYLCOCLAURINE HYDROCHLORIDE
CAS:1087708-38-0
Formula: C18H21NO3 • HCl
M294325
CN1[C@](CC2=CC=C(O)C=C2)([H])C3=CC(O)=C(OC)C=C3CC1
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-SPARTEINE
CAS:492-08-0
Formula: C15H26N2
S679505
C1CCN2C[C@H]3C[C@H](CN4CCCC[C@@H]34)[C@H]2C1
Building Blocks; Chiral Molecules;
(+)-SS-CEDRENE
CAS:546-28-1
Formula: C15H24
C364869
C=C1CC[C@](C2)([C@H](C)CC3)[C@]3([H])C(C)(C)[C@]12
Standards; Steroids;
(+)-SS-CEDRENE (MAJOR, CONTAINS (-)-CEDRENE)
CAS:546-28-1
Formula: C15H24
C364868
C[C@H]1[C@@](C[C@]2([H])C3(C)C)(CCC2=C)[C@@]3([H])
Standards; Natural Products; Extracted;
(+)-SS-DIHYDROTETRABENAZINE
CAS:924854-60-4
Formula: C19H29NO3
D453610
Standards; Enzyme Activators and Inhibitors; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-SS-DIHYDROTETRABENAZINE-13C2D6
Formula: C1713C2H23D6NO3
D453612
[H][C@]12N(C[C@@H](CC(C)C)[C@@H](O)C2)CCC3=CC(O[13
Standards; Isotopic Labeled Analogues; Enzyme Activators and Inhibitors; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-SS-EUDESMOL-7,7,8A,8’8’-D5
Formula: C15H21D5O
E938602
[2H][C@]12[C@@](CC[C@@H](C(O)(C)C)C2)(C)CCC([2H])(
Standards; Isotopic Labeled Analogues;
(+)-SS-HYDRASTINE
CAS:29617-43-4
Formula: C21H21NO6
H675700
CN1CCC2=CC3=C(C=C2[C@H]1[C@H]4C5=C(C(=C(C=C5)OC)OC
Standards; Enzyme Activators and Inhibitors; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-SS-METHYL-A,A-DIPHENYL-4-MORPHOLINEBUTANENITRILE
CAS:6134-93-6
Formula: C21H24N2O
M295437
N#CC(C1=CC=CC=C1)(C2=CC=CC=C2)[C@H](C)CN3CCOCC3
Standards; Chiral Molecules; Pharmaceutical/API Drug Impurities/Metabolites; Controlled Substances and Drugs of Abuse for Forensic Testing; Opiates;
(+)-SS-METHYL-A,A-DIPHENYL-4-MORPHOLINEBUTANOIC ACID
Formula: C21H25NO3
M303093
C[C@@H](C(C1=CC=CC=C1)(C2=CC=CC=C2)C(O)=O)CN3CCOCC
Standards; Chiral Molecules; Pharmaceutical/API Drug Impurities/Metabolites; Controlled Substances and Drugs of Abuse for Forensic Testing; Opiates; Methadones/Synthetic Opiates;
(+)-SS-PINENE
CAS:19902-08-0
Formula: C10H16
P466618
CC1([C@@H]2C[C@H]1CCC2=C)C
Building Blocks; Miscellaneous;
(+)-STRIGOLACTONE GR24
CAS:151716-22-2
Formula: C17H14O5
S687600
O=C1O[C@@H](O/C=C2C(O[C@@]3([H])[C@]/2([H])CC4=C3C
Standards; Chiral Molecules; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-SYLVATESMIN
CAS:487-39-8
Formula: C21H24O6
S213020
COC1=C(C=C(C=C1)[C@H]2[C@H]3CO[C@@H]([C@H]3CO2)C4=
(+)-SYRINGARESINOL
CAS:21453-69-0
Formula: C22H26O8
S213045
COC1=CC(=CC(=C1O)OC)[C@@H]2[C@H]3CO[C@@H]([C@H]3CO
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-TADDOL
CAS:93379-49-8
Formula: C31H30O4
T779313
CC1(C)O[C@H](C(C2=CC=CC=C2)(O)C3=CC=CC=C3)[C@@H](C
Building Blocks; Chiral Molecules; Catalyst;
(+)-TAXIFOLIN
CAS:17654-26-1
Formula: C15H12O7
T100080
O=C(C1=C(O)C=C(O)C=C1O2)[C@H](O)[C@H]2C3=CC(O)=C(O
Standards; Natural Products;
(+)-TERPINEN-4-OL
CAS:2438-10-0
Formula: C10H18O
T223390
CC1=CC[C@@](CC1)(C(C)C)O
(+)-THEASPIRANE A
CAS:66537-39-1
Formula: C13H22O
T986140
CC1=CCCC(C)([C@@]12CC[C@H](O2)C)C
Standards; Environmental Standards, Mutagens and Metabolites; Pesticides;
(+)-THEASPIRANE B
CAS:66537-40-4
Formula: C13H22O
T986145
CC1=CCCC(C)([C@@]12CC[C@@H](O2)C)C
Standards; Environmental Standards, Mutagens and Metabolites; Pesticides;
(+)-TIANEPTINE MONOSODIUM SALT
CAS:169293-32-7
Formula: C21H24ClN2NaO4S
T436795
CN1C2=CC=CC=C2C(C3=C(S1(=O)=O)C=C(C=C3)Cl)NCCCCCCC
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-TRAMADOL
CAS:123154-38-1
Formula: C16H25NO2
T712510
O[C@]1(C2=CC(OC)=CC=C2)CCCC[C@@H]1CN(C)C
Standards; Pharmaceutical/API Drug Impurities/Metabolites; Controlled Substances and Drugs of Abuse for Forensic Testing;
(+)-TRAMADOL HYDROCHLORIDE
CAS:148229-78-1
Formula: C16H26ClNO2
T712515
O[C@]1(C2=CC(OC)=CC=C2)CCCC[C@@H]1CN(C)C.Cl
Standards; Chiral Molecules; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-TRAMADOL-D6 HYDROCHLORIDE
CAS:1109217-84-6
Formula: C16H19D6NO2 • HCl
T712517
[2H]C([2H])([2H])N(C[C@H]1CCCC[C@@]1(C2=CC(=CC=C2)
Standards; Chiral Molecules; Isotopic Labeled Analogues; Pharmaceutical/API Drug Impurities/Metabolites; Controlled Substances and Drugs of Abuse for Forensic Testing;
(+)-TRANS TAXIFOLIN
CAS:480-18-2
Formula: C15H12O7
T010005
C1=CC(=C(C=C1C2[C@H](C(=O)C3=C(C=C(C=C3O2)O)O)O)O)
Standards; Chiral Molecules; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-TRANS,TRANS-ABSCISIC ACID
CAS:6755-41-5
Formula: C15H20O4
A110025
O=C1C=C(C)[C@@](/C=C/C(C)=C/C(O)=O)(O)C(C)(C)C1
Standards; Environmental Standards, Mutagens and Metabolites;
(+)-TRANS,TRANS-ABSCISIC ACID-D3
CAS:82298-40-6
Formula: C15H17D3O4
A110098
O=C1C=C(C)[C@@](/C=C/C(C([2H])([2H])[2H])=C/C(O)=O
Standards; Isotopic Labeled Analogues; Environmental Standards, Mutagens and Metabolites;
(+)-TRANS-1,2-CYCLOHEXANEDICARBOXYLIC ANHYDRIDE
CAS:71749-03-6
Formula: C8H10O3
T272945
C1CC[C@@H]2[C@@H](C1)C(=O)OC2=O
(+)-TRANS-2-METHOXYCYCLOHEXAN-1-OL
CAS:7429-40-5
Formula: C7H14O2
T243960
COC1CCCCC1O
(+)-TRANS-ALLETHRIN (MAY CONTAIN UP TO 10% CIS ISOMER)
CAS:28434-00-6
Formula: C19H26O3
A542205
C=CCC1=C(C)[C@@H](OC([C@H]2[C@H](/C=C(C)/C)C2(C)C)
Standards; Environmental Standards, Mutagens and Metabolites;
(+)-TRANS-ANTI-BPDE-N2-DG
CAS:65437-20-9
Formula: C30H27N5O7
B676640
CCCCC(=O)Oc1cc2c(cc1)[C@H]3[C@@H](CC2)[C@@H]4[C@@]
Standards; Pharmaceutical/API Drug Impurities/Metabolites; Environmental Standards, Mutagens and Metabolites;
(+)-TRANS-ANTI-BPDE-N2-DG-D8
Formula: C30H19D8N5O7
B676642
Oc1cc2c(cc1)[C@H]3[C@@H](CC2)[C@@H]4[C@@](CC3)(C)C
Standards; Isotopic Labeled Analogues; Pharmaceutical/API Drug Impurities/Metabolites; Environmental Standards, Mutagens and Metabolites;
(+)-TRANS-CHRYSANTHEMIC ACID
CAS:4638-92-0
Formula: C10H16O2
C432765
OC([C@H]1[C@H](/C=C(C)/C)C1(C)C)=O
Building Blocks; Miscellaneous;
(+)-TRANS-CHRYSANTHEMIC ACID-D6
Formula: C10H10D6O2
C432766
CC1(C)[C@H](/C=C(C([2H])([2H])[2H])\C([2H])([2H])[
Building Blocks; Isotopic Labeled Analogues; Miscellaneous;
(+)-TRANS-JASMONIC ACID
CAS:126372-33-6
Formula: C12H18O3
J210540
O=C1[C@@H](C/C=C\CC)[C@H](CC(O)=O)CC1
Standards; Natural Products;
(+)-TRANS-VERBENOL
CAS:22339-08-8
Formula: C10H16O
V128020
CC1=C[C@H](O)[C@H]2C(C)(C)[C@@H]1C2
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-TRIMETHAPHAN CAMPHORSULFONATE
CAS:87335-42-0
Formula: C32H41N2O5S2+
T795445
O=C1N(CC2=CC=CC=C2)[C@@]3([H])[C@@H]4[S+](CCC4)C[C
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-TUBERONIC ACID
CAS:124649-26-9
Formula: C12H18O4
T897105
COc1cc(CC(C)N)c(OC)cc1
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-TUBOCURARINE CHLORIDE HYDROCHLORIDE PENTAHYDRATE
CAS:6989-98-6
Formula: C37H52Cl2N2O11
T947620
[H][C@]1(CC2=CC=C(OC3=C([C@](CC4=CC=C(O)C(O5)=C4)(
Research Tools; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-U-50488 HYDROCHLORIDE
CAS:114528-81-3
Formula: C19H26Cl2N2O • HCl
H942983
O=C(N(C)[C@H]1[C@@H](CCCC1)N2CCCC2)CC3=CC(Cl)=C(C=
Building Blocks; Miscellaneous;
(+)-UH 232
CAS:95999-12-5
Formula: C18H29NO
U850310
C[C@@H]1[C@H](N(CCC)CCC)CCC2=C(OC)C=CC=C21
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-UH 232 MALEATE
CAS:1217473-50-1
Formula: C22H33NO5
U850333
OC(/C=C\C(O)=O)=O.CCCN([C@@H]1CCC2=C([C@@H]1C)C=CC
Building Blocks; Miscellaneous;
(+)-VALERIANOL
CAS:20489-45-6
Formula: C15H26O
V914000
OC(C)(C)[C@@H]1CCC2=CCC[C@@H](C)[C@]2(C)C1
Standards; Chiral Molecules; Natural Products;
(+)-VALIENAMINE HYDROCHLORIDE
CAS:38231-88-8
Formula: C7H14ClNO4
V094000
O[C@@H]1C(CO)=C[C@H](N)[C@H](O)[C@H]1O.Cl
Standards; Enzyme Activators and Inhibitors; Glycosidase Inhibitors;
(+)-VARITRIOL
CAS:419568-67-5
Formula: C15H20O5
V099010
C[C@H]1[C@@H]([C@@H]([C@H](O1)/C=C/C2=C(C(=CC=C2)O
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(+)-VERNOLIC ACID METHYL ESTER
CAS:2733-91-7
Formula: C19H34O3
V128715
O=C(OC)CCCCCCC/C=C\C[C@@H]1O[C@@H]1CCCCC
Standards; Chiral Molecules; Food; Lipids/Fatty Acids, Glycerol Derivatives;
(+)-VINYLBORONIC ACID PINANEDIOL ESTER
CAS:132488-71-2
Formula: C12H19BO2
V757040
B1(O[C@H]2C[C@H]3C[C@@H]([C@]2(O1)C)C3(C)C)C=C
Building Blocks; Chiral Molecules;
(+)-VIRIDIFLOROL
CAS:552-02-3
Formula: C15H26O
V673900
C[C@@H]1CC[C@H]2[C@@H]1[C@H]3[C@H](C3(C)C)CC[C@]2(
Standards; Food;
(+)?-?BORNEOL
CAS:464-43-7
Formula: C10H18O
B675540
OC1[C@@](C2(C)C)(C)CCC2C1
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(+)?-?BORNEOL-D3 (CONTAINS UP TO 1% D0)
Formula: C10H15D3O
B675542
O[C@]1([2H])[C@@](C2(C)C)(C)CCC2C1([2H])[2H]
Standards; Isotopic Labeled Analogues; Pharmaceutical/API Drug Impurities/Metabolites;
(+)?-?TRANS-?LIMONENE OXIDE
CAS:6909-30-4
Formula: C10H16O
L365875
Building Blocks; Chiral Molecules; Miscellaneous;
(+)2΄-EPI-5-DEOXY-STRIGOL
CAS:151716-19-7
Formula: C19H22O5
E582290
O=C(/C1=C/O[C@H](C=C2C)OC2=O)O[C@@]3([H])[C@]1([H]
Standards; Environmental Standards, Mutagens and Metabolites;
(+)MELEARORIDE A
CAS:2287179-32-0
Formula: C30H47NO4
M017005
O=C(O[C@@H](CCCCC)CC[C@@H](C)CCCCC1=O)[C@@H](CC2=C
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(+/-) 2'-HYDROXY-1,1'-BINAPHTHYL-2-YL PHOSPHATE
Formula: C20H15O5P
H387360
OC1=C(C2=C(C=CC=C3)C3=CC=C2OP(O)(O)=O)C4=CC=CC=C4C
Building Blocks; Chiral Molecules; Materials;
(+/-) ANNONACIN (MIXTURE OF ISOMERS)
CAS:111035-65-5
Formula: C35H64O7
A293640
O=C1C(C[C@H](O)CCCCC[C@@H](O)CCCC[C@@H](O)[C@H]2CC
Standards; Chiral Molecules; Pharmaceutical/API Drug Impurities/Metabolites;
(+/-)-((ENDO, RS), RS) BIPERIDEN HYDROCHLORIDE
Formula: C21H29NO •HCl
B397948
O[C@](CCN1CCCCC1)(C2=CC=CC=C2)[C@]3([H])[C@@H]4C=C
Building Blocks;
(+/-)-((EXO, RS), RS) BIPERIDEN HYDROCHLORIDE
CAS:475563-22-5
Formula: C21H29NO •HCl
B397945
O[C@@](CCN1CCCCC1)(C2=CC=CC=C2)[C@@]3([H])[C@@H]4C
Building Blocks;
(+/-)-1,1,1-TRIFLUORO-2-PHENYLBUTANE
CAS:90794-17-5
Formula: C10H11F3
T193735
CCC(C1=CC=CC=C1)C(F)(F)F
(+/-)-1,2-PROPYLENE-D6 OXIDE (STABILIZED WITH HYDROQUINONE)
CAS:202468-69-7
Formula: C3D6O
P835242
[2H]C1([2H])C([2H])(C([2H])([2H])[2H])O1
Building Blocks; Isotopic Labeled Analogues; Miscellaneous;
(+/-)-1,4-DIAZABICYCLO[4.4.0]DECANE
CAS:4430-75-5
Formula: C8H16N2
D417580
N12CCCCC1CNCC2
Building Blocks; Miscellaneous;
(+/-)-1-(1,2-DIPHENYLETHYL)PIPERIDINE MALEATE
CAS:207461-99-2
Formula: C19H23N • C4H4O4
D491563
OC(/C=C\C(O)=O)=O.N1(C(C2=CC=CC=C2)CC3=CC=CC=C3)CC
Standards; Molecular Biology; Enzyme Activators and Inhibitors;
(+/-)-1-(1,3-BENZODIOXOL-5-YL)-2-BROMO-1-PENTANONE
CAS:146721-06-4
Formula: C12H13BrO3
B203490
CCCC(C(=O)C1=CC2=C(C=C1)OCO2)Br
Building Blocks; Pharmaceutical/API Drug Impurities/Metabolites;
(+/-)-1-(3-AMINO-PYRIDIN-2-YL)ETHYLAMINE
CAS:1270326-64-1
Formula: C7H11N3
A629035
Building Blocks; Miscellaneous;
(+/-)-1-AMINO-3-N-(4'-BOC-PIPERAZINYL)-2-PROPANOL
CAS:811841-98-2
Formula: C12H25N3O3
A579340
CC(C)(C)OC(=O)N1CCN(CC1)CC(CN)O
Building Blocks; Miscellaneous;
(+/-)-1-METHOXY-1-(TRIFLUOROMETHYL)PHENYLACETYL CHLORIDE
CAS:40793-68-8
Formula: C10H8O2F3Cl
M219043
COC(C1=CC=CC=C1)(C(=O)Cl)C(F)(F)F
Building Blocks; Miscellaneous;
(+/-)-1-N-BOC-PIPERIDINE-2-CARBOXAMIDE
CAS:388077-74-5
Formula: C11H20N2O3
B662048
CC(C)(OC(N1CCCCC1C(N)=O)=O)C
Building Blocks; Miscellaneous;
(+/-)-11-HYDROXY-?9-TETRAHYDROCANNABINOL-D3
CAS:130410-26-3
Formula: C21H27D3O3
T293187
OCC1=C[C@@H]2[C@H](C(C)(C)OC3=C2C(O)=CC(CCCCC([2H]
Standards; Isotopic Labeled Analogues; Pharmaceutical/API Drug Impurities/Metabolites; Controlled Substances and Drugs of Abuse for Forensic Testing; Cannabis Constituents;
(+/-)-11-NOR-9-CARBOXY-?9-TETRAHYDROCANNABINOL-D3-GLUCURONIDE
Formula: C27H33D3O10
T293207
OC1=C2C(OC(C)(C)[C@H]3[C@H]2C=C(C(O[C@H]4[C@H](O)[
Standards; Isotopic Labeled Analogues; Pharmaceutical/API Drug Impurities/Metabolites; Controlled Substances and Drugs of Abuse for Forensic Testing; Cannabis Constituents;
(+/-)-2,2,2-TRIFLUORO-1-PYRIDIN-3-YLETHYLAMINE HYDROCHLORIDE
CAS:1138011-22-9
Formula: C7H8ClF3N2
T896900
C1=CC(=CN=C1)C(C(F)(F)F)N.Cl
Building Blocks; Miscellaneous;
(+/-)-2,2-DIFLUORO-1-METHYLCYCLOPROPAN1-YL-METHANOL
CAS:1241675-78-4
Formula: C4H6OF2
D474968
CC1(CC1(F)F)O
Building Blocks; Miscellaneous;
(+/-)-2,2-DIFLUORO-1-METHYLCYCLOPROPYLAMINE HYDROCHLORIDE
CAS:128230-76-2
Formula: C4H7NF2.HCl
D485338
CC1(CC1(F)F)N.Cl
Building Blocks; Miscellaneous;
(+/-)-2-(METHYLAMINO)SUCCINIC ACID, MONOHYDRATE
CAS:303750-06-3
Formula: C5H11NO5
M328708
CNC(C(O)=O)CC(O)=O.O
Building Blocks; Amino Acids;
(+/-)-2-ACETYLAMINOBUTANOIC ACID
CAS:114285-09-5
Formula: C6H11NO3
A168195
CCC(NC(C)=O)C(O)=O
Building Blocks; Amino Acids;
(+/-)-2-ACETYLAMINOBUTANOIC ACID-D3
CAS:1219397-36-0
Formula: C6H8D3NO3
A168197
[2H]C([2H])([2H])CC(NC(C)=O)C(O)=O
Building Blocks; Amino Acids; Isotopic Labeled Analogues;
(+/-)-2-AMINO-6,7-DIHYDROXY-1,2,3,4-TETRAHYDRONAPHTHALENE HYDROBROMIDE
CAS:13575-86-5
Formula: C10H13NO2 •HBr
A610023
OC1=C(O)C=C(CCC(N)C2)C2=C1.Br
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(+/-)-2-METHYLNICOTINE
CAS:64114-31-4
Formula: C11H16N2
M323245
CC1=NC=CC=C1C2N(C)CCC2
Standards; Nicotine Derivatives and Metabolites;
(+/-)-2-PROPYL-4-PENTENOIC ACID
CAS:1575-72-0
Formula: C8H14O2
P838305
C=CCC(CCC)C(O)=O
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(+/-)-2-PROPYL-4-PENTENOIC ACID METHYL ESTER-D3
Formula: C9H13D3O2
P838427
CCCCCCCCCCCCOS(=O)(O)=O.CCC(=O)OC1C(OC(C)CC1N(C)C)
Building Blocks; Isotopic Labeled Analogues;
(+/-)-3-(FMOC-AMINO)-2-PHENYLPROPIONIC ACID
CAS:683217-60-9
Formula: C24H21NO4
F603975
C1=CC=C(C=C1)C(CNC(=O)OCC2C3=CC=CC=C3C4=CC=CC=C24)
Building Blocks; Miscellaneous;
(+/-)-3-CAMPHORCARBOXYLIC ACID
CAS:474-98-6
Formula: C11H16O3
C175183
CC1(C2CCC1(C(=O)C2C(=O)O)C)C
Building Blocks; Miscellaneous;
(+/-)-4'-BROMOHYMENIN
CAS:184887-85-2
Formula: C11H10Br3N5O
B684425
C1CNC(=O)C2=C(C1C3=C(N=C(N3)N)Br)C(=C(N2)Br)Br
Standards; Enzyme Activators and Inhibitors;
(+/-)-4-(TRANS-2-(TRIFLUOROMETHYL)CYCLOPROPYL)PHENOL
CAS:1416432-54-6
Formula: C10H9F3O
T193190
C1[C@@H]([C@H]1C(F)(F)F)C2=CC=C(C=C2)O
(+/-)-4-BENZYLAZETIDIN-2-ONE
CAS:777885-07-1
Formula: C10H11NO
B411745
C1C(NC1=O)CC2=CC=CC=C2
Building Blocks; Miscellaneous;
(+/-)-4-CHLOROPHENYL-5-[(3,4-ISOPROPYLIDINE)-2-METHYLPYRIDINE]METHANOL
CAS:133545-64-9
Formula: C17H18ClNO3
C378550
CC1=C2C(=C(C=N1)C(C3=CC=C(C=C3)Cl)O)COC(C)(C)O2
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(+/-)-4-CHLOROPHENYL-5-[(3,4-ISOPROPYLIDINE)-2-METHYLPYRIDINE]METHANOL-D4
CAS:1216968-24-9
Formula: C17H14D4ClNO3
C378552
CC1=C2C(=C(C=N1)C(C3=C([2H])C([2H])=C(C([2H])=C3[2
Building Blocks; Isotopic Labeled Analogues; Pharmaceutical/API Drug Impurities/Metabolites;
(+/-)-4-HYDROXY MEPHENYTOIN
CAS:61837-65-8
Formula: C12H14N2O3
H944875
O=C1NC(C2=CC=C(O)C=C2)(CC)C(N1C)=O
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(+/-)-4-HYDROXY MEPHENYTOIN-D3
CAS:1173022-56-4
Formula: C12H11D3N2O3
H944877
O=C1NC(C2=CC=C(O)C=C2)(CC)C(N1C([2H])([2H])[2H])=O
Standards; Isotopic Labeled Analogues; Pharmaceutical/API Drug Impurities/Metabolites;
(+/-)-4-HYDROXY MEPHENYTOIN-D3 SODIUM SALT
Formula: C12H10D3N2O3Na
H944878
O=C(C(C1=CC=C(O[Na])C=C1)(CC)N2)N(C([2H])([2H])[2H
Standards; Isotopic Labeled Analogues; Miscellaneous; Pharmaceutical/API Drug Impurities/Metabolites;
(+/-)-6-METHYLNICOTINE
CAS:101540-79-8
Formula: C11H16N2
M323255
CC1=CC=C(C2N(C)CCC2)C=N1
Standards; Nicotine Derivatives and Metabolites;
(+/-)-7-HYDROXY-1,2,3,4-TETRAHYDRO-3-ISOQUINOLINE-4-CARBOXYLIC ACID METHYL ESTER HYDROCHLORIC ACID SALT
CAS:672310-19-9
Formula: C11H13NO3.HCl
A411333
COC(=O)C1C2=CC=C(C=C2CCN1)O.Cl
Building Blocks; Miscellaneous;
(+/-)-8,9-EPOXYEICOSA-5Z,11Z,14Z-TRIENOIC ACID
CAS:81246-85-7
Formula: C20H32O3
E589143
O=C(O)CCC/C=C/CC1C(/C=C/CC/C=C/CCCCC)O1
Research Tools; Standards; Molecular Biology;
(+/-)-9-HETE
CAS:79495-85-5
Formula: C20H32O3
H290018
CCCCC/C=C\C/C=C\CC(O)/C=C/C=C\CCCC(O)=O
Standards; Food;
(+/-)-BLEBBISTATIN
CAS:674289-55-5
Formula: C18H16N2O2
B592490
O=C1C2(O)C(N(C3=CC=CC=C3)CC2)=NC4=C1C=C(C)C=C4
Standards; Enzyme Activators and Inhibitors; Pharmaceutical/API Drug Impurities/Metabolites;
(+/-)-BUTACLAMOL HYDROCHLORIDE
CAS:36504-94-6
Formula: C25H31NO •HCl
B694300
CC(C)(C)[C@](CC1)(O)C[C@](N1C2)([H])C3=CC=CC4=C3[C
Standards; Pharmaceutical/API Drug Impurities/Metabolites; Anti-virals/Anti-retrovirals;
(+/-)-CATECHIN XHYDRATE
CAS:7295-85-4
Formula: C15H14O6 • x(H2O)
C217520
O[C@@H]1[C@@H](C2=CC=C(O)C(O)=C2)OC3=CC(O)=CC(O)=C
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(+/-)-CIS-2-AMINOCYCLOHEXANE-1-CARBOXYLIC ACID HYDROCHLORIDE
CAS:158414-45-0
Formula: C7H13NO2.HCL
A938158
C1CC[C@H]([C@H](C1)C(=O)O)N.Cl
Building Blocks; Chiral Molecules;
(+/-)-CIS-3-(CARBOBENZOXYAMINO)CYCLOHEXANECARBOXYLIC ACID
CAS:952616-39-6
Formula: C15H19NO4
C183865
C1C[C@@H](C[C@@H](C1)NC(=O)OCC2=CC=CC=C2)C(=O)O
Building Blocks; Miscellaneous;
(+/-)-CIS-6-HYDROXY-1-METHYLBICYCLO[4.3.0]NONANE-2,7-DIONE
CAS:1192178-33-8
Formula: C10H14O3
H302535
C[C@]12CCC(=O)[C@@]2(CCCC1=O)O
Building Blocks; Miscellaneous;
(+/-)-CIS-ANTI-N2-BPDE-DG-15N5
Formula: C30H2915N5O7
B676638
O=C1C([15N]=C[15N]2[C@H]3C[C@H](O)[C@@H](CO)O3)=C2
Standards; Isotopic Labeled Analogues; Environmental Standards, Mutagens and Metabolites;
(+/-)-CROMAKALIM
CAS:94470-67-4
Formula: C16H18N2O3
C795000
CC1(C)[C@H](O)[C@@H](N2CCCC2=O)C3=CC(C#N)=CC=C3O1
Standards; Enzyme Activators and Inhibitors;
(+/-)-DECANOYLCARNITINE CHLORIDE
CAS:18822-87-2
Formula: C17H34ClNO4
D212660
CCCCCCCCCC(OC(CC(O)=O)C[N+](C)(C)C)=O.[Cl-]
Standards; Pharmaceutical/API Drug Impurities/Metabolites; Lipids/Fatty Acids, Glycerol Derivatives;
(+/-)-EPINEPHRINE HYDROCHLORIDE
CAS:329-63-5
Formula: C9H13NO3 •HCl
E588698
OC(CNC)C1=CC(O)=C(O)C=C1.Cl
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(+/-)-ESTRA-4,9-DIENE-3,17-DIONE(MIXTURE OF 2 ENANTIOMERS)
CAS:13885-20-6
Formula: C18H22O2
E668545
C[C@]12CCC3=C4CCC(=O)C=C4CC[C@H]3[C@@H]1CCC2=O
Standards; Pharmaceutical/API Drug Impurities/Metabolites; Controlled Substances and Drugs of Abuse for Forensic Testing; Steroids;
(+/-)-EVODIAMINE
CAS:518-18-3
Formula: C19H17N3O
E975133
CN1C2=CC=CC=C2C(=O)N3CCC4=C(C13)NC5=CC=CC=C45
Standards; Natural Products; Extracted;
(+/-)-EXO-6-HYDROXYTROPINONE
CAS:5932-53-6
Formula: C8H13NO2
E975135
CN1[C@H]2CC(=O)C[C@@H]1[C@H](C2)O
Building Blocks; Miscellaneous;
(+/-)-FENCHONE-D6
Formula: C10H10D6O
F247452
CC(CC1C2(C([2H])([2H])[2H])C([2H])([2H])[2H])(CC1)
Standards; Isotopic Labeled Analogues; Pharmaceutical/API Drug Impurities/Metabolites;
(+/-)-HEXAHYDRO-3-METHYLENE-CIS-FURO[2,3-B]FURAN
CAS:109789-17-5
Formula: C7H10O2
H294190
C=C1[C@H]2CCO[C@H]2OC1
Building Blocks; Chiral Molecules;
(+/-)-HIP-A
CAS:227619-64-9
Formula: C6H8N2O4
H347003
O=C(O)[C@@H]1[C@@H](C(NO2)=O)[C@@H]2CN1
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(+/-)-HOMOHISTIDINE
CAS:5817-77-6
Formula: C7H11N3O2
H597500
NC(C(O)=O)CCC1=CN=CN1
Standards; Amino Acids; Pharmaceutical/API Drug Impurities/Metabolites;
(+/-)-HOMOPROLINE
CAS:56879-46-0
Formula: C6H11NO2
H605000
O=C(O)CC1CCCN1
Standards; Enzyme Activators and Inhibitors;
(+/-)-HOMOPROLINE HYDROCHLORIDE
CAS:71985-79-0
Formula: C6H11NO2 • (HCl)
H605005
C1CC(CC(=O)O)NC1.Cl
Standards; Enzyme Activators and Inhibitors;
(+/-)-HUPERZINE A
CAS:120786-18-7
Formula: C15H18N2O
H826003
O=C1C=CC(C(/C2=C/C)(N)CC(C)=CC2C3)=C3N1
Research Tools; Molecular Biology;
(+/-)-HYDROBENZOIN
CAS:655-48-1
Formula: C14H14O2
H191170
C1=CC=C(C=C1)C(C(C2=CC=CC=C2)O)O
(+/-)-HYMENIN
CAS:154569-13-8
Formula: C11H11Br2N5O
H998030
C1CNC(=O)C2=C(C1C3=CN=C(N3)N)C(=C(N2)Br)Br
Standards; Natural Products;
(+/-)-HYPOPHYLLANTHIN
CAS:78215-54-0
Formula: C24H30O7
H998450
Cl.C=CCc1c(cccc1)OCC(O)CNC(C)C
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(+/-)-HYPOPHYLLANTHIN-D6
Formula: C24H24D6O7
H998452
COC1=CC(C[C@H](COC([2H])([2H])[2H])[C@H]2COC([2H])
Standards; Isotopic Labeled Analogues; Pharmaceutical/API Drug Impurities/Metabolites;
(+/-)-ISO MYOSMINE, TECHNICAL GRADE
CAS:53844-46-5
Formula: C9H10N2
I821350
C1(C2=CC=CN=C2)CCC=N1
Standards; Environmental Standards, Mutagens and Metabolites;
(+/-)-ISOSTEVIOL-D3
Formula: C20H27D3O3
I902202
O=C1C2(C)C[C@@]3(C1)CC[C@]4([H])[C@@](C(O)=O)(C([2
Standards; Isotopic Labeled Analogues; Pharmaceutical/API Drug Impurities/Metabolites;
(+/-)-ISOSTEVIOL-D3 ACYL-SS-D-GLUCURONIDE SODIUM SALT
Formula: C26H34D3NaO9
I902212
O=C1C2(C)C[C@@]3(C1)CC[C@]4([H])[C@@](C(O[C@H]5[C@
Standards; Isotopic Labeled Analogues; Pharmaceutical/API Drug Impurities/Metabolites;
(+/-)-J 113397
CAS:217461-40-0
Formula: C24H37N3O2
J211040
O=C1N(CC)C2=CC=CC=C2N1[C@@H]3[C@@H](CO)CN(CC4CCCCC
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(+/-)-LISOFYLLINE
CAS:6493-06-7
Formula: C13H20N4O3
L469050
O=C1C2=C(N=CN2C)N(C)C(N1CCCCC(O)C)=O
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(+/-)-LISOFYLLINE-D6
CAS:1185995-26-9
Formula: C13H14D6N4O3
L469052
O=C1C2=C(N=CN2C([2H])([2H])[2H])N(C([2H])([2H])[2H
Standards; Isotopic Labeled Analogues; Pharmaceutical/API Drug Impurities/Metabolites;
(+/-)-LISOFYLLINE-D6
CAS:1185995-47-4
Formula: C13H14D6N4O3
L469053
Nc1ccc(cc1)C(N)=N
Standards; Isotopic Labeled Analogues; Pharmaceutical/API Drug Impurities/Metabolites;
(+/-)-MDA-D5 (1 MG/ML IN METHANOL)
CAS:136765-42-9
Formula: C10H13NO2
KIT8860
[2H]C(C(C([2H])([2H])[2H])(N)[2H])C1=CC2=C(OCO2)C=
Building Blocks; Miscellaneous; Solutions;
(+/-)-MDEA-D5
CAS:160227-43-0
Formula: C12H12D5NO2
M199518
[2H]C(C1=CC2=C(C=C1)OCO2)C([2H])(C([2H])([2H])[2H]
Standards; Isotopic Labeled Analogues; Pharmaceutical/API Drug Impurities/Metabolites;
(+/-)-MEDICARPIN
CAS:33983-39-0
Formula: C16H14O4
M214350
COC1=CC2=C(C=C1)[C@H]3COC4=C([C@H]3O2)C=CC(=C4)O
(+/-)-METHOXYVERAPAMIL
CAS:16662-47-8
Formula: C28H41ClN2O5
M271768
COC1=C(OC)C(OC)=CC(C(CCCN(CCC2=CC(OC)=C(OC)C=C2)C)
Standards; Enzyme Activators and Inhibitors; Pharmaceutical/API Drug Impurities/Metabolites;
(+/-)-MEVALONIC ACID 5-DIPHOSPHATE TETRALITHIUM SALT
CAS:108869-00-7
Formula: C6H10Li4O10P2
M340485
O=C(CC(O)(C)CCOP(OP(O[Li])(O[Li])=O)(O[Li])=O)O[Li
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(+/-)-MUSCARINE CHLORIDE
CAS:2936-25-6
Formula: C9H20ClNO2
M814005
C[C@@H]1[C@@H](O)C[C@H](C[N+](C)(C)C)O1.[Cl-]
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(+/-)-MUSCARINE CHLORIDE HYDRATE
Formula: C9H20ClNO2 • H2O
M814020
C[C@@H]1O[C@H](C[N+](C)(C)C)C[C@H]1O.[Cl-].O
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(+/-)-MUSCARINE-D9 CHLORIDE
Formula: C9H11D9ClNO2
M814007
C[C@@H]1[C@@H](O)C[C@H](C[N+](C([2H])([2H-])[2H])(
Standards; Isotopic Labeled Analogues; Pharmaceutical/API Drug Impurities/Metabolites;
(+/-)-MYRICANOL
CAS:33606-81-4
Formula: C21H26O5
M214385
COC1=C2C=C(CCCC[C@H](CCC3=CC2=C(C=C3)O)O)C(=C1OC)O
(+/-)-MYRISTOYLCARNITINE CHLORIDE
CAS:14919-38-1
Formula: C21H42ClNO4
M885003
O=C(CCCCCCCCCCCCC)OC(C[N+](C)(C)C)CC(O)=O.[Cl-]
Standards; Lipids/Fatty Acids, Glycerol Derivatives;
(+/-)-N-(BENZYLIDENE)ALANINE ETHYL ESTER
CAS:60930-36-1
Formula: C12H15NO2
B279155
CC(/N=C/C1=CC=CC=C1)C(OCC)=O
Building Blocks; Amino Acids;
(+/-)-N-3-BENZYLNIRVANOL
CAS:93879-40-4
Formula: C18H18N2O2
B285770
O=C(C(C1=CC=CC=C1)(CC)N2)N(CC3=CC=CC=C3)C2=O
Standards; Enzyme Activators and Inhibitors; Pharmaceutical/API Drug Impurities/Metabolites;
(+/-)-N-DESMETHYL TRIFLUOROACETOTRAMADOL-D3
CAS:1346602-78-5
Formula: C17H19D3F3NO3
D295452
[2H]C([2H])([2H])N(C[C@H]1CCCC[C@@]1(C2=CC(=CC=C2)
Standards; Isotopic Labeled Analogues; Pharmaceutical/API Drug Impurities/Metabolites;
(+/-)-NICOTINE-D3 SALICYLATE SALT
Formula: C17H17D3N2O3
N424600
[2H]C([2H])([2H])N1CCC[C@H]1C2=CC=CN=C2.OC3=CC=CC=
Standards; Isotopic Labeled Analogues;
(+/-)-NIPECOTIC ACID
CAS:498-95-3
Formula: C6H11NO2
N478400
C1CC(CNC1)C(=O)O
Building Blocks; Miscellaneous;
(+/-)-NOR-SS-HYDRASTINE
CAS:66408-36-4
Formula: C20H19NO6
N705600
COC1=C(C2=C(C=C1)[C@@H](OC2=O)[C@@H]3C4=CC5=C(C=C4
Standards; Enzyme Activators and Inhibitors; Pharmaceutical/API Drug Impurities/Metabolites;
(+/-)-NOREPINEPHRINE (+)-BITARTRATE SALT
CAS:3414-63-9
Formula: C8H11NO3 • C4H6O6
N674538
OC1=C(O)C=CC(C(CN)O)=C1.OC([C@H](O)[C@@H](O)C(O)=O
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(+/-)-NUTLIN-3
CAS:548472-68-0
Formula: C30H30Cl2N2O4
N925535
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(+/-)-ORTHO-COTININE
CAS:147732-31-8
Formula: C10H12N2O
C725050
O=C1CCC(C2=NC=CC=C2)N1C
Standards; Stimulant; Nicotine Derivatives and Metabolites;
(+/-)-ORTHO-COTININE PERCHLORATE
CAS:147732-32-9
Formula: C10H13ClN2O5
C725010
O=C1CCC(C2=NC=CC=C2)N1C.O=[ClH]([O])([O])=O
Standards; Nicotine Derivatives and Metabolites;
(+/-)-ORTHO-COTININE-D3
CAS:66269-66-7
Formula: C10H9D3N2O
C725008
Standards; Isotopic Labeled Analogues; Pharmaceutical/API Drug Impurities/Metabolites;
(+/-)-PD 128,907 HYDROCHLORIDE
CAS:112960-16-4
Formula: C14H19NO3 •HCl
P218323
OC1=CC=C(OC[C@@]2([H])[C@@]3([H])OCCN2CCC)C3=C1.Cl
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(+/-)-PPHT HYDROCHLORIDE
CAS:71787-90-1
Formula: C21H27NO • (HCl)
P699003
OC1=C2CCC(N(CCC3=CC=CC=C3)CCC)CC2=CC=C1.Cl
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(+/-)-PRONETHALOL
CAS:54-80-8
Formula: C15H19NO
P757170
CC(C)NCC(C1=CC2=CC=CC=C2C=C1)O
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(+/-)-PRONETHALOL-D6
CAS:1329805-79-9
Formula: C15H13D6NO
P757172
[2H]C([2H])([2H])C(C([2H])([2H])[2H])NCC(C1=CC2=CC
Standards; Isotopic Labeled Analogues; Pharmaceutical/API Drug Impurities/Metabolites;
(+/-)-PROPYL2-4-PENTENOIC ACID (1.0 MG/ML IN METHANOL)
CAS:1575-72-0
Formula: C8H14O2
KIT8055
C=CCC(CCC)C(O)=O
Standards; Solutions; Kits;
(+/-)-QUINPIROLE DIHYDROCHLORIDE
CAS:73625-62-4
Formula: C13H21N3 • 2HCl
Q796710
CCCN1CCC[C@@]2([H])CC3=NNC=C3C[C@]12[H].Cl
Research Tools; Molecular Biology;
(+/-)-SDZ-201106(DPI-201106)
CAS:97730-95-5
Formula: C29H30N4O2
S211110
OC(COC1=CC=CC2=C1C=C(C#N)N2)CN3CCN(C(C4=CC=CC=C4)C
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(+/-)-SLV 319
CAS:362519-49-1
Formula: C23H20Cl2N4O2S
S560013
C/N=C(N1N=C(C2=CC=C(Cl)C=C2)C(C3=CC=CC=C3)C1)/NS(=
Research Tools; Molecular Biology;
(+/-)-SS-HYDRASTINE
CAS:60594-55-0
Formula: C21H21NO6
H675690
CN1CCC2=CC3=C(C=C2[C@@H]1[C@@H]4C5=C(C(=C(C=C5)OC)
Standards; Enzyme Activators and Inhibitors; Pharmaceutical/API Drug Impurities/Metabolites;
(+/-)-SS-HYDRASTINE-D3
CAS:1346598-42-2
Formula: C21H18D3NO6
H675692
[2H]C([2H])([2H])N1CCC2=CC3=C(C=C2[C@H]1[C@H]4C5=C
Standards; Isotopic Labeled Analogues; Enzyme Activators and Inhibitors; Pharmaceutical/API Drug Impurities/Metabolites;
(+/-)-TERT-BUTYL 6-CHLORO-5-HYDROXY-3-OXOHEXANOATE
CAS:319924-73-7
Formula: C10H17lO4
B692830
Building Blocks; Miscellaneous;
(+/-)-THREO-3-METHYLGLUTAMIC ACID
CAS:63088-04-0
Formula: C6H11NO4
M311585
N[C@H](C(O)=O)[C@H](C)CC(O)=O
Standards; Chiral Molecules; Pharmaceutical/API Drug Impurities/Metabolites;
(+/-)-TRANS TAXIFOLIN
CAS:24198-97-8
Formula: C15H12O7
T010000
OC1=CC([C@@H]2[C@@H](O)C(C3=C(O)C=C(O)C=C3O2)=O)=C
Standards; Enzyme Activators and Inhibitors;
(+/-)-TRANS TAXIFOLIN-D3
Formula: C15H9D3O7
T010002
OC1=C([2H])C([C@@H]2[C@@H](O)C(C3=C(O)C=C(O)C=C3O2
Standards; Isotopic Labeled Analogues; Enzyme Activators and Inhibitors;
(+/-)-TRANS-1,2-BIS(2-MERCAPTOACETAMIDO)CYCLOHEXANE
CAS:257641-01-3
Formula: C10H18N2O2S2
B481450
SCC(N[C@@H]1[C@@H](NC(CS)=O)CCCC1)=O
Research Tools; Miscellaneous;
(+/-)-TRANS-1,2-BIS(CHLOROACETAMIDO)CYCLOHEXANE
CAS:150576-46-8
Formula: C10H16Cl2N2O2
B418325
ClCC(N[C@@H]1[C@@H](NC(CCl)=O)CCCC1)=O
Building Blocks; Cross-linkers; Sulfhydryl Active Reagents;
(+/-)-TRANS-3-BROMOTETRAHYDRO-2-(2-PROPYNYLOXY)-FURAN
CAS:109789-15-3
Formula: C7H9BrO2
B688040
Br[C@@H]1CCO[C@H]1OCC#C
Building Blocks; Chiral Molecules;
(+/-)-TRANS-4-(1-NAPHTHYL)-PYRROLIDINE-3-CARBOXYLIC ACID HYDROCHLORIDE
CAS:1330750-42-9
Formula: C15H15NO2.HCl
T705338
C1[C@@H]([C@H](CN1)C(=O)O)C2=CC=CC3=CC=CC=C32.Cl
Building Blocks; Miscellaneous;
(+/-)-TRANS-4-(2,3-DICHLORO-PHENYL)-PYRROLIDINE-3-CARBOXYLIC ACID HYDROCHLORIDE
CAS:1392210-64-8
Formula: C11H11NO2Cl2.HCl
T705345
C1[C@@H]([C@H](CN1)C(=O)O)C2=CC=CC=C2Cl.Cl
Building Blocks; Miscellaneous;
(+/-)-TRANS-4-(2,5-DICHLOROPHENYL)PYRROLIDINE-3-CARBOXYLIC ACID HYDROCHLORIDE
CAS:1049734-30-6
Formula: C11H11NO2Cl2 • HCl
T705260
C1[C@@H]([C@H](CN1)C(=O)O)C2=C(C=CC(=C2)Cl)Cl.Cl
Building Blocks; Chiral Molecules;
(+/-)-TRANS-4-(2-CHLOROPHENYL)PYRROLIDINE-3-CARBOXYLIC ACID HCL
CAS:1049727-60-7
Formula: C11H13Cl2NO2
T275015
C1[C@H]([C@@H](CN1)C(=O)O)C2=CC=CC=C2Cl.Cl
(+/-)-TRANS-4-(2-CYANOPHENYL)PYRROLIDINE-3-CARBOXYLIC ACID HYDROCHLORIDE
CAS:1049734-84-0
Formula: C12H12N2O2 • HCl
T705250
C1[C@H]([C@@H](CN1)C(=O)O)C2=CC=CC=C2C#N.Cl
Building Blocks; Chiral Molecules;
(+/-)-TRANS-4-(2-HYDROXY-PHENYL)-PYRROLIDINE-3-CARBOXYLIC ACID HYDROCHLORIDE
CAS:1392213-92-1
Formula: C11H13NO3.HCl
T705348
C1[C@@H]([C@H](CN1)C(=O)O)C2=CC=CC=C2O.Cl
Building Blocks; Miscellaneous;
(+/-)-TRANS-4-(2-METHOXY-PHENYL)-PYRROLIDINE-3-CARBOXYLIC ACID HYDROCHLORIDE
CAS:1330750-51-0
Formula: C12H15NO3.HCl
T705343
COC1=CC=CC=C1[C@H]2CNC[C@@H]2C(=O)O.Cl
Building Blocks; Miscellaneous;
(+/-)-TRANS-4-(2-METHOXY-PHENYL)-PYRROLIDINE-3-CARBOXYLIC ACID HYDROCHLORIDE
CAS:1049735-11-6
Formula: C12H16ClNO3
T243940
COC1=CC=CC=C1[C@@H]2CNC[C@H]2C(=O)O.Cl
(+/-)-TRANS-4-(2-NAPHTHYL)-PYRROLIDINE-3-CARBOXYLIC ACID HYDROCHLORIDE
CAS:1049734-17-9
Formula: C15H15NO2 • HCl
T705245
C1[C@@H]([C@H](CN1)C(=O)O)C2=CC3=CC=CC=C3C=C2.Cl
Building Blocks; Chiral Molecules;
(+/-)-trans-4-(2-Pyriidinyl)pyrollidine-3-carboxylic acid dihydrochloride
CAS:1049739-70-9
Formula: C10H12N2O2·2HCl
T225970
C1[C@H]([C@@H](CN1)C(=O)O)C2=CC=CC=N2.Cl.Cl
(+/-)-TRANS-4-(3-BROMO-PHENYL)-PYRROLIDINE-3-CARBOXYLIC ACID HYDROCHLORIDE
CAS:1423037-48-2
Formula: C11H12NO2Br.HCl
T705358
C1[C@H]([C@@H](CN1)C(=O)O)C2=CC(=CC=C2)Br.Cl
Building Blocks; Miscellaneous;
(+/-)-TRANS-4-(3-CHLORO-PHENYL)-PYRROLIDINE-3-CARBOXYLIC ACID HYDROCHLORIDE
CAS:1284228-59-6
Formula: C11H12NO2Cl.HCl
T705325
C1=CC(=CC(=C1)Cl)[C@H]2CNC[C@@H]2C(=O)O.Cl
Building Blocks; Miscellaneous;
(+/-)-TRANS-4-(3-HYDROXYPHENYL)-PYRROLIDINE-3-CARBOXYLIC ACID HYDROCHLORIDE
CAS:1392213-98-7
Formula: C11H13NO3.HCl
T705350
C1[C@@H]([C@H](CN1)C(=O)O)C2=CC(=CC=C2)O.Cl
Building Blocks; Miscellaneous;
(+/-)-TRANS-4-(4-HYDROXY-PHENYL)-PYRROLIDINE-3-CARBOXYLIC ACID HYDROCHLORIDE
CAS:1392211-71-0
Formula: C11H13NO3.HCl
T705340
C1[C@H]([C@@H](CN1)C(=O)O)C2=CC=C(C=C2)O.Cl
Building Blocks; Miscellaneous;
(+/-)-TRANS-4-(4-PYRIDINYL)PYRROLIDINE-3-CARBOXYLIC ACID DIHYDROCHLORIDE
CAS:1049740-23-9
Formula: C10H12N2O2 • 2HCl
T705255
C1[C@H]([C@@H](CN1)C(=O)O)C2=CC=NC=C2.Cl.Cl
Building Blocks; Miscellaneous;
(+/-)-TRANS-4-ISOPROPYLPYRROLIDINE-3-CARBOXYLIC ACID HYDROCHLORIDE
CAS:1330750-36-1
Formula: C8H15NO2.HCL
T705323
CC(C)[C@H]1CNC[C@@H]1C(=O)O.Cl
Building Blocks; Miscellaneous;
(+/-)-TRANS-ANTI-N2-BPDE-DG-15N5
Formula: C30H2915N5O7
B676633
O=C1C([15N]=C[15N]2[C@H]3C[C@H](O)[C@@H](CO)O3)=C2
Standards; Isotopic Labeled Analogues; Environmental Standards, Mutagens and Metabolites;
(+/-)-U-50488 HYDROCHLORIDE
CAS:67197-96-0
Formula: C19H26Cl2N2O•HCl
U850328
O=C(N(C)[C@H]1[C@H](N2CCCC2)CCCC1)CC3=CC=C(Cl)C(Cl
Standards; Chiral Molecules;
(+/-)11-HDOHE
CAS:87018-59-5
Formula: C22H32O3
H999770
CC/C=C/C/C=C/C/C=C/CC(O)/C=C/C=C/C/C=C/CCC(O)=O
Standards; Lipids/Fatty Acids, Glycerol Derivatives; Carbohydrates and Oligosaccharides;
(+/-)12-HEPE
CAS:81187-21-5
Formula: C20H30O3
H290015
CC/C=C\C/C=C\CC(O)/C=C/C=C\C/C=C\CCCC(O)=O
Standards; Food;
(+/-)12-HPETE
CAS:71030-35-8
Formula: C20H32O4
B529755
CCCCC/C=C\CC(OO)/C=C/C=C\C/C=C\CCCC(O)=O
Standards; Environmental Standards, Mutagens and Metabolites;
(+/-)13-HODE CHOLESTERYL ESTER
CAS:167354-91-8
Formula: C45H76O3
H669570
CCCCCC(O)/C=C/C=C\CCCCCCCC(O[C@H]1CC[C@]2(C)[C@@]3
Standards; Steroids;
(+/-)17-HDOHE
CAS:90780-52-2
Formula: C22H32O3
H999758
CC/C=C\CC(O)/C=C/C=C\C/C=C\C/C=C\C/C=C\CCC(O)=O
Standards; Food;
(+/-)20-HDOHE
CAS:90906-41-5
Formula: C22H32O3
H999765
CCC(O)/C=C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(O)=O
Standards; Pharmaceutical/API Drug Impurities/Metabolites; Lipids/Fatty Acids, Glycerol Derivatives;
(+/-)20-HDOHE-D5
Formula: C22H27D5O3
H999767
O[C@H](C(F)(F)F)[C@@]1([H])CCCN1C2=CC(C(F)(F)F)=C(
Standards; Isotopic Labeled Analogues; Pharmaceutical/API Drug Impurities/Metabolites; Lipids/Fatty Acids, Glycerol Derivatives;
(+/-)5-HETE
CAS:73307-52-5
Formula: C20H32O3
H290023
CCCCC/C=C\C/C=C\C/C=C\C=C\C(O)CCCC(O)=O
Standards; Food;
(+/-)9,10-DIHOME
CAS:263399-34-4
Formula: C18H34O4
D446388
CCCCC/C=C\CC(O)C(O)CCCCCCCC(O)=O
Standards; Environmental Standards, Mutagens and Metabolites;
(+/-)9-HODE
CAS:98524-19-7
Formula: C18H32O3
H669555
CCCCC/C=C\C=C\C(O)CCCCCCCC(O)=O
Standards; Lipids/Fatty Acids, Glycerol Derivatives;
(+/-)9-HODE CHOLESTERYL ESTER
CAS:33783-76-5
Formula: C45H76O3
H669573
CCCCC/C=C\C=C\C(O)CCCCCCCC(O[C@H]1CC[C@]2(C)[C@@]3
Standards; Steroids;
(+/-)ALPHA-METHYLSEROTONIN MALEATE
CAS:304-52-9
Formula: C15H18N2O5
M326858
OC1=CC2=C(NC=C2CC(N)C)C=C1
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(+/-)AMETHOPTERIN
CAS:60388-53-6
Formula: C20H22N8O5
A576403
NC1=NC(N)=NC2=C1N=C(CN(C3=CC=C(C(NC(CCC(O)=O)C(O)=
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(-) METHYL DIHYDROJASMONATE
CAS:2630-39-9
Formula: C13H22O3
M224730
CCCCC[C@@H]1[C@H](CCC1=O)CC(=O)OC
Building Blocks; Miscellaneous;
(-)-(1-OXYL-2,2,5,5-TETRAMETHYLPYRROLIDIN-3-YL)METHYL METHANETHIOSULFONATE
CAS:681034-15-1
Formula: C10H20NO3S2
O873910
O=S(SC[C@@H]1C(C)(C)N([O])C(C)(C)C1)(C)=O
Research Tools; Spin Labels; Sulfhydryl Active Reagents;
(-)-(14A)-DIHYDROVINPOCETINE-D5
Formula: C22H23D5N2O2
D448352
O=C(OC([2H])([2H])C([2H])([2H])[2H])[C@]1([H])N2C3
Research Tools;
(-)-(18-CROWN-6)-2,3,11,12-TETRACARBOXAMIDE
CAS:61740-37-2
Formula: C24H44N4O10
C825010
O=C(N(C)C)[C@@H]1[C@@H](C(N(C)C)=O)OCCOCCO[C@H](C(
Building Blocks; Chiral Molecules;
(-)-(18-CROWN-6)-2,3,11,12-TETRACARBOXYLIC ACID
CAS:73891-15-3
Formula: C16H24O14
C825005
O=C(O)[C@@H]1[C@@H](C(O)=O)OCCOCCO[C@H](C(O)=O)[C@
Building Blocks; Chiral Molecules;
(-)-(1R)-MENTHYL CHLOROFORMATE
CAS:14602-86-9
Formula: C11H19ClO2
M219450
CO/N=C(/c1nc(NCOC(=O)C(C)(C)C)sc1)C(=O)N[C@H]2[C@H
Building Blocks; Miscellaneous;
(-)-(1R,3S)-N-BOC-1-AMINOCYCLOPENTANE-3-CARBOXYLIC ACID
CAS:261165-05-3
Formula: C11H19NO4
B617665
O=C([C@H]1CC[C@@H](NC(OC(C)(C)C)=O)C1)O
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(-)-(1R,3S)-N-FMOC-3-AMINOCYCLOPENTANECARBOXYLIC ACID
CAS:220497-67-6
Formula: C21H21NO4
F603670
C1C[C@@H](C[C@@H]1C(=O)O)NC(=O)OCC2C3=CC=CC=C3C4=C
Building Blocks; Chiral Molecules;
(-)-(1S,2R)-1,2-DIHYDRO-1,2-NAPHTHALENEDIOL
CAS:90365-29-0
Formula: C10H10O2
D450200
O[C@@H]1[C@H](O)C=CC2=CC=CC=C21
Building Blocks; Miscellaneous;
(-)-(1S,2S,5S)-2-HYDROXY-3-PINANONE
CAS:1845-25-6
Formula: C10H16O2
H952020
O[C@]1(C)C(C[C@H]2C(C)(C)[C@@H]1C2)=O
Building Blocks; Chiral Molecules; Pharmaceutical/API Drug Impurities/Metabolites;
(-)-(1S,4R)-4-AMINOCYCLOPENT-2-ENECARBOXYLIC ACID
CAS:168471-40-7
Formula: C6H9NO2
A604140
OC([C@H]1C[C@@H](N)C=C1)=O
Building Blocks; Miscellaneous;
(-)-(1S,4R)-CAMPHANOYL CHLORIDE
CAS:39637-74-6
Formula: C10H13ClO3
C165000
C[C@@]12CC[C@@](C1(C)C)(OC2=O)C(=O)Cl
Building Blocks; Chiral Molecules;
(-)-(1S,4R)-N-BOC-4-AMINOCYCLOPENT-2-ENECARBOXYLIC ACID
CAS:151907-79-8
Formula: C11H17NO4
B667863
CC(C)(C)OC(=O)N[C@@H]1C[C@@H](C=C1)C(=O)O
Building Blocks; Miscellaneous;
(-)-(2R,5R)-2,5-DIMETHYLPYRROLIDINE, HYDROCHLORIDE, 90% (CONTAINS MESO-ISOMER)
CAS:70144-18-2
Formula: C6H14ClN
D478000
C[C@H]1N[C@H](C)CC1.Cl
Building Blocks; Chiral Molecules;
(-)-(2R,5S)-1-ALLYL-2,5-DIMETHYLPIPERAZINE
CAS:155836-78-5
Formula: C9H18N2
A552540
C=CCN1[C@H](C)CN[C@@H](C)C1
Standards; Chiral Molecules;
(-)-(2S,3S)-VIRIDIFLORIC ACID ACETONIDE
CAS:95462-09-2
Formula: C10H18O4
V673875
Building Blocks; Miscellaneous;
(-)-(2S,3S)-VIRIDIFLORIC ACID ACETONIDE-D7
Formula: C10H11D7O4
V673877
[2H]C(C([2H])([2H])[2H])(C([2H])([2H])[2H])[C@@]1(
Building Blocks; Isotopic Labeled Analogues;
(-)-(2S,3S)-VIRIDIFLORIC ACID ETHYL ESTER-D7
Formula: C9H11D7O4
V673872
O=C([C@@]([C@H](O)C)(O)C([2H])(C([2H])([2H])[2H])C
Building Blocks; Isotopic Labeled Analogues;
(-)-(2Z,5S,6E)-5-{[TERT-BUTYL(DIMETHYL)SILYL]OXY}-2,6-DIMETHYL-7-(2-METHYL-1,3-THIAZOL-4-YL)HEPTA-2,6-DIEN-1-OL
CAS:218614-16-5
Formula: C19H33NO2SSi
B691440
CC1=NC(/C=C(C)/[C@@H](O[Si](C)(C)C(C)(C)C)C/C=C(C)
Standards; Chiral Molecules;
(-)-(3S)-3-{[TERT-BUTYL(DIMETHYL)SILYL]OXY}DIHYDROFURAN-2(3H)-ONE
CAS:164264-14-6
Formula: C10H20O3Si
B691425
O=C1[C@@H](O[Si](C)(C)C(C)(C)C)CCO1
Building Blocks; Chiral Molecules;
(-)-(3S)-3-HYDROXY QUININE
CAS:78549-61-8
Formula: C20H24N2O3
H953235
C=C[C@@]1(O)C[N@]2[C@@]([C@H](O)C3=CC=NC4=CC=C(OC)
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(-)-(3S)-3-HYDROXY QUININE-VINYL-D3
CAS:78549-61-8
Formula: C20H21D3N2O3
H953237
O[C@]1(/C([2H])=C([2H])/[2H])C[N@]2[C@@]([C@H](O)C
Standards; Isotopic Labeled Analogues; Pharmaceutical/API Drug Impurities/Metabolites;
(-)-(3S,4E)-3-{[TERT-BUTYL(DIMETHYL)SILYL]OXY}-4-METHYL-5-(2-METHYL-1,3-THIAZOL-4-YL)PENT-4-EN-1-OL
CAS:188899-14-1
Formula: C16H29O2NSiS
B691515
OCC[C@H](O[Si](C(C)(C)C)(C)C)/C(C)=C/C1=CSC(C)=N1
Building Blocks; Chiral Molecules;
(-)-(3S,4S)-3,4-DIMETHYL-4-(3-HYDROXYPHENYL)PIPERIDINE
CAS:145678-87-1
Formula: C13H19NO
D479018
OC1=CC=CC(C2[C@H](C)CNC[C@H]2C)=C1
Building Blocks; Miscellaneous;
(-)-(3S,5R)-FLUVASTATIN-D7
Formula: C24H19D7FNO4
F601248
O[C@H](C[C@H](O)CC(O)=O)/C=C/C1=C(C2=CC=C(F)C=C2)C
Standards; Isotopic Labeled Analogues; Pharmaceutical/API Drug Impurities/Metabolites;
(-)-(R)-(S)-BPPFA
CAS:74311-56-1
Formula: C38H37FeNP2
B676690
Building Blocks; Chiral Molecules;
(-)-(S)-CHEILANTHIFOLINE HYDROCHLORIDE
Formula: C19H19NO4 • HCl
C483440
OC1=CC2=C([C@@](CC(C=CC3=C4OCO3)=C4C5)([H])N5CC2)C
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(-)-?-CADINENE
CAS:1460-97-5
Formula: C15H24
C058505
CC1=C[C@@]2([H])[C@@](CC1)([H])C(CC[C@@H]2C(C)C)=C
Standards; Natural Products;
(-)-[(8,8-DICHLOROCAMPHORYL)SULFONYL]OXAZIRIDINE
CAS:139628-16-3
Formula: C10H13Cl2NO3S
D433975
O=S1(C[C@@]2(C3(C)C)CC[C@H]3C(Cl)(Cl)[C@]24N1O4)=O
Building Blocks;
(-)-[(S)-1-(4-METHOXYPHENYL)ETHYL]AMINE
CAS:41851-59-6
Formula: C9H13NO
M266385
N[C@H](C1=CC=C(OC)C=C1)C
Building Blocks; Chiral Molecules;
(-)-[3R,4S]-CHROMANOL 293B
CAS:163163-24-4
Formula: C15H20N2O4S
C350260
CCS(=O)(N([C@@H]1[C@@H](O)C(C)(C)OC2=CC=C(C#N)C=C1
Research Tools; Molecular Biology; Enzyme Activators and Inhibitors;
(-)-[N-[(R)-TETRAHYDROFURFURYL]NOROXYMORPHONE HYDROCHLORIDE
CAS:62509-10-8
Formula: C21H25NO5 • HCl
T492205
O=C1[C@@]2([H])[C@]34C5=C(O2)C(O)=CC=C5C[C@@H](N(C
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(-)-1,2-BIS((2R,5R)-2,5-DIETHYLPHOSPHOLANO)BENZENE(CYCLOOCTADIENE)RHODIUM(I) TRIFLUOROMETHANESULFONATE
CAS:136705-77-6
Formula: C31H48F3O3P2RhS
B016031
CC[C@H]1P([C@@H](CC1)CC)C2=CC=CC=C2P3[C@@H](CC[C@H
(-)-1,4-DI-O-BENZYL-L-THREITOL
CAS:17401-06-8
Formula: C18H22O4
D423060
C1=CC=C(C=C1)COC[C@@H]([C@H](COCC2=CC=CC=C2)O)O
Building Blocks; Chiral Molecules;
(-)-1,6-EPOXYISODIHYDROCARVEOL
CAS:35692-59-2
Formula: C10H16O2
E589230
CC(=C)[C@H]1C[C@@H]([C@]2([C@@H](C1)O2)C)O
Standards; Chiral Molecules; Pharmaceutical/API Drug Impurities/Metabolites;
(-)-1-(2,5-DIMETHOXY-4-IODOPHENYL)-2-AMINOPROPANE HYDROCHLORIDE
CAS:82864-02-6
Formula: C11H16INO2• HCl
D267580
C[C@@H](N)CC1=CC(OC)=C(I)C=C1OC.Cl
Building Blocks; Miscellaneous;
(-)-1-(4-FLUOROPHENYL)ETHANOL
CAS:101219-73-2
Formula: C8H9FO
F593618
C[C@H](O)C1=CC=C(F)C=C1
Building Blocks; Miscellaneous;
(-)-1-(9-FLUORENYL)ETHANOL
CAS:151775-20-1
Formula: C15H14O
F647655
O[C@H](C1C2=CC=CC=C2C3=CC=CC=C13)C
Building Blocks; Chiral Molecules; Miscellaneous;
(-)-1-(9-FLUORENYL)ETHYL CHLOROFORMATE
CAS:154479-90-0
Formula: C16H13ClO2
F647505
CC(C1C2=CC=CC=C2C3=CC=CC=C13)OC(Cl)=O
Building Blocks; Miscellaneous;
(-)-1’-Methyl-N-Benzyl Normetazocine
Formula: C22H27NO
M292650
OC1=CC2=C(C=C1)C[C@H]3N(C(C4=CC=CC=C4)C)CC[C@@]2(C
Standards; Chiral Molecules; Pharmaceutical/API Drug Impurities/Metabolites; Benzomorphans;
(-)-11-HYDROXY-?8-TETRAHYDROCANNABINOL-O-ACETYL
CAS:121929-00-8
Formula: C23H32O4
H957110
CCCCCC1=CC(OC(C)=O)=C([C@@]2([H])[C@@](C(C)(C)O3)(
Standards; Pharmaceutical/API Drug Impurities/Metabolites; Controlled Substances and Drugs of Abuse for Forensic Testing; Cannabis Constituents; Cannabinols;
(-)-15-DEOXYSPERGUALIN TRIHYDROCHLORIDE
CAS:84937-45-1
Formula: C17H37N7O3 · HCl
D263420
O=C(N[C@@H](O)C(NCCCCNCCCN)=O)CCCCCCNC(N)=N.[3 HCl
Standards; Chiral Molecules; Pharmaceutical/API Drug Impurities/Metabolites;
(-)-18-METHOXYCORONARIDINE-D4 HYDROCHLORIDE
Formula: C22H24D4N2O3
M262212
[H][C@](C1[N@@](C([2H])([2H])C2([2H])[2H])C3)(CCOC
Standards; Isotopic Labeled Analogues; Pharmaceutical/API Drug Impurities/Metabolites;
(-)-2'-DEOXY-3'-OXA-4'-THIOCYTIDINE (APRICITABINE)
CAS:160707-69-7
Formula: C8H11N3O3S
D245513
O=C1N=C(N)C=CN1[C@@H]2S[C@H](CO)OC2
Building Blocks; Chiral Molecules;
(-)-2,2'-METHYLENEBIS[(3AS,8AR)-3A,8A-DIHYDRO-8HINDENO[1,2-D]OXAZOLE]
CAS:175166-49-1
Formula: C21H18N2O2
M304475
C1[C@@H]2[C@H](C3=CC=CC=C31)N=C(O2)CC4=N[C@@H]5[C@
Building Blocks; Chiral Molecules;
(-)-2-AMINO-6-PROPIONAMIDO-D3-TETRAHYDROBENZOTHIAZOLE
CAS:1217644-20-6
Formula: C10H12D3N3OS
A628152
NC(S1)=NC2=C1C[C@@H](NC(CC([2H])([2H])[2H])=O)CC2
Building Blocks; Chiral Molecules; Isotopic Labeled Analogues;
(-)-2-AMINO-6-PROPIONAMIDO-TETRAHYDROBENZOTHIAZOLE
CAS:106006-84-2
Formula: C10H15N3OS
A628150
CCC(N[C@@H]1CC2=C(N=C(N)S2)CC1)=O
Standards; Chiral Molecules;
(-)-2-CYANO-6-PHENYLOXAZOLOPIPERIDINE
CAS:88056-92-2
Formula: C14H16N2O
C999270
C1=CC=C(C=C1)[C@@H]2CO[C@@H]3CCC[C@@H](C#N)N23
Building Blocks; Chiral Molecules;
(-)-2-METHYL ISOBORNEOL
CAS:68330-43-8
Formula: C11H20O
M314000
O[C@@]1(C)[C@@]2(C)CC[C@H](C2(C)C)C1
Standards; Miscellaneous;
(-)-2-METHYL ISOBORNEOL-D3
CAS:135441-89-3
Formula: C11H17D3O
M314002
O[C@]1(C([2H])([2H])[2H])[C@@]2(C)CC[C@H](C2(C)C)C
Standards; Isotopic Labeled Analogues; Miscellaneous;
(-)-2SS-CARBOMETHOXY-3SS-(4-(IODOPHENYL-D4))NORTROPANE
Formula: C15H14D4INO2
C176612
[2H]C1=C([2H])C(I)=C([2H])C([2H])=C1[C@@H]2[C@H](C
Standards; Enzyme Activators and Inhibitors;
(-)-2SS-CARBOMETHOXY-3SS-(4-IODOPHENYL)NORTROPANE
CAS:136794-87-1
Formula: C15H18INO2
C176610
IC(C=C1)=CC=C1[C@@H]2[C@H](C(OC)=O)[C@H]3CC[C@@H](
Standards; Enzyme Activators and Inhibitors; Neurochemicals;
(-)-3,4,4A,5,6,10B-HEXAHYDRO-2H-NAPHTHO[1,2-B][1,4]OXAZIN-9-OL, HYDROCHLORIDE
CAS:1322623-41-5
Formula: C12H16ClNO2
H294070
[H][C@@]12NCCO[C@@]1([H])C3=C(C=CC(O)=C3)CC2.Cl
Standards; Chiral Molecules; Neurochemicals;
(-)-3,4,4A,5,6,10B-HEXAHYDRO-9-METHOXY-2H-NAPHTHO[1,2-B][1,4]OXAZIN, HYDROCHLORIDE
CAS:99833-85-9
Formula: C13H18ClNO2
H294120
[H][C@@]12NCCO[C@@]1([H])C3=C(C=CC(OC)=C3)CC2.Cl
Standards; Chiral Molecules; Neurochemicals; Ephedrine; Phenethylamines/Amphetamines;
(-)-3,4,4A,5,6,10B-HEXAHYDRO-9-METHOXY-2H-NAPHTHO[1,2-B][1,4]OXAZIN-3-ONE
CAS:99833-90-6
Formula: C13H15NO3
H294145
[H][C@@]12NC(CO[C@@]1([H])C3=C(C=CC(OC)=C3)CC2)=O
Research Tools; Molecular Biology; Neurochemicals;
(-)-3,4-DIHYDROXY NOREPHEDRINE
CAS:829-74-3
Formula: C9H13NO3
D454000
OC1=C(O)C=CC([C@@H](O)[C@@H](N)C)=C1
Standards; Ephedrine; Pharmaceutical/API Drug Impurities/Metabolites; Phenethylamines/Amphetamines;
(-)-3-ACETYL-1,3-THIAZOLIDINE-4-CARBOXYLIC ACID
CAS:24877-72-3
Formula: C6H9NO3S
A298455
CC(=O)N1CSCC1C(=O)O
(-)-3-CARBOXY-2,2,5,5-TETRAMETHYLPYRROLIDINYL-1-OXY
CAS:68354-47-2
Formula: C9H16NO3
C182750
[O]N1C(C)(C)C[C@H](C(O)=O)C1(C)C
Research Tools; Spin Labels;
(-)-3-CHLORO-N-(A-METHYLPHENETHYL)-PROPIONAMIDE
CAS:15269-41-7
Formula: C12H16NOCl
C378583
CC(CC1=CC=CC=C1)NC(=O)CCCl
Building Blocks; Miscellaneous;
(-)-3-DEHYDRO SHIKIMIC ACID
CAS:2922-42-1
Formula: C7H8O5
D230475
O=C1[C@@H](O)[C@H](O)CC(C(O)=O)=C1
Building Blocks; Chiral Molecules;
(-)-3-EPIMUSCARINE CHLORIDE
CAS:35119-40-5
Formula: C9H20ClNO2
E588880
C[C@@H]1[C@H](O)C[C@H](C[N+](C)(C)C)O1.[Cl-]
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(-)-3-EPIMUSCARINE-D9 CHLORIDE
Formula: C9H11D9ClNO2
E588882
C[C@@H]1[C@H](O)C[C@H](C[N+](C([2H])([2H-])[2H])(C
Standards; Isotopic Labeled Analogues; Pharmaceutical/API Drug Impurities/Metabolites;
(-)-3-METHOXY BUTORPHANOL
CAS:63730-48-3
Formula: C22H31NO2
M261255
COC1=CC2=C(C[C@@H]3[C@]4([C@@]2(CCCC4)CCN3CC5CCC5)
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(-)-3-METHOXY BUTORPHANOL 6-ETHYLENE KETAL
CAS:67753-31-5
Formula: C24H33NO4
M261270
COC1=CC2=C(C[C@@H]3[C@]4([C@]2(CCN3CC5CCC5)CC6(CC4
Standards; Pharmaceutical/API Drug Impurities/Metabolites; Controlled Substances and Drugs of Abuse for Forensic Testing;
(-)-3-METHOXY BUTORPHANOL-D6
CAS:1329610-46-9
Formula: C22H25D6NO2
M261257
[2H]C1(C[C@]2([C@H]3CC4=C([C@@]2(CCN3CC5CCC5)C(C1(
Standards; Isotopic Labeled Analogues; Pharmaceutical/API Drug Impurities/Metabolites;
(-)-3-METHOXY-6-OXO BUTORPHANOL
CAS:67753-29-1
Formula: C22H29NO3
M265260
COC1=CC2=C(C[C@@H]3[C@]4([C@]2(CCN3CC5CCC5)CC(=O)C
Standards; Pharmaceutical/API Drug Impurities/Metabolites; Controlled Substances and Drugs of Abuse for Forensic Testing;
(-)-4'-FLUOROTARTRANILIC ACID
CAS:238401-54-2
Formula: C10H10NO5F
F598733
C1=C(C=CC(=C1)NC(=O)[C@H]([C@@H](C(=O)O)O)O)F
Building Blocks; Miscellaneous;
(-)-4'-METHYLTARTRANILIC ACID
CAS:206761-78-6
Formula: C11H13NO5
M263713
CC1=CC=C(C=C1)NC(=O)[C@H]([C@@H](C(=O)O)O)O
Building Blocks; Miscellaneous;
(-)-4'-NITROTARTRANILIC ACID
CAS:206761-80-0
Formula: C10H10N2O7
N572338
C1=C(C=CC(=C1)[N+](=O)[O-])NC(=O)[C@H]([C@@H](C(=O
Building Blocks; Miscellaneous;
(-)-5'-DMH-CBD
CAS:97452-63-6
Formula: C25H38O2
D494153
CC1=C[C@@H](C2=C(O)C=C(C(C)(C)CCCCCC)C=C2O)[C@H](C
Standards; Chiral Molecules; Enzyme Activators and Inhibitors; Controlled Substances and Drugs of Abuse for Forensic Testing; Cannabis Constituents;
(-)-5-AMINOBENZOVESAMICOL
CAS:141436-23-9
Formula: C21H26N2O
A141430
O[C@H](CC1=CC=C2)[C@H](N3CCC(C4=CC=CC=C4)CC3)CC1=C
Research Tools; Molecular Biology;
(-)-5-DEOXY-STRIGOL
CAS:1259948-84-9
Formula: C19H22O5
D231715
O=C(/C1=C/O[C@H](C=C2C)OC2=O)O[C@]3([H])[C@@]1([H]
Standards; Enzyme Activators and Inhibitors; Environmental Standards, Mutagens and Metabolites;
(-)-5-EPI CP 55,940
Formula: C24H40O3
C781615
CC(CCCCCC)(C1=CC=C([C@@H]2C[C@@H](O)CC[C@H]2CCCO)C
Standards; Pharmaceutical/API Drug Impurities/Metabolites; Controlled Substances and Drugs of Abuse for Forensic Testing; Cannabis Constituents;
(-)-8,9-DIHYDROXY-8,9-DIHYDROBENZ[A]ANTHRACENE
CAS:72522-86-2
Formula: C18H14O2
D452995
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(-)-8-PHENYLMENTHOL
CAS:65253-04-5
Formula: C16H24O
P295305
Building Blocks; Chiral Molecules;
(-)-8-PRENYLNARINGENIN
CAS:53846-50-7
Formula: C20H20O5
P712890
NCCCC[C@H](N)C(N[C@H](C)CC1=CC=CC=C1)=O.[2HCl]
Standards; Food;
(-)-9-DEME-DTBZ
CAS:1065193-41-0
Formula: C18H27NO3
D230740
OC1=C(OC)C=C2C(CCN(C[C@H](CC(C)C)[C@@H](O)C3)[C@]2
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(-)-A-[1-(DIBUTYLAMINO)ETHYL]BENZYL ALCOHOL
CAS:114389-70-7
Formula: C17H29NO
A575908
CCCCN(CCCC)[C@H](C)[C@H](C1=CC=CC=C1)O
Building Blocks; Chiral Molecules;
(-)-A-ACETYLMETHADOL HYDROCHLORIDE
CAS:1477-40-3
Formula: C23H31NO2 • HCl
A186325
CC[C@H](OC(C)=O)C(C1=CC=CC=C1)(C2=CC=CC=C2)C[C@@H]
Standards; Neurochemicals; Pharmaceutical/API Drug Impurities/Metabolites; Controlled Substances and Drugs of Abuse for Forensic Testing; Methadones/Synthetic Opiates;
(-)-A-ACETYLMETHADOL HYDROCHLORIDE (1.0MG/ML IN ACETONITRILE)
CAS:43033-72-3
Formula: C23H31NO2 • HCl
KIT2720
CC[C@@H](C(C[C@H](C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2
Standards; Solutions; Kits;
(-)-A-ACETYLMETHADOL-D3 HYDROCHLORIDE
Formula: C23H29D3ClNO2
A186327
[2H]C([2H])([2H])C[C@H](OC(C)=O)C(C1=CC=CC=C1)(C2=
Standards; Isotopic Labeled Analogues; Pharmaceutical/API Drug Impurities/Metabolites; Controlled Substances and Drugs of Abuse for Forensic Testing;
(-)-A-BENIDIPINE HYDROCHLORIDE
CAS:129262-07-3
Formula: C28H32ClN3O6
B157490
O=C(C1=C(C)NC(C)=C(C(OC)=O)[C@H]1C2=CC([N+]([O-])=
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(-)-A-CEDRENE (MAJOR, CONTAINS (+)-SS-CEDRENE)
CAS:469-61-4
Formula: C15H24
C364863
C[C@H]1[C@@](C[C@]2([H])C3(C)C)(CC=C2C)[C@@]3([H])
Standards; Chiral Molecules;
(-)-A-KAINIC ACID
CAS:487-79-6
Formula: C10H15NO4
K135010
Standards; Chiral Molecules; Enzyme Activators and Inhibitors; Neurochemicals; Pharmaceutical/API Drug Impurities/Metabolites;
(-)-A-KAINIC ACID LITHIUM SALT
Formula: C10H14LiNO4
K135015
C=C(C)[C@@H]1[C@H](CC(O[Li])=O)[C@@H](C(O)=O)N([H]
Standards; Chiral Molecules; Enzyme Activators and Inhibitors; Neurochemicals; Pharmaceutical/API Drug Impurities/Metabolites;
(-)-A-KAINIC ACID MONOHYDRATE
CAS:58002-62-3
Formula: C10H17NO5
K445000
C[C@H]1OC(=O)C[C@@H]2[C@H](OC)[C@@H](O[C@H]3C(O)C(
Building Blocks; Miscellaneous;
(-)-A-METHADOL
CAS:14019-10-4
Formula: C21H29NO
M225861
CC[C@@H](C(C[C@H](C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2
Standards; Neurochemicals; Pharmaceutical/API Drug Impurities/Metabolites; Controlled Substances and Drugs of Abuse for Forensic Testing; Opiates; Methadones/Synthetic Opiates;
(-)-A-METHYLBENZYL ISOTHIOCYANATE
CAS:24277-44-9
Formula: C9H9NS
M456850
C[C@@H](N=C=S)C1=CC=CC=C1
Building Blocks; Chiral Molecules;
(-)-A-METHYLDOPA HYDROCHLORIDE
CAS:884-39-9
Formula: C10H14ClNO4
M102133
C[C@](CC1=CC(=C(C=C1)O)O)(C(=O)O)N.Cl
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(-)-A-NARCOTINEDIOL
CAS:23942-99-6
Formula: C22H27NO7
N378890
Standards; Pharmaceutical/API Drug Impurities/Metabolites; Natural Products;
(-)-A-NORACETYLMETHADOL HYDROCHLORIDE
CAS:55096-75-8
Formula: C22H30ClNO2
N660600
CC[C@@H](C(C[C@H](C)NC)(C1=CC=CC=C1)C2=CC=CC=C2)OC
Standards; Neurochemicals; Pharmaceutical/API Drug Impurities/Metabolites; Controlled Substances and Drugs of Abuse for Forensic Testing; Methadones/Synthetic Opiates;
(-)-A-NORACETYLMETHADOL-D3 HYDROCHLORIDE
Formula: C22H27D3ClNO2
N660602
[2H]C([2H])([2H])C[C@H](OC(C)=O)C(C1=CC=CC=C1)(C2=
Standards; Isotopic Labeled Analogues; Pharmaceutical/API Drug Impurities/Metabolites; Controlled Substances and Drugs of Abuse for Forensic Testing;
(-)-A-SANTALENE
CAS:512-61-8
Formula: C15H24
S115065
C/C(C)=C\CC[C@]1(C)C2(C)[C@H]3C2CC1C3
Standards; Chiral Molecules; Natural Products;
(-)-ACTINONIN
CAS:13434-13-4
Formula: C19H35N3O5
A192000
OC[C@@H]1CCCN1C([C@H](C(C)C)NC([C@H](CC(NO)=O)CCCC
Standards; Chiral Molecules; Enzyme Activators and Inhibitors; Others; Pharmaceutical/API Drug Impurities/Metabolites; Antibotics;
(-)-ACYLFULVENE
CAS:125392-76-9
Formula: C14H16O2
A852960
CC(C1(CC1)[C@@](O)(C2=O)C)=C3C2=CC(C)=C3
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(-)-ADENOSINE 3'-MONOPHOSPHATE HYDRATE
CAS:699012-36-7
Formula: C10H16N5O8P
A212550
C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3
(-)-AGELOXIME D
CAS:1219817-25-0
Formula: C26H40N5O
A430035
CN1C=[N+](C/C=C(C)/CC[C@H]2[C@@](CCCC3(C)C)(C)[C@]
Standards; Antibotics; Natural Products;
(-)-ALTENUENE
CAS:889101-41-1
Formula: C15H16O6
A575740
O=C1C2=C(O)C=C(OC)C=C2C3=C[C@@H](O)[C@H](O)C[C@@]3
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(-)-AMBROXIDE
CAS:6790-58-5
Formula: C16H28O
A575915
[H][C@]1(CCO2)[C@@]2(C)CC[C@]3([H])[C@]1(C)CCCC3(C
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(-)-ANATOXIN A
CAS:92142-32-0
Formula: C10H15NO
A637415
O=C(C)C1=CCCC2([H])CC[C@]1([H])N2
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(-)-ANYMOL
CAS:78148-59-1
Formula: C15H26O
A697860
C[C@]([C@@]1(CCC(C)=CC1)[H])(CC/C=C(C)\C)O
Standards; Natural Products; Extracted;
(-)-ARGEMONINE
CAS:6901-16-2
Formula: C21H25NO4
A769760
CN1[C@]2([H])C3=C(C=C(OC)C(OC)=C3)C[C@@]1([H])C4=C
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(-)-ARTERENOL BITARTRATE SALT
CAS:51-40-1
Formula: C8H11NO3 • (C4H6O6)
A614163
OC([C@H](O)[C@@H](O)C(O)=O)=O.NC[C@H](O)C1=CC(O)=C
Standards; Enzyme Activators and Inhibitors; Pharmaceutical/API Drug Impurities/Metabolites;
(-)-ASARININ
CAS:133-05-1
Formula: C20H18O6
A780155
C1C2C(COC2C3=CC4=C(C=C3)OCO4)C(O1)C5=CC6=C(C=C5)OC
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(-)-ASCOFURANONE
CAS:38462-04-3
Formula: C23H29ClO5
A787035
O=CC1=C(O)C(C/C=C(C)/CC/C=C([C@H](C2)OC(C)(C)C2=O)
Standards; Enzyme Activators and Inhibitors; Pharmaceutical/API Drug Impurities/Metabolites; Antibotics;
(-)-B-METHOXYDIISOPINOCAMPHEYLBORANE HYDRATE
CAS:85134-98-1
Formula: C21H37BO • x(H2O)
M269740
CC1[C@H]2C[C@H](C2(C)C)C[C@H]1B(OC)C3CC4CC(C4(C)C)
Building Blocks; Chiral Molecules;
(-)-BENZOTETRAMISOLE
CAS:950194-37-3
Formula: C15H12N2S
B130425
C1=CC=C(C=C1)[C@H]2CN3C4=CC=CC=C4SC3=N2
Building Blocks; Chiral Molecules;
(-)-BENZYLMETHYLPHENYLSILYLACETIC ACID
CAS:95349-35-2
Formula: C16H18O2Si
B535523
C[Si](CC1=CC=CC=C1)(CC(=O)O)C2=CC=CC=C2
Building Blocks; Chiral Molecules;
(-)-BICIFADINE HYDROCHLORIDE
CAS:66504-88-9
Formula: C12H16ClN
B382245
CC1=CC=C(C=C1)C23CC2CNC3.Cl
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(-)-BICUCULLINE METHOBROMIDE
CAS:73604-30-5
Formula: C21H20BrNO6
B382513
C[N+]1(C)CCC2=CC3=C(OCO3)C=C2C1C4C5=C(C(O4)=O)C6=C
Standards; Molecular Biology; Enzyme Activators and Inhibitors;
(-)-BICUCULLINE METHOCHLORIDE
CAS:53552-05-9
Formula: C21H20ClNO6
B382510
CCCC(=O)O[C@]1(C(=O)COC(C)=O)[C@]2(C)[C@H](CC1)[C@
Research Tools;
(-)-BIOTIN SULFOXIDE
CAS:3376-83-8
Formula: C10H16N2O4S
B389045
O=C1N[C@@H]2[C@@H]([C@H](CCCCC(O)=O)S(C)(C)C2)N1.[
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(-)-BIS[(S)-1-PHENYLETHYL]AMINE
CAS:56210-72-1
Formula: [C6H5CH(CH3)]2NH
B016004
C[C@@H](C1=CC=CC=C1)N[C@@H](C)C2=CC=CC=C2
(-)-BORNEOL
CAS:464-45-9
Formula: C10H18O
B675545
O[C@H]1CC2CC[C@]1(C)C2(C)C
Building Blocks; Pharmaceutical/API Drug Impurities/Metabolites;
(-)-BORNEOL-D3
Formula: C10H15D3O
B675546
O[C@@]1([2H])C([2H])([2H])C2CC[C@]1(C)C2(C)C
Standards; Isotopic Labeled Analogues; Pharmaceutical/API Drug Impurities/Metabolites;
(-)-BORNYL ACETATE
CAS:5655-61-8
Formula: C12H20O2
B675530
CC1(C)[C@]2(C)CC[C@H]1C[C@H]2OC(C)=O
Building Blocks; Pharmaceutical/API Drug Impurities/Metabolites;
(-)-BORNYL FERULATE
CAS:55511-07-4
Formula: C20H26O4
B675550
O=C(/C=C/C1=CC=C(O)C(OC)=C1)O[C@H]2C[C@H]3CC[C@]2(
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(-)-BREMAZOCINE HYDROCHLORIDE
CAS:74100-60-0
Formula: C20H30ClNO2
B677350
OC1=CC([C@@](CCN2CC3(O)CC3)(CC)C(C)(C)C2C4)=C4C=C1
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(-)-BUTACLAMOL HYDROCHLORIDE
CAS:55528-08-0
Formula: C25H32ClNO
B690463
CC(C)(C)[C@](CC1)(O)C[C@](N1C2)([H])C3=CC=CC4=C3[C
Research Tools; Standards; Molecular Biology;
(-)-BUTORPHANOL
CAS:42408-82-2
Formula: C21H29NO2
B690550
C1CC[C@]2([C@H]3CC4=C([C@]2(C1)CCN3CC5CCC5)C=C(C=C
Standards; Pharmaceutical/API Drug Impurities/Metabolites; Controlled Substances and Drugs of Abuse for Forensic Testing;
(-)-BUTORPHANOL-D6
CAS:1287084-97-2
Formula: C21H23D6NO2
B690552
O[C@]1([C@H]2C3)[C@@](C([2H])([2H])C([2H])([2H])C(
Standards; Chiral Molecules; Isotopic Labeled Analogues; Pharmaceutical/API Drug Impurities/Metabolites; Controlled Substances and Drugs of Abuse for Forensic Testing; Natural Products;
(-)-CAFEDRINE
CAS:58166-83-9
Formula: C18H23N5O3
C799035
O=C(N1C)N(C)C2=C(N(CCN[C@@H](C)[C@H](O)C3=CC=CC=C3
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(-)-CAMPHENE
CAS:5794-04-7
Formula: C10H16
C173135
CC1([C@@H](CC2)C[C@@H]2C1=C)C
Building Blocks; Miscellaneous;
(-)-CAMPHENE-13C,D2 (MAJOR)
Formula: C913CH14D2
C173136
CC1(C)[C@H]2CC[C@@H](C1=C([2H])[2H])C2
Building Blocks; Isotopic Labeled Analogues;
(-)-CAMPHENILONE
CAS:50896-19-0
Formula: C9H14O
C173130
O=C1[C@@H]2CC[C@@H](C2)C1(C)C
Building Blocks; Miscellaneous;
(-)-CANADALISOL
CAS:123878-19-3
Formula: C21H25NO5
C175195
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(-)-CANADALISOL-D3
Formula: C21H22D3NO5
C175197
[H][C@@]1(CC2=C(CO)C(OC)=C(OC)C=C2)N(C([2H])([2H])
Standards; Isotopic Labeled Analogues; Pharmaceutical/API Drug Impurities/Metabolites;
(-)-CANDIDONE
CAS:77727-18-5
Formula: C22H24O4
C175208
O=C(N1N=C(OC)N(C)C1=O)N([Na])S(=O)(C2=CC=CC=C2OC(F
Standards; Food;
(-)-CARBOVIR
CAS:120443-30-3
Formula: C11H13N5O2
C177685
O=C(N=C(N)N1)C2=C1N([C@H]3C=C[C@@H](CO)C3)C=N2
Standards; Enzyme Activators and Inhibitors; Pharmaceutical/API Drug Impurities/Metabolites;
(-)-CARBOVIR-5’-TRIPHOSPHATE TRIETHYLAMMONIUM SALT
Formula: C11H16N5O11P3 • (C6H15N)x
C177970
CCN(CC)CC.O=P(OP(O)(OP(O)(O)=O)=O)(O)OC[C@H]1C[C@@
Building Blocks; Enzyme Activators and Inhibitors; Pharmaceutical/API Drug Impurities/Metabolites;
(-)-CATECHIN
CAS:18829-70-4
Formula: C15H14O6
C217505
OC1=CC2=C(C[C@@H](O)[C@H](C3=CC=C(O)C(O)=C3)O2)C(O
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(-)-CATECHIN GALLATE
CAS:130405-40-2
Formula: C22H18O10
C217510
O=C(C1=CC(O)=C(O)C(O)=C1)O[C@H]2[C@H](C3=CC(O)=C(O
Standards; Chiral Molecules; Enzyme Activators and Inhibitors; Pharmaceutical/API Drug Impurities/Metabolites;
(-)-CHOLESTEROL NHS SUCCINATE
CAS:88848-79-7
Formula: C35H53NO6
C274095
C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H
(-)-CIS-2-BENZAMIDOCYCLOHEXANECARBOXYLIC ACID
CAS:26693-55-0
Formula: C14H17NO3
B201928
C1CC[C@@H]([C@@H](C1)C(=O)O)NC(=O)C2=CC=CC=C2
Building Blocks; Chiral Molecules;
(-)-CIS-2-BENZYLAMINOCYCLOHEXANEMETHANOL
CAS:71581-93-6
Formula: C14H21NO
B411175
C1=CC=C(C=C1)CN[C@@H]2CCCC[C@@H]2CO
Building Blocks; Chiral Molecules;
(-)-CIS-5-METHYL-L-PROLINE
CAS:38533-38-9
Formula: C6H11NO2
M338555
O=C(O)[C@H]1N[C@@H](C)CC1
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(-)-CIS-ANTI-N2-BPDE-DG
CAS:66113-73-3
Formula: C30H27N5O7
B676635
OC(=O)CO/N=C1c2c(ccc(O)c2)[C@@H]3[C@@H](C/1)[C@H]4
Standards; Pharmaceutical/API Drug Impurities/Metabolites; Environmental Standards, Mutagens and Metabolites;
(-)-CIS-ANTI-N2-BPDE-DG-D8
Formula: C30H19D8N5O7
B676637
O[C@@H]1C[C@@H]2[C@H](CC1)[C@H]3[C@@H](CC2)[C@@H]4
Standards; Isotopic Labeled Analogues; Pharmaceutical/API Drug Impurities/Metabolites; Environmental Standards, Mutagens and Metabolites;
(-)-CIS-PENTAZOCINE
CAS:7488-49-5
Formula: C19H27NO
P274295
Nc1cc2c(cc1)NC(=O)c3c(ccc(Cl)c3)O2
Standards; Pharmaceutical/API Drug Impurities/Metabolites; Controlled Substances and Drugs of Abuse for Forensic Testing;
(-)-CIS-PENTAZOCINE N-OXIDE
Formula: C19H27NO2
P274325
OC1=CC2=C(C=C1)C[C@@H]([C@@H](C)[C@@]2(C)CC3)N3(C/
Standards; Pharmaceutical/API Drug Impurities/Metabolites; Controlled Substances and Drugs of Abuse for Forensic Testing;
(-)-CITRININ
CAS:518-75-2
Formula: C13H14O5
C523500
C[C@H]1[C@H](C)OC=C2C1=C(C)C(=O)C(=C2O)C(=O)O
Standards; Chiral Molecules; Others; Pharmaceutical/API Drug Impurities/Metabolites; Antibotics;
(-)-CITRININ 4,5-BIS(TRIDEUTEROMETHYL)
Formula: C13H8D6O5
C523502
O=C1C(C(O)=O)=C(O)C2=CO[C@H](C)[C@@H](C([2H])([2H]
Standards; Isotopic Labeled Analogues; Pharmaceutical/API Drug Impurities/Metabolites; Antibotics;
(-)-CITRONELLAL
CAS:5949-05-3
Formula: C10H18O
C525050
C/C(C)=C\CC[C@H](C)CC=O
Building Blocks; Miscellaneous;
(-)-COCLAURINE HYDROCHLORIDE
CAS:3422-42-2
Formula: C17H20ClNO3
C633550
COC1=C(C=C2C(=C1)CCN[C@H]2CC3=CC=C(C=C3)O)O.Cl
Standards; Pharmaceutical/API Drug Impurities/Metabolites; Phenethylamines/Amphetamines;
(-)-COREY LACTONE
CAS:31752-99-5
Formula: C21H20O5
C695000
C1[C@H]2[C@H](CC(=O)O2)[C@H]([C@@H]1OC(=O)C3=CC=C(
Building Blocks; Chiral Molecules; Pharmaceutical/API Drug Impurities/Metabolites;
(-)-COREY LACTONE BENZOATE
CAS:39746-00-4
Formula: C15H16O5
C694990
C1=CC=C(C=C1)C(=O)O[C@@H]2C[C@H]3[C@H](CC(=O)O3)[C
Building Blocks; Pharmaceutical/API Drug Impurities/Metabolites;
(-)-COREY LACTONE DIOL
CAS:32233-40-2
Formula: C8H12O4
C694995
Building Blocks; Chiral Molecules;
(-)-CORYNANTHEIDINE
CAS:23407-35-4
Formula: C22H28N2O3
C685605
[H][C@@]12N(C[C@@H](CC)[C@@H](/C(C(OC)=O)=C\OC)C2)
Standards; Natural Products;
(-)-COUMACHLOR
CAS:70888-76-5
Formula: C19H15ClO4
C725060
OC(C1=CC=CC=C1O2)=C([C@@H](CC(C)=O)C3=CC=C(Cl)C=C3
Standards; Chiral Molecules; Environmental Standards, Mutagens and Metabolites; Pesticides;
(-)-CP 55,940 (10 MG/ML IN METHANOL)
CAS:83002-04-4
Formula: C24H40O3
C781410
CCCCCCC(C)(C)c1ccc(c(O)c1)[C@@H]1C[C@H](O)CCC1CCCO
Standards; Pharmaceutical/API Drug Impurities/Metabolites; Controlled Substances and Drugs of Abuse for Forensic Testing;
(-)-CP-47947
CAS:114753-51-4
Formula: C21H34O2
C781325
O[C@H]1C[C@@H](C2=CC=C(C(C)(C)CCCCCC)C=C2O)CCC1
Standards; Pharmaceutical/API Drug Impurities/Metabolites; Controlled Substances and Drugs of Abuse for Forensic Testing; JWH Compounds/Synthetic Cannabinoids;
(-)-CYCLAZOCINE
CAS:7313-86-2
Formula: C18H25NO
C987740
CC1[C@@H]2CC3=C([C@@]1(CCN2CC4CC4)C)C=C(C=C3)O
Standards; Chiral Molecules; Pharmaceutical/API Drug Impurities/Metabolites; Benzomorphans;
(-)-CYCLAZOCINE-D3
Formula: C18H22D3NO
C987742
OC1=CC2=C(C=C1)C[C@H]3N(C([2H])([2H])C4([2H])CC4)C
Standards; Isotopic Labeled Analogues; Pharmaceutical/API Drug Impurities/Metabolites;
(-)-DEHYDRO GRISEOFULVIN
CAS:3573-90-8
Formula: C17H15ClO6
D229940
CC1=CC(=O)C=C([C@]12C(=O)C3=C(O2)C(=C(C=C3OC)OC)Cl
Standards; Chiral Molecules; Pharmaceutical/API Drug Impurities/Metabolites;
(-)-DEOXOPROSOPHYLLINE
CAS:74843-69-9
Formula: C18H37NO2
D231515
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(-)-DEOXYFEBRIFUGINE DIHYDROBROMIDE
CAS:1820023-30-0
Formula: C16H21Br2N3O2
D232215
O=C1C2=CC=CC=C2N=CN1CC(C[C@@H]3NCCCC3)=O.[2HBr]
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(-)-DEOXYHALOFEBRIFUGINE DIHYDROBROMIDE
CAS:1819989-18-8
Formula: C16H19Br3ClN3O2
D232225
BrC1=C(Cl)C=C(C(N(CC(C[C@H]2CCCCN2)=O)C=N3)=O)C3=C
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(-)-DEPUDECIN
CAS:139508-73-9
Formula: C11H16O4
D289313
C[C@@H](O)[C@H](O1)[C@@H]1/C=C/[C@H](O2)[C@@H]2[C@
Building Blocks; Miscellaneous;
(-)-DESETHYL METHYL ETODOLAC
CAS:109518-50-5
Formula: C16H19NO3
D289485
CCC1=C2C(C(CCO[C@@]3(CC(O)=O)C)=C3N2)=CC=C1
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(-)-DI-TERT-BUTYL D-TARTRATE
CAS:117384-46-0
Formula: C12H22O6
D679390
CC(C)(C)OC(=O)[C@H]([C@@H](C(=O)OC(C)(C)C)O)O
Building Blocks; Miscellaneous;
(-)-DIACETYL-L-TARTARIC ACID
CAS:51591-38-9
Formula: C8H10O8
D366015
OC([C@H](OC(C)=O)[C@@H](OC(C)=O)C(O)=O)=O
Standards; Chiral Molecules; Food; Carbohydrates and Oligosaccharides; Semi-Synthetic;
(-)-DIBENZOYL-L-TARTARIC ACID MONOHYDRATE
CAS:62708-56-9
Formula: C18H14O8 • H2O
D422815
C1=CC=C(C=C1)C(=O)O[C@H]([C@H](C(=O)O)OC(=O)C2=CC=
Building Blocks; Miscellaneous;
(-)-DIHYDROAFLATOXIN CARBOXALDEHYDE D2-D3
Formula: C12H9D3O5
D443106
OC1=C(C=O)C([C@@](CCO2)([H])[C@@]2([H])O3)=C3C=C1O
Building Blocks; Isotopic Labeled Analogues; Miscellaneous;
(-)-DIHYDROAFLATOXIN D2
CAS:6795-22-8
Formula: C11H12O4
D495330
OC1=C2[C@@]3([H])[C@@](OCC3)([H])OC2=CC(OC)=C1
Standards; Chiral Molecules; Pharmaceutical/API Drug Impurities/Metabolites; Natural Products;
(-)-DIHYDROAFLATOXIN D2-D3
Formula: C11H9D3O4
D495332
OC1=C2[C@@]3([H])[C@@](OCC3)([H])OC2=CC(OC([2H])([
Standards; Chiral Molecules; Isotopic Labeled Analogues; Pharmaceutical/API Drug Impurities/Metabolites; Natural Products;
(-)-DIHYDROAPOVINCAMINIC ACID ETHYL ESTER
CAS:57327-92-1
Formula: C22H28N2O2
D448350
O=C(OCC)[C@]1([H])N2C3=CC=CC=C3C4=C2[C@](N5CC4)([H
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(-)-DIHYDROQUININE
CAS:522-66-7
Formula: C20H26N2O2
D449915
[H][C@@]1(CC)C2C[C@]([C@H](O)C3=CC=NC4=CC=C(OC)C=C
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(-)-DIHYDROTHEBAINONE
CAS:847-86-9
Formula: C18H23NO3
D449820
CN1CC[C@]23CC(=O)CC[C@H]2[C@H]1CC4=C3C(=C(C=C4)OC)
Standards; Pharmaceutical/API Drug Impurities/Metabolites; Controlled Substances and Drugs of Abuse for Forensic Testing;
(-)-DIISOPINOCAMPHEYLBORANE
CAS:21932-54-7
Formula: C20H35B
D455353
OC[C@@H]1[C@H](O)C[C@H](N2C(NC(C(COC)=C2)=O)=O)O1
Building Blocks; Catalyst;
(-)-DIISOPROPYL-L-MALATE
CAS:83541-68-8
Formula: C10H18O5
D492865
CC(C)OC(=O)C[C@@H](C(=O)OC(C)C)O
Building Blocks; Chiral Molecules;
(-)-DIMENTHYL FUMARATE
CAS:34675-24-6
Formula: C24H40O4
D460205
O=C(/C=C/C(O[C@@H]1C[C@H](C)CC[C@H]1C(C)C)=O)O[C@H
Building Blocks; Chiral Molecules;
(-)-DIMETHYL 2,3-O-ISOPROPYLIDENE-L-TARTRATE
CAS:37031-29-1
Formula: C9H14O6
D474240
O=C(OC)[C@@H]1OC(C)(C)O[C@H]1C(OC)=O
Building Blocks; Chiral Molecules;
(-)-DIOP
CAS:32305-98-9
Formula: C31H32O2P2
D494003
CC1(OC(CP(C2=CC=CC=C2)C3=CC=CC=C3)(C(CP(C4=CC=CC=C
Building Blocks; Miscellaneous;
(-)-DIPIVALOYL-L-TARTARIC ACID
CAS:65259-81-6
Formula: C14H22O8
D493210
CC(C)(C)C(=O)O[C@H]([C@H](C(=O)O)OC(=O)C(C)(C)C)C(
Building Blocks; Chiral Molecules;
(-)-DONEPEZIL
CAS:142057-80-5
Formula: C24H29NO3
D531765
O=C1[C@@H](CC2CCN(CC3=CC=CC=C3)CC2)CC4=C1C=C(OC)C(
Building Blocks; Enzyme Activators and Inhibitors; Pharmaceutical/API Drug Impurities/Metabolites;
(-)-EBURNAMONINE
CAS:4880-88-0
Formula: C19H22N2O
E320600
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(-)-ECGONINE HYDROCHLORIDE
CAS:5796-31-6
Formula: C9H16ClNO3
E325550
CN1[C@H]2CC[C@@H]1[C@H]([C@H](C2)O)C(=O)O.Cl
Standards; Stimulant; Pharmaceutical/API Drug Impurities/Metabolites; Controlled Substances and Drugs of Abuse for Forensic Testing; Ecgonines/Cocaine Derivatives;
(-)-ECGONINE-D3 HYDROCHLORIDE
CAS:115144-41-7
Formula: C9H13D3ClNO3
E325552
O[C@@H]1[C@H](C(O)=O)[C@H]2CC[C@@H](C1)N2C([2H])([
Standards; Isotopic Labeled Analogues; Neurochemicals; Stimulant; Pharmaceutical/API Drug Impurities/Metabolites; Controlled Substances and Drugs of Abuse for Forensic Testing; Ecgonines/Cocaine Derivatives;
(-)-EMTRICITABINE O-B-D-GLUCURONIDE
CAS:152128-78-4
Formula: C14H18FN3O9S
E209515
C1[C@H](O[C@H](S1)CO[C@H]2[C@@H]([C@H]([C@@H]([C@H
(-)-EPIAFZELECHIN
CAS:24808-04-6
Formula: C15H14O5
E716000
O[C@@H]1CC2=C(O)C=C(O)C=C2O[C@@H]1C3=CC=C(O)C=C3
(-)-EPIBATIDINE
Formula: C11H13ClN2
E582210
[H]C1(C2=CN=C(Cl)C=C2)CC3CC[C@@H]1N3
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(-)-EPICATECHIN
CAS:490-46-0
Formula: C15H14O6
E582260
O[C@H]1[C@@H](C2=CC=C(O)C(O)=C2)OC(C=C(O)C=C3O)=C3
Standards; Chiral Molecules; Enzyme Activators and Inhibitors; Pharmaceutical/API Drug Impurities/Metabolites;
(-)-EPICATECHIN GALLATE
CAS:1257-08-5
Formula: C22H18O10
E582265
C1C(C(OC2=CC(=CC(=C21)O)O)C3=CC(=C(C=C3)O)O)OC(=O)
Standards; Chiral Molecules; Pharmaceutical/API Drug Impurities/Metabolites;
(-)-EPICATECHIN GALLATE-13C3
Formula: C1913C3H18O10
E582267
OC1=CC(O)=C([13CH2][13C@@H](OC(C2=CC(O)=C(O)C(O)=C
Standards; Isotopic Labeled Analogues; Pharmaceutical/API Drug Impurities/Metabolites;
(-)-EPICATECHIN-13C2D2
Formula: C1313C2H12D2O6
E582264
OC1=CC(O)=C([13C]([2H])([2H])[C@@H](O)[13C@@H](C2=
Standards; Isotopic Labeled Analogues; Pharmaceutical/API Drug Impurities/Metabolites;
(-)-EPICATECHIN-13C3
Formula: C1213C3H14O6
E582262
OC1=CC(O)=C([13CH2][13C@@H](O)[13C@@H](C2=CC=C(O)C
Standards; Isotopic Labeled Analogues; Enzyme Activators and Inhibitors; Pharmaceutical/API Drug Impurities/Metabolites;
(-)-EPICATECHIN-3'-O-GLUCURONIDE
CAS:603133-91-1
Formula: C21H22O12
E582335
O[C@H]1[C@@H](C2=CC(O[C@@H]([C@@H]([C@@H](O)[C@@H]
Standards; Carbohydrates and Oligosaccharides; Natural Products;
(-)-EPICATECHIN-5-SULFATE
CAS:1194377-44-0
Formula: C15H14O9S
E583260
O[C@H]1[C@@H](C2=CC(O)=C(O)C=C2)OC3=CC(O)=CC(OS(O)
(-)-EPICATECHIN-7-SULFATE
CAS:1194378-94-3
Formula: C15H14O9S
E583265
O[C@H]1[C@@H](C2=CC(O)=C(O)C=C2)OC3=CC(OS(O)(=O)=O
(-)-EPICATECHIN-D5
Formula: C15H9D5O6
E582268
OC1=C(O)C([2H])=C([2H])C([C@@H]2[C@H](O)CC3=C(O)C(
Building Blocks; Isotopic Labeled Analogues;
(-)-EPIGALLOCATECHIN
CAS:970-74-1
Formula: C15H14O7
E588490
C1=C(C=C(C(=C1O)O)O)[C@@H]2[C@@H](CC3=C(C=C(C=C3O2
Standards; Enzyme Activators and Inhibitors;
(-)-EPIGALLOCATECHIN GALLATE
CAS:989-51-5
Formula: C22H18O11
E588500
OC1=CC(O)=C(C[C@@H](OC(C2=CC(O)=C(O)C(O)=C2)=O)[C@
Standards; Enzyme Activators and Inhibitors;
(-)-EPIGALLOCATECHIN GALLATE-13C3
Formula: C1913C3H18O11
E588503
OC1=CC(O)=C([13CH2][13C@@H](OC(C2=CC(O)=C(O)C(O)=C
Standards; Isotopic Labeled Analogues; Enzyme Activators and Inhibitors; Pharmaceutical/API Drug Impurities/Metabolites;
(-)-EPIGALLOCATECHIN GALLATE-D3/D4
Formula: C22H15D3O11
E588502
OC1=C([H])C(O)=C(C[C@@H](OC(C2=C([2H])C(O)=C(O)C(O
Building Blocks; Isotopic Labeled Analogues; Enzyme Activators and Inhibitors;
(-)-EPIGALLOCATECHIN GALLATE-D4
Formula: C22H14D4O11
E588501
OC1=C([H])C(O)=C(C[C@@H](OC(C2=C([2H])C(O)=C(O)C(O
(-)-EPIGALLOCATECHIN-13C3
Formula: C1213C3H14O7
E588492
OC1=CC(O)=C([13CH2][13C@@H](O)[13C@@H](C2=CC(O)=C(
Standards; Isotopic Labeled Analogues; Pharmaceutical/API Drug Impurities/Metabolites;
(-)-EPIGALLOCATECHIN-GALLATE
CAS:989-51-5
Formula: C22H18O11
E585928
OC1=CC(O)=C(C[C@@H](OC(C2=CC(O)=C(O)C(O)=C2)=O)[C@
(-)-ERINACIN A
CAS:180854-04-0
Formula: C25H36O6
E600095
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(-)-ERINACIN A-D3
Formula: C25H33D3O6
E600097
O[C@@H]1[C@@H](O)[C@H](O)CO[C@H]1O[C@H]2[C@@](C3=C
Standards; Isotopic Labeled Analogues; Pharmaceutical/API Drug Impurities/Metabolites;
(-)-ESERMETHOLE
CAS:65166-97-4
Formula: C14H20N2O
E887800
CN1[C@](N(C)CC2)([H])[C@]2(C)C3=C1C=CC(OC)=C3
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(-)-ESEROLINE FUMARATE SALT
CAS:70310-73-5
Formula: C13H18N2O • (C4H4O4)
E889163
OC(/C=C/C(O)=O)=O.OC1=CC=C2C([C@@]([C@@]3([H])N2C)
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(-)-ESTRA-4,9-DIENE-3,17-DIONE
CAS:5173-46-6
Formula: C18H22O2
E668550
C[C@@]12CCC3=C4CCC(=O)C=C4CC[C@H]3[C@@H]2CCC1=O
Standards; Steroids; Pharmaceutical/API Drug Impurities/Metabolites; Controlled Substances and Drugs of Abuse for Forensic Testing;
(-)-ETHYL L-LACTATE
CAS:687-47-8
Formula: C5H10O3
E921970
Building Blocks; Chiral Molecules; Miscellaneous;
(-)-FARREROL
CAS:24211-30-1
Formula: C17H16O5
F101070
CC1=C(C(=C2C(=C1O)C(=O)C[C@@H](C3=CC=C(C=C3)O)O2)C
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(-)-GALANTHAMINYL (-)-CAMPHANATE
CAS:1025881-27-9
Formula: C27H33NO6
G188561
CN1CC2=C3[C@@]4(C=C[C@H](OC([C@]5(CC6)OC([C@@]6(C)
Standards; Miscellaneous;
(-)-GALLOCATECHIN GALLATE
CAS:4233-96-9
Formula: C22H18O11
G188985
OC1=CC(O)=C(C[C@@H](OC(C2=CC(O)=C(O)C(O)=C2)=O)[C@
Standards; Chiral Molecules;
(-)-GRINDELIC ACID
CAS:1438-57-9
Formula: C20H32O3
G786800
CC(CC(C)(C)C)=C
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(-)-HALOSALINE
CAS:26648-71-5
Formula: C10H21NO
H012330
O[C@@H](CC1CCCCN1)CCC
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(-)-HORSFILINE
CAS:136247-72-8
Formula: C13H16N2O2
H669630
O=C(O)C1=CC(C(C)=O)=CN1
Standards; Natural Products;
(-)-HUPERZINE A
CAS:102518-79-6
Formula: C15H18N2O
H826000
N[C@@]1(C(C=C2)=C(C[C@@H]/3C=C(C)C1)NC2=O)C3=C\C
Standards; Enzyme Activators and Inhibitors; Pharmaceutical/API Drug Impurities/Metabolites;
(-)-HUPERZINE A-D6 (MAJOR)
Formula: C15H12D6N2O
H826002
N[C@@]1(C(C=C2[2H])=C(C([2H])([2H])[C@@H]/3C([2H])
Building Blocks; Enzyme Activators and Inhibitors; Pharmaceutical/API Drug Impurities/Metabolites;
(-)-HUPERZINE A-D7 MAJOR (>90%)
Formula: C15H11D7N2O
H826006
N[C@@]1(C(C=C2[2H])=C(C([2H])([2H])[C@@H]/3C([2H])
Building Blocks; Enzyme Activators and Inhibitors; Pharmaceutical/API Drug Impurities/Metabolites;
(-)-HYCOSAMINE
CAS:101-31-5
Formula: C17H23NO3
H674300
CN1[C@H]2CC[C@@H]1C[C@H](OC([C@@H](C3=CC=CC=C3)CO)
Standards; Enzyme Activators and Inhibitors; Pharmaceutical/API Drug Impurities/Metabolites; Ecgonines/Cocaine Derivatives;
(-)-HYCOSAMINE-D3
Formula: C17H20D3NO3
H674302
O=C([C@@H](C1=CC=CC=C1)CO)O[C@H]2C[C@H]3CC[C@@H](C
Standards; Isotopic Labeled Analogues; Enzyme Activators and Inhibitors; Pharmaceutical/API Drug Impurities/Metabolites; Ecgonines/Cocaine Derivatives;
(-)-INDOLACTAM V
CAS:90365-57-4
Formula: C17H23N3O2
I577325
O=C(N[C@@H](CO)C1)[C@](C(C)C)([H])N(C)C2=CC=CC3=C2
Building Blocks; Chiral Molecules;
(-)-INDOLACTAM V-D8
Formula: C17H15D8N3O2
I577327
O=C(N[C@H](CO)C1)[C@@](C([2H])(C([2H])([2H])[2H])C
Standards; Isotopic Labeled Analogues; Pharmaceutical/API Drug Impurities/Metabolites;
(-)-INOSINE
CAS:58-63-9
Formula: C10H12N4O5
I661000
OC1=NC=NC2=C1N=CN2[C@@H]3O[C@H](CO)[C@@H](O)[C@H]3
Standards; Nucleic Acids; Pharmaceutical/API Drug Impurities/Metabolites;
(-)-INOSINE DEHYDROXY-N-(6-IMINOHEXYL)-2,2,2-TRIFLUOROACETAMIDE
Formula: C18H25F3N6O5
I661005
CO[C@@H]1[C@H](OC(C2=CC=CC=C2)=O)[C@@H](COC(C3=CC=
Standards; Miscellaneous;
(-)-INOSINE DEHYDROXY-N-(6-IMINOHEXYL)-2,2,2-TRIFLUOROACETAMIDE PHOSPHATE
Formula: C18H26F3N6O8P
I661010
FC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)
Standards; Miscellaneous;
(-)-INOSINE DEHYDROXY-N-(6-IMINOHEXYL)-2,2,2-TRIFLUOROACETAMIDE PHOSPHO-MORPHOLINE
Formula: C22H33F3N7O9P
I661015
BrC1=C(Br)C=C2OC3=CC(Cl)=C(Cl)C=C3OC2=C1
Standards; Miscellaneous;
(-)-INOSINE-1',2',3',4',5'-13C5
Formula: C513C5H12N4O5
I661003
OC1=NC=NC2=C1N=CN2[13C@@H]3O[13C@H]([13CH2]O)[13C@
Standards; Chiral Molecules; Isotopic Labeled Analogues; Pharmaceutical/API Drug Impurities/Metabolites; Carbohydrates and Oligosaccharides;
(-)-INOSINE-13C2,15N
Formula: C813C2H12N315NO5
I661002
OC1=NC=N[13C]2=[13C]1[15N]=CN2[C@@H]3O[C@H](CO)[C@
Standards; Isotopic Labeled Analogues; Pharmaceutical/API Drug Impurities/Metabolites;
(-)-ISOCORYPALMINE
CAS:483-34-1
Formula: C20H23NO4
I798000
COC1=CC=C2C[C@H]3C4=CC(=C(C=C4CCN3CC2=C1OC)OC)O
Standards; Chiral Molecules; Pharmaceutical/API Drug Impurities/Metabolites;
(-)-ISOMENTHONE (~80%)
CAS:18309-28-9
Formula: C10H18O
M199560
O=C1[C@H](C(C)C)CC[C@H](C)C1
Standards; Miscellaneous;
(-)-ISOPERITENONE
CAS:80995-97-7
Formula: C10H14O
I824035
O=C1C=C(C)CC[C@@H]1C(C)=C
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(-)-ISOPINOCAMPHEOL
CAS:1206968-90-2
Formula: C10H18O
I779190
C1=C(C=NC(=C1C(F)(F)F)CO)Br
Building Blocks; Miscellaneous;
(-)-ISOPROTERENOL (+)-BITARTRATE SALT
CAS:54750-10-6
Formula: C11H17NO3 • C4H6O6
I874213
CC(C)NC[C@H](O)C1=CC(O)=C(C=C1)O.OC([C@@H]([C@H](C
Standards; Chiral Molecules; Pharmaceutical/API Drug Impurities/Metabolites;
(-)-ISOPROTERENOL HYDROCHLORIDE
CAS:5984-95-2
Formula: C11H17NO3 • HCl
I870080
OC1=C(O)C=C(C(O)CNC(C)C)C=C1.Cl
Standards; Chiral Molecules; Pharmaceutical/API Drug Impurities/Metabolites; Phenethylamines/Amphetamines;
(-)-ISOPULEGOL
CAS:89-79-2
Formula: C10H18O
I874650
C[C@H]1C[C@@H](O)[C@H](C(C)=C)CC1
Standards; Food;
(-)-ISOSAMIDIN
CAS:53023-18-0
Formula: C21H22O7
S110505
[Na+].CCC(C)C(=O)C(=O)[O-]
Standards; Chiral Molecules; Pharmaceutical/API Drug Impurities/Metabolites;
(-)-ISOXANTHOHUMOL
CAS:70872-29-6
Formula: C21H22O5
I918235
CC(=CCC1=C2C(=C(C=C1O)OC)C(=O)C[C@@H](C3=CC=C(C=C3
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(-)-JASMONIC ACID METHYL ESTER
CAS:1211-29-6
Formula: C13H20O3
J210535
O=C1CC[C@H](CC(OC)=O)[C@H]1C/C=C\CC
Standards; Environmental Standards, Mutagens and Metabolites;
(-)-JQ1
CAS:1268524-71-5
Formula: C23H25ClN4O2S
J973153
CC1=C(C)C(C(C2=CC=C(Cl)C=C2)=N[C@@H]3CC(OC(C)(C)C)
(-)-KETO CYCLAZOCINE
CAS:36292-69-0
Formula: C18H23NO2
K187500
OC1=CC([C@](CCN2CC3CC3)(C)[C@@H](C)C2C4=O)=C4C=C1
Standards; Pharmaceutical/API Drug Impurities/Metabolites; Controlled Substances and Drugs of Abuse for Forensic Testing;
(-)-KETOCONAZOLE
CAS:142128-57-2
Formula: C26H28Cl2N4O4
K186025
CC(N1CCN(C2=CC=C(OC[C@H]3O[C@@](C4=CC=C(Cl)C=C4Cl)
Standards; Enzyme Activators and Inhibitors; Pharmaceutical/API Drug Impurities/Metabolites;
(-)-LENTIGINOSINE
CAS:125279-72-3
Formula: C8H15NO2
L329000
O[C@@H]1CN2CCCC[C@]2([H])[C@H]1O
Standards; Enzyme Activators and Inhibitors; Pharmaceutical/API Drug Impurities/Metabolites;
(-)-LICARIN B
CAS:51020-87-2
Formula: C20H20O4
L246595
C/C=C/C1=CC2=C(C(=C1)OC)O[C@H]([C@@H]2C)C3=CC4=C(C
(-)-LIMONENE
CAS:5989-54-8
Formula: C10H16
L461745
Standards; Food;
(-)-LIMONENE 2,3,3,5,5,-D5
Formula: C10H11D5
L461749
CC([C@H]1C([2H])([2H])CC(C)=C([2H])C1([2H])[2H])=C
Standards; Chiral Molecules; Isotopic Labeled Analogues; Pharmaceutical/API Drug Impurities/Metabolites;
(-)-LUPININE
CAS:486-70-4
Formula: C10H19NO
L478018
OC[C@@H]1CCCN2CCCC[C@H]12
Standards; Natural Products;
(-)-LY-338979
Formula: C20H21N5O7
L486660
O=C(N[C@H](C(O)=O)CCC(O)=O)C1=CC=C(CC[C@@H](C(N2)=
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(-)-LYCORINE
CAS:476-28-8
Formula: C16H17NO4
L214300
C1CN2CC3=CC4=C(C=C3[C@H]5[C@H]2C1=C[C@@H]([C@H]5O)
(-)-LYONIRESINOL 9'-O-GLUCOSIDE
CAS:143236-02-6
Formula: C28H38O13
L208585
COC1=CC(=CC(=C1O)OC)[C@H]2[C@@H]([C@H](CC3=CC(=C(C
(-)-MAACKIAIN
CAS:2035-15-6
Formula: C16H12O5
M214390
C1[C@@H]2[C@H](C3=C(O1)C=C(C=C3)O)OC4=CC5=C(C=C24)
(-)-MARMESIN
CAS:495-32-9
Formula: C14H14O4
M000225
CC(C)(O)[C@H](O1)CC2=C1C=C(OC(C=C3)=O)C3=C2
Standards; Pharmaceutical/API Drug Impurities/Metabolites;